CN107287106A - The novel method and system of detection of nucleic acids are carried out using quantitative PCR and digital pcr - Google Patents
The novel method and system of detection of nucleic acids are carried out using quantitative PCR and digital pcr Download PDFInfo
- Publication number
- CN107287106A CN107287106A CN201710681242.5A CN201710681242A CN107287106A CN 107287106 A CN107287106 A CN 107287106A CN 201710681242 A CN201710681242 A CN 201710681242A CN 107287106 A CN107287106 A CN 107287106A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- droplet
- biological sample
- detection zone
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 282
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 279
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 279
- 238000001514 detection method Methods 0.000 title claims abstract description 234
- 238000000034 method Methods 0.000 title claims abstract description 147
- 238000003753 real-time PCR Methods 0.000 title abstract description 20
- 239000012472 biological sample Substances 0.000 claims description 263
- 238000006243 chemical reaction Methods 0.000 claims description 251
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 220
- 230000003321 amplification Effects 0.000 claims description 218
- 239000012530 fluid Substances 0.000 claims description 170
- 230000003287 optical effect Effects 0.000 claims description 96
- 239000000523 sample Substances 0.000 claims description 96
- 230000033001 locomotion Effects 0.000 claims description 25
- 238000005286 illumination Methods 0.000 claims description 21
- 238000012937 correction Methods 0.000 claims description 11
- 239000013598 vector Substances 0.000 claims description 11
- 230000008878 coupling Effects 0.000 claims description 10
- 238000010168 coupling process Methods 0.000 claims description 10
- 238000005859 coupling reaction Methods 0.000 claims description 10
- 239000003086 colorant Substances 0.000 claims description 9
- 238000013519 translation Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 description 170
- 108020004414 DNA Proteins 0.000 description 152
- 238000004519 manufacturing process Methods 0.000 description 134
- 239000013615 primer Substances 0.000 description 131
- 239000003153 chemical reaction reagent Substances 0.000 description 99
- 229920002477 rna polymer Polymers 0.000 description 94
- 239000000376 reactant Substances 0.000 description 84
- 239000007788 liquid Substances 0.000 description 76
- 238000004925 denaturation Methods 0.000 description 70
- 230000036425 denaturation Effects 0.000 description 70
- 239000000047 product Substances 0.000 description 70
- 239000003795 chemical substances by application Substances 0.000 description 66
- 230000004087 circulation Effects 0.000 description 62
- -1 cell or Biomedia Substances 0.000 description 60
- 239000004094 surface-active agent Substances 0.000 description 45
- 239000012139 lysis buffer Substances 0.000 description 42
- 238000010839 reverse transcription Methods 0.000 description 41
- 230000000670 limiting effect Effects 0.000 description 39
- 239000000839 emulsion Substances 0.000 description 38
- 230000008859 change Effects 0.000 description 33
- 230000006854 communication Effects 0.000 description 33
- 238000004891 communication Methods 0.000 description 32
- 238000010367 cloning Methods 0.000 description 30
- 238000011534 incubation Methods 0.000 description 30
- 239000000243 solution Substances 0.000 description 30
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- 239000006228 supernatant Substances 0.000 description 25
- 239000000463 material Substances 0.000 description 24
- 239000003921 oil Substances 0.000 description 24
- 102100034343 Integrase Human genes 0.000 description 23
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 23
- 241000700605 Viruses Species 0.000 description 22
- 239000002609 medium Substances 0.000 description 21
- 238000003752 polymerase chain reaction Methods 0.000 description 21
- 229920000642 polymer Polymers 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 235000014113 dietary fatty acids Nutrition 0.000 description 18
- 239000000975 dye Substances 0.000 description 18
- 239000000194 fatty acid Substances 0.000 description 18
- 229930195729 fatty acid Natural products 0.000 description 18
- 238000012545 processing Methods 0.000 description 18
- 239000002253 acid Substances 0.000 description 17
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 16
- 230000002550 fecal effect Effects 0.000 description 16
- 239000002751 oligonucleotide probe Substances 0.000 description 16
- 229920001223 polyethylene glycol Polymers 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 14
- 239000003995 emulsifying agent Substances 0.000 description 14
- 125000003729 nucleotide group Chemical group 0.000 description 14
- 239000000872 buffer Substances 0.000 description 13
- 239000001963 growth medium Substances 0.000 description 13
- 235000015097 nutrients Nutrition 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 108020004635 Complementary DNA Proteins 0.000 description 12
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 12
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000010804 cDNA synthesis Methods 0.000 description 12
- 239000002299 complementary DNA Substances 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 12
- KDXKERNSBIXSRK-UHFFFAOYSA-N lysine Chemical compound NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 230000004544 DNA amplification Effects 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 239000002202 Polyethylene glycol Substances 0.000 description 11
- 238000005452 bending Methods 0.000 description 11
- 239000007853 buffer solution Substances 0.000 description 11
- 239000000306 component Substances 0.000 description 11
- 150000001875 compounds Chemical class 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 238000007689 inspection Methods 0.000 description 10
- 239000002773 nucleotide Substances 0.000 description 10
- 230000011664 signaling Effects 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 9
- 238000003384 imaging method Methods 0.000 description 9
- 210000004940 nucleus Anatomy 0.000 description 9
- 241000725303 Human immunodeficiency virus Species 0.000 description 8
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 241000607142 Salmonella Species 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 8
- 230000005284 excitation Effects 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- AQZYBQIAUSKCCS-UHFFFAOYSA-N perfluorotripentylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F AQZYBQIAUSKCCS-UHFFFAOYSA-N 0.000 description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 8
- 238000001556 precipitation Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 229920001213 Polysorbate 20 Polymers 0.000 description 7
- 229920001214 Polysorbate 60 Polymers 0.000 description 7
- 229930182558 Sterol Natural products 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 230000002441 reversible effect Effects 0.000 description 7
- 150000003432 sterols Chemical class 0.000 description 7
- 235000003702 sterols Nutrition 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 241001515965 unidentified phage Species 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 239000013616 RNA primer Substances 0.000 description 6
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
- 210000003608 fece Anatomy 0.000 description 6
- 239000007850 fluorescent dye Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 230000003595 spectral effect Effects 0.000 description 6
- 229920000428 triblock copolymer Polymers 0.000 description 6
- 241000701161 unidentified adenovirus Species 0.000 description 6
- 210000002845 virion Anatomy 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 230000004075 alteration Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 229920001400 block copolymer Polymers 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 5
- 239000003398 denaturant Substances 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000010871 livestock manure Substances 0.000 description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 5
- 239000004810 polytetrafluoroethylene Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- 210000003705 ribosome Anatomy 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 150000005846 sugar alcohols Polymers 0.000 description 5
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 4
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000007995 HEPES buffer Substances 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 239000001977 bismuth sulfite agar Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000005336 cracking Methods 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 230000005611 electricity Effects 0.000 description 4
- 238000000835 electrochemical detection Methods 0.000 description 4
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 4
- 229960005542 ethidium bromide Drugs 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000710 homodimer Substances 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 4
- 230000001788 irregular Effects 0.000 description 4
- 239000000787 lecithin Substances 0.000 description 4
- 235000010445 lecithin Nutrition 0.000 description 4
- 229940067606 lecithin Drugs 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 238000001821 nucleic acid purification Methods 0.000 description 4
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 4
- 229940124530 sulfonamide Drugs 0.000 description 4
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 239000012807 PCR reagent Substances 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- GHBFNMLVSPCDGN-UHFFFAOYSA-N caprylic acid monoglyceride Natural products CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 238000011304 droplet digital PCR Methods 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 125000005456 glyceride group Chemical group 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 230000008676 import Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229940070765 laurate Drugs 0.000 description 3
- 238000007834 ligase chain reaction Methods 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- OOHAUGDGCWURIT-UHFFFAOYSA-N n,n-dipentylpentan-1-amine Chemical compound CCCCCN(CCCCC)CCCCC OOHAUGDGCWURIT-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 3
- 238000005382 thermal cycling Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 238000005809 transesterification reaction Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GBWARTHIRIVTNI-PJHQGUKWSA-N (2s)-2,6-diaminohexanoic acid;(2r,3s,4r)-2,3,4,5-tetrahydroxypentanal Chemical compound NCCCC[C@H](N)C(O)=O.OC[C@@H](O)[C@H](O)[C@@H](O)C=O GBWARTHIRIVTNI-PJHQGUKWSA-N 0.000 description 2
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical class CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- OEZPKXDBWNXBRE-UHFFFAOYSA-N 2,3-bis(2-hydroxyethoxy)propyl dodecanoate Chemical class CCCCCCCCCCCC(=O)OCC(OCCO)COCCO OEZPKXDBWNXBRE-UHFFFAOYSA-N 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- QCPFFGGFHNZBEP-UHFFFAOYSA-N 4,5,6,7-tetrachloro-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 QCPFFGGFHNZBEP-UHFFFAOYSA-N 0.000 description 2
- 108700012813 7-aminoactinomycin D Proteins 0.000 description 2
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000282470 Canis latrans Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 241001135265 Cronobacter sakazakii Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 241000725619 Dengue virus Species 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 241001115402 Ebolavirus Species 0.000 description 2
- 241000991587 Enterovirus C Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 208000037262 Hepatitis delta Diseases 0.000 description 2
- 241000724709 Hepatitis delta virus Species 0.000 description 2
- 241000709721 Hepatovirus A Species 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000186781 Listeria Species 0.000 description 2
- 241000186779 Listeria monocytogenes Species 0.000 description 2
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 2
- 239000004425 Makrolon Substances 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000712079 Measles morbillivirus Species 0.000 description 2
- 206010027906 Monocytosis Diseases 0.000 description 2
- 241000202240 Morone americana Species 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 241000224016 Plasmodium Species 0.000 description 2
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 241000315672 SARS coronavirus Species 0.000 description 2
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 108091027967 Small hairpin RNA Proteins 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 108010001244 Tli polymerase Proteins 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 102000006943 Uracil-DNA Glycosidase Human genes 0.000 description 2
- 108010072685 Uracil-DNA Glycosidase Proteins 0.000 description 2
- 241000700647 Variola virus Species 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 108020000999 Viral RNA Proteins 0.000 description 2
- 201000006449 West Nile encephalitis Diseases 0.000 description 2
- 206010057293 West Nile viral infection Diseases 0.000 description 2
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 108010004469 allophycocyanin Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- CZPLANDPABRVHX-UHFFFAOYSA-N cascade blue Chemical compound C=1C2=CC=CC=C2C(NCC)=CC=1C(C=1C=CC(=CC=1)N(CC)CC)=C1C=CC(=[N+](CC)CC)C=C1 CZPLANDPABRVHX-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- TUESWZZJYCLFNL-DAFODLJHSA-N chembl1301 Chemical compound C1=CC(C(=N)N)=CC=C1\C=C\C1=CC=C(C(N)=N)C=C1O TUESWZZJYCLFNL-DAFODLJHSA-N 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 2
- 229960003964 deoxycholic acid Drugs 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 238000006389 diacetylation reaction Methods 0.000 description 2
- 229920000359 diblock copolymer Polymers 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- QVYDJMHVRTXERY-UHFFFAOYSA-N dimorpholin-4-yl hydrogen phosphate Chemical compound C1COCCN1OP(=O)(O)ON1CCOCC1 QVYDJMHVRTXERY-UHFFFAOYSA-N 0.000 description 2
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 229960000878 docusate sodium Drugs 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 230000005518 electrochemistry Effects 0.000 description 2
- CTSPAMFJBXKSOY-UHFFFAOYSA-N ellipticine Chemical compound N1=CC=C2C(C)=C(NC=3C4=CC=CC=3)C4=C(C)C2=C1 CTSPAMFJBXKSOY-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000003682 fluorination reaction Methods 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 229950005911 hydroxystilbamidine Drugs 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 201000006747 infectious mononucleosis Diseases 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 239000002563 ionic surfactant Substances 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 108091070501 miRNA Proteins 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229940067605 phosphatidylethanolamines Drugs 0.000 description 2
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229920005573 silicon-containing polymer Polymers 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000004055 small Interfering RNA Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 230000035322 succinylation Effects 0.000 description 2
- 238000010613 succinylation reaction Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
- 229940045145 uridine Drugs 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 230000010148 water-pollination Effects 0.000 description 2
- XOMRRQXKHMYMOC-NRFANRHFSA-N (3s)-3-hexadecanoyloxy-4-(trimethylazaniumyl)butanoate Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H](CC([O-])=O)C[N+](C)(C)C XOMRRQXKHMYMOC-NRFANRHFSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical class CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical group OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- DUIOKRXOKLLURE-UHFFFAOYSA-N 2-octylphenol Chemical class CCCCCCCCC1=CC=CC=C1O DUIOKRXOKLLURE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 description 1
- VIIIJFZJKFXOGG-UHFFFAOYSA-N 3-methylchromen-2-one Chemical compound C1=CC=C2OC(=O)C(C)=CC2=C1 VIIIJFZJKFXOGG-UHFFFAOYSA-N 0.000 description 1
- DBMJYWPMRSOUGB-UHFFFAOYSA-N 5-hexyl-6-phenylphenanthridin-5-ium-3,8-diamine;iodide Chemical compound [I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCCCCC)=C1C1=CC=CC=C1 DBMJYWPMRSOUGB-UHFFFAOYSA-N 0.000 description 1
- IHHSSHCBRVYGJX-UHFFFAOYSA-N 6-chloro-2-methoxyacridin-9-amine Chemical compound C1=C(Cl)C=CC2=C(N)C3=CC(OC)=CC=C3N=C21 IHHSSHCBRVYGJX-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- 101150037123 APOE gene Proteins 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 102000012440 Acetylcholinesterase Human genes 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- TYBKADJAOBUHAD-UHFFFAOYSA-J BoBo-1 Chemical compound [I-].[I-].[I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC3=[N+](C4=CC=CC=C4S3)C)C=C2)C=C1 TYBKADJAOBUHAD-UHFFFAOYSA-J 0.000 description 1
- UIZZRDIAIPYKJZ-UHFFFAOYSA-J BoBo-3 Chemical compound [I-].[I-].[I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC=CC3=[N+](C4=CC=CC=C4S3)C)C=C2)C=C1 UIZZRDIAIPYKJZ-UHFFFAOYSA-J 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 206010050337 Cerumen impaction Diseases 0.000 description 1
- 102100023336 Chymotrypsin-like elastase family member 3B Human genes 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 101001023092 Condylactis gigantea Delta-actitoxin-Cps1a Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 241001429382 Coxsackievirus A16 Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- 241001289635 Curetis Species 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 108050009160 DNA polymerase 1 Proteins 0.000 description 1
- 102100026816 DNA-dependent metalloprotease SPRTN Human genes 0.000 description 1
- 101710175461 DNA-dependent metalloprotease SPRTN Proteins 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000000666 Fowlpox Diseases 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 108010033128 Glucan Endo-1,3-beta-D-Glucosidase Proteins 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
- ZIXGXMMUKPLXBB-UHFFFAOYSA-N Guatambuinine Natural products N1C2=CC=CC=C2C2=C1C(C)=C1C=CN=C(C)C1=C2 ZIXGXMMUKPLXBB-UHFFFAOYSA-N 0.000 description 1
- 101700012268 Holin Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241000692870 Inachis io Species 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- FGBAVQUHSKYMTC-UHFFFAOYSA-M LDS 751 dye Chemical compound [O-]Cl(=O)(=O)=O.C1=CC2=CC(N(C)C)=CC=C2[N+](CC)=C1C=CC=CC1=CC=C(N(C)C)C=C1 FGBAVQUHSKYMTC-UHFFFAOYSA-M 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241001003141 Lactobacillus prophage Lj928 Species 0.000 description 1
- 101001014650 Lactococcus phage SK1 Baseplate protein gp16 Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- WLLGXSLBOPFWQV-UHFFFAOYSA-N MGK 264 Chemical compound C1=CC2CC1C1C2C(=O)N(CC(CC)CCCC)C1=O WLLGXSLBOPFWQV-UHFFFAOYSA-N 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- 241000532183 Norovirus GI Species 0.000 description 1
- 241000532184 Norovirus GII Species 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- FUJLYHJROOYKRA-QGZVFWFLSA-N O-lauroyl-L-carnitine Chemical compound CCCCCCCCCCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C FUJLYHJROOYKRA-QGZVFWFLSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 1
- QBKMWMZYHZILHF-UHFFFAOYSA-L Po-Pro-1 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)C)C=C1 QBKMWMZYHZILHF-UHFFFAOYSA-L 0.000 description 1
- CZQJZBNARVNSLQ-UHFFFAOYSA-L Po-Pro-3 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)C)C=C1 CZQJZBNARVNSLQ-UHFFFAOYSA-L 0.000 description 1
- BOLJGYHEBJNGBV-UHFFFAOYSA-J PoPo-1 Chemical compound [I-].[I-].[I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC3=[N+](C4=CC=CC=C4O3)C)C=C2)C=C1 BOLJGYHEBJNGBV-UHFFFAOYSA-J 0.000 description 1
- GYPIAQJSRPTNTI-UHFFFAOYSA-J PoPo-3 Chemical compound [I-].[I-].[I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C=CN(CCC[N+](C)(C)CCC[N+](C)(C)CCCN2C=CC(=CC=CC3=[N+](C4=CC=CC=C4O3)C)C=C2)C=C1 GYPIAQJSRPTNTI-UHFFFAOYSA-J 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 241000701550 Pseudoalteromonas virus PM2 Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 108010019653 Pwo polymerase Proteins 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- SUYXJDLXGFPMCQ-INIZCTEOSA-N SJ000287331 Natural products CC1=c2cnccc2=C(C)C2=Nc3ccccc3[C@H]12 SUYXJDLXGFPMCQ-INIZCTEOSA-N 0.000 description 1
- 240000000136 Scabiosa atropurpurea Species 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 241001247837 Streptococcus phage B30 Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 239000001833 Succinylated monoglyceride Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- DPXHITFUCHFTKR-UHFFFAOYSA-L To-Pro-1 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 DPXHITFUCHFTKR-UHFFFAOYSA-L 0.000 description 1
- QHNORJFCVHUPNH-UHFFFAOYSA-L To-Pro-3 Chemical compound [I-].[I-].S1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 QHNORJFCVHUPNH-UHFFFAOYSA-L 0.000 description 1
- MZZINWWGSYUHGU-UHFFFAOYSA-J ToTo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3S2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2S1 MZZINWWGSYUHGU-UHFFFAOYSA-J 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 108010020713 Tth polymerase Proteins 0.000 description 1
- VGQOVCHZGQWAOI-UHFFFAOYSA-N UNPD55612 Natural products N1C(O)C2CC(C=CC(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 description 1
- ULHRKLSNHXXJLO-UHFFFAOYSA-L Yo-Pro-1 Chemical compound [I-].[I-].C1=CC=C2C(C=C3N(C4=CC=CC=C4O3)C)=CC=[N+](CCC[N+](C)(C)C)C2=C1 ULHRKLSNHXXJLO-UHFFFAOYSA-L 0.000 description 1
- ZVUUXEGAYWQURQ-UHFFFAOYSA-L Yo-Pro-3 Chemical compound [I-].[I-].O1C2=CC=CC=C2[N+](C)=C1C=CC=C1C2=CC=CC=C2N(CCC[N+](C)(C)C)C=C1 ZVUUXEGAYWQURQ-UHFFFAOYSA-L 0.000 description 1
- GRRMZXFOOGQMFA-UHFFFAOYSA-J YoYo-1 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC[N+](C)(C)CCC[N+](C)(C)CCC[N+](C1=CC=CC=C11)=CC=C1C=C1N(C)C2=CC=CC=C2O1 GRRMZXFOOGQMFA-UHFFFAOYSA-J 0.000 description 1
- JSBNEYNPYQFYNM-UHFFFAOYSA-J YoYo-3 Chemical compound [I-].[I-].[I-].[I-].C12=CC=CC=C2C(C=CC=C2N(C3=CC=CC=C3O2)C)=CC=[N+]1CCC(=[N+](C)C)CCCC(=[N+](C)C)CC[N+](C1=CC=CC=C11)=CC=C1C=CC=C1N(C)C2=CC=CC=C2O1 JSBNEYNPYQFYNM-UHFFFAOYSA-J 0.000 description 1
- CWRILEGKIAOYKP-SSDOTTSWSA-M [(2r)-3-acetyloxy-2-hydroxypropyl] 2-aminoethyl phosphate Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCCN CWRILEGKIAOYKP-SSDOTTSWSA-M 0.000 description 1
- KGUHOFWIXKIURA-VQXBOQCVSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl dodecanoate Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCC)O[C@@H]1O[C@@]1(CO)[C@@H](O)[C@H](O)[C@@H](CO)O1 KGUHOFWIXKIURA-VQXBOQCVSA-N 0.000 description 1
- BQODPTQLXVVEJG-UHFFFAOYSA-N [O].C=C Chemical compound [O].C=C BQODPTQLXVVEJG-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- BGLGAKMTYHWWKW-UHFFFAOYSA-N acridine yellow Chemical compound [H+].[Cl-].CC1=C(N)C=C2N=C(C=C(C(C)=C3)N)C3=CC2=C1 BGLGAKMTYHWWKW-UHFFFAOYSA-N 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- VGQOVCHZGQWAOI-HYUHUPJXSA-N anthramycin Chemical compound N1[C@@H](O)[C@@H]2CC(\C=C\C(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-HYUHUPJXSA-N 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 201000009310 astigmatism Diseases 0.000 description 1
- 238000007846 asymmetric PCR Methods 0.000 description 1
- JPNZKPRONVOMLL-UHFFFAOYSA-N azane;octadecanoic acid Chemical class [NH4+].CCCCCCCCCCCCCCCCCC([O-])=O JPNZKPRONVOMLL-UHFFFAOYSA-N 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical class OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 210000002939 cerumen Anatomy 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 239000007805 chemical reaction reactant Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- 108700043024 cholylsarcosine Proteins 0.000 description 1
- ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- GLNDAGDHSLMOKX-UHFFFAOYSA-N coumarin 120 Chemical class C1=C(N)C=CC2=C1OC(=O)C=C2C GLNDAGDHSLMOKX-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 229920005570 flexible polymer Polymers 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical class O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940074046 glyceryl laurate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000007999 glycylglycine buffer Substances 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 108091006086 inhibitor proteins Proteins 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000007852 inverse PCR Methods 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 229940059904 light mineral oil Drugs 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 229940040452 linolenate Drugs 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-M linolenate Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC([O-])=O DTOSIQBPPRVQHS-PDBXOOCHSA-M 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 108010056929 lyticase Proteins 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000001006 meconium Anatomy 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000007269 microbial metabolism Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000007856 miniprimer PCR Methods 0.000 description 1
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- VMCOQLKKSNQANE-UHFFFAOYSA-N n,n-dimethyl-4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]aniline Chemical compound C1=CC(N(C)C)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 VMCOQLKKSNQANE-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- SNQQPOLDUKLAAF-UHFFFAOYSA-N nonylphenol Chemical class CCCCCCCCCC1=CC=CC=C1O SNQQPOLDUKLAAF-UHFFFAOYSA-N 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000005311 nuclear magnetism Effects 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- NJCBUSHGCBERSK-UHFFFAOYSA-N perfluoropentane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F NJCBUSHGCBERSK-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000005053 phenanthridines Chemical class 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229960003171 plicamycin Drugs 0.000 description 1
- 238000013001 point bending Methods 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000008389 polyethoxylated castor oil Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 125000004424 polypyridyl Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940101027 polysorbate 40 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229960000286 proflavine Drugs 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 108010043524 protease E Proteins 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- APTZNLHMIGJTEW-UHFFFAOYSA-N pyraflufen-ethyl Chemical compound C1=C(Cl)C(OCC(=O)OCC)=CC(C=2C(=C(OC(F)F)N(C)N=2)Cl)=C1F APTZNLHMIGJTEW-UHFFFAOYSA-N 0.000 description 1
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical class CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 239000002342 ribonucleoside Substances 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- 238000002174 soft lithography Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940114926 stearate Drugs 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 235000019327 succinylated monoglyceride Nutrition 0.000 description 1
- 229940032085 sucrose monolaurate Drugs 0.000 description 1
- 229940035023 sucrose monostearate Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 238000007861 thermal asymmetric interlaced PCR Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000004634 thermosetting polymer Substances 0.000 description 1
- 238000000427 thin-film deposition Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- XJCQPMRCZSJDPA-UHFFFAOYSA-L trimethyl-[3-[4-[(e)-(3-methyl-1,3-benzothiazol-2-ylidene)methyl]pyridin-1-ium-1-yl]propyl]azanium;diiodide Chemical compound [I-].[I-].S1C2=CC=CC=C2N(C)\C1=C\C1=CC=[N+](CCC[N+](C)(C)C)C=C1 XJCQPMRCZSJDPA-UHFFFAOYSA-L 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical class [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention provides the novel method and system that detection of nucleic acids is carried out for quantitative PCR and digital pcr.
Description
Background technology
Nucleic acid amplification method allows selectively to expand and identify core interested from complex mixture such as biological sample
Acid.In order to detect the nucleic acid in biological sample, generally biological sample is handled, with from the other components of biological sample and its
He may interfere with other materials of nucleic acid and/or amplification and isolates nucleic acid.Core interested is being isolated from biological sample
, can be for example, by amplification method, the method (for example, polymerase chain reaction (PCR)) such as based on thermal cycle, to interested after acid
Nucleic acid expanded.After nucleic acid interested is expanded, amplified production can be detected, and detection knot is understood by end user
Really.However, when needing to carry out multiple or multiple amplified reactions, methods described is probably cumbersome, tediously long and inefficiency.
Have been reported and deliver droplets on as the chemistry and biochemical reaction in container progress confined volume (for example, nucleic acid expands
Increase), and developed a variety of methods to generate such droplet.However, these technologies generally differ with droplet size, group
Into different, relatively low flux, and/or the problems such as monodispersity droplet can not be generated.
The content of the invention
This area is present for analyzing quick, the accurate and high-throughout preparation of the nucleic acid from complex sample type, method
With the demand of device.This method and apparatus can be used for, for example, realizing rapid sample-response detection (sample to
Answer detection) and reply can be by the disease of its detection of nucleic acids.
The invention provides for effectively amplification of nucleic acid, such as RNA and DNA molecular method and system are particularly used for
With the method and system of a large amount of different nucleic acid molecules of high flux and/or parallel amplification and analysis.The nucleic acid product of amplification can be rapid
Ground is detected with high sensitive.
In one aspect, the invention provides a kind of target nucleic acid for being used to identify the biological sample for obtain since subject
The presence or absence of molecule, or relative quantity method.Methods described may include:(a) generate emulsion, the emulsion comprising fluorinated oil,
Electric liquid and the surfactant based on bay ether, wherein the emulsion includes multiple droplets, the droplet includes (i)
Multiple nucleic acid molecules of the biological sample from the subject, and (ii) carry out DNA (DNA) amplification and
Reagent needed for optional reverse transcription amplification;(b) the multiple nucleic acid molecules in the multiple droplet are being enough to produce
The DNA cloning is carried out under conditions of the amplified production of the multiple nucleic acid molecules;And (c) detection comes from the multiple small liquid
The signal of one or more of drop droplet, wherein the target nucleic acid point in the multiple nucleic acid molecules of the signal designation
The presence or absence of son or relative quantity.
In some embodiments, the DNA cloning is polymerase chain reaction (PCR).
In some embodiments, the biological sample is directly obtained from the subject, without preculture, non-selective
Enrichment, selective enrichment, it is plated on differentiation culture medium, and/or the biomedicine identification of expected property.In some embodiments, institute
State tissue or fluid of the biological sample from the subject.
In some embodiments, the reagent in (a) includes the report agent for generating the signal.In some embodiment party
In case, the intensity of the signal is proportional to the amount of the amplified production of the multiple nucleic acid molecules.In some embodiments
In, the report agent is dyestuff.In some embodiments, the dyestuff is fluorescent dye.
In some embodiments, the droplet is encapsulated in the aqueous phase of oil phase, wherein the aqueous phase is comprising described
Multiple nucleic acid molecules and the reagent.
In some embodiments, the droplet is stable at a temperature of higher than 95 DEG C, does not deform or closes
And.
In some embodiments, be contained in the multiple droplet the multiple nucleic acid molecules it is un-extracted and/or
Purifying.
In some embodiments, the emulsion by by aqueous first fluid and non-aqueous second fluid mix come
Generation.In some embodiments, the emulsion is by the way that aqueous first fluid and non-aqueous second fluid are mixed to produce
Raw mixture, then is vortexed to generate to the mixture.
In some embodiments, the electric liquid is electrically insulating liquid.In some embodiments, the electronics liquid
Body is the liquid based on fluorohydrocarbon.In some embodiments, the electric liquid includes perfluor triamylamine.
In some embodiments, the surfactant based on bay ether is glycolic polyoxyethanyl bay ether.
In some embodiments, the emulsion also includes another surfactant.In some embodiments, another surface
Activating agent is polyoxyethylene sorbitan monolaurate.
In some embodiments, wherein (b) includes carry out reverse transcription amplification parallel with the DNA cloning.In some realities
Apply in scheme, the multiple nucleic acid molecules are carried out with reverse transcription amplification to produce complementary DNA (cDNA) point wherein (b) includes (i)
Son, and (ii) carry out the DNA cloning parallel with the reverse transcription amplification to produce at least one subset of the cDNA molecules
The amplified production.
In some embodiments, methods described also includes exporting the information on the amount of the amplified production to reception
Person.In some embodiments, wherein described information is used as report output.
In one aspect, the invention provides a kind of target nucleic acid for being used to identify the biological sample for obtain since subject
The presence or absence of molecule, or relative quantity system.The system may include:Droplet maker, it generates emulsion, the emulsion
Surfactant comprising fluorinated oil, electric liquid and based on bay ether, wherein the emulsion includes multiple droplets, it is described small
Drop includes multiple nucleic acid molecules of the described biological sample of (i) from the subject, and (ii) carries out DNA
(DNA) amplification and the reagent needed for optional reverse transcription amplification;Controller, it operationally connects with the droplet maker
Connect, the multiple nucleic acid molecules in the multiple droplet are being enough to produce institute wherein the controller is programmed to (i)
State and carry out the DNA cloning under conditions of the amplified production of multiple nucleic acid molecules;And (ii) detection comes from the multiple small liquid
The signal of one or more of drop droplet, wherein the target nucleic acid point in the multiple nucleic acid molecules of the signal designation
The presence or absence of son or relative quantity.
In some embodiments, the system further comprises detector, and the detector is used to detect the signal,
Wherein described controller is operably coupled to the detector, and manipulates the detector detection signal.
In some embodiments, the emulsion by by aqueous first fluid and non-aqueous second fluid mix come
Generation.In some embodiments, the emulsion is by the way that aqueous first fluid and non-aqueous second fluid are mixed to produce
Raw mixture, then is vortexed to generate to the mixture.
In some embodiments, the electric liquid is electrically insulating liquid.In some embodiments, the electronics liquid
Body is the liquid based on fluorohydrocarbon.In some embodiments, the electric liquid includes perfluor triamylamine.
In some embodiments, the surfactant based on bay ether is glycolic polyoxyethanyl bay ether.
In some embodiments, the emulsion also includes another surfactant.In some embodiments, another surface
Activating agent is polyoxyethylene sorbitan monolaurate.
In some embodiments, the controller is programmed to (i) to the multiple core in the multiple droplet
Acid molecule carries out the DNA cloning under conditions of being enough to produce the amplified production of the multiple nucleic acid molecules, wherein with it is described
The parallel carry out reverse transcription amplification of DNA cloning;And (ii) detection is from one or more of the multiple droplet droplet
Signal, wherein presence or absence or the relative quantity of the target nucleic acid molecule in the multiple nucleic acid molecules of the signal designation.
In some embodiments, the controller is programmed to (i) and carries out reverse transcription expansion to the multiple nucleic acid molecules
Increase to produce complementary DNA (cDNA) molecule, and at least one subset of the cDNA molecules is carried out and the reverse transcription amplification
Parallel DNA cloning is to produce the amplified production;And (ii) detection is from one or more of the multiple droplet
The signal of droplet, wherein presence or absence or the phase of the target nucleic acid molecule in the multiple nucleic acid molecules of the signal designation
To amount.
In some embodiments, the controller also includes output module, and the output module is used for will be on described
The information of the amount of amplified production is exported to recipient.In some embodiments, described information is used as report output.
In one aspect, it is used for the system of droplet or biology sample detection the invention provides a kind of.The system can
Including:Sample holder, it is arranged to detecting that one or more of the subset or the subset of multiple droplets are raw
During thing sample, the multiple droplet is kept along single plane;Detection unit, including:(i) at least one excitaton source, its quilt
It is configured to guide exciting light in multiple detection zones in the single plane into given detection zone, and the inspection of (ii) optics
Survey device, its be arranged in the given detection zone along optical window detect the multiple droplet the subset or
One or more of biological samples;And at least one actuator, it is arranged to make the optical window along described many
Individual detection zone relative movement.
In some embodiments, at least one described actuator is a part for the detection unit.In some implementations
In scheme, at least one described actuator is multiple actuators.In some embodiments, at least one actuator coupling
To the detection unit.In some embodiments, at least one described actuator is coupled to the sample holder.
In some embodiments, the excitaton source of energy is arranged to guide into the exciting light described to regular inspection
Survey region.
In some embodiments, the system may also include one or more computer processors, its operationally coupling
The detection unit and at least one described actuator are bonded to, wherein one or more of computer processors are individually or always
It is programmed for body:(i) at least one described actuator is guided, so as to when the multiple droplet is along the single plane phase
During adjacent to the sample holder so that the optical window is relatively moved along the multiple detection zone, wherein described relative
The optical window is positioned in the given detection zone by movement, and at least one described excitaton source of (ii) guiding swashs described
It is luminous to guide the given detection zone, and (iii) guiding fluorescence detector into detect in the given detection zone
The subset or one or more of biological samples of the multiple droplet in the optical window.
In some embodiments, one or more of computer processors individually or are generally programmed for drawing
At least one described actuator is led, so that each detection along the multiple detection zone of the optical window in order
Region is relatively moved.
In some embodiments, one or more of computer processors individually or are generally programmed for:
(i) at least one illumination correction chart picture is collected from the multiple detection zone using the fluorescence detector, and (ii) uses institute
At least one illumination correction chart picture is stated to compensate or correct the multiple droplet come from the multiple detection zone
Illuminate heterogeneity.
In some embodiments, at least one described excitaton source is multiple excitaton sources.In some embodiments, it is described
Multiple excitaton sources are multiple light emitting diodes (LED).In some embodiments, the multiple LED each LED transmittings are different
The light of frequency.In some embodiments, the multiple LED produces white light.In some embodiments, the multiple excitaton source
Produce the light of multiple color.In some embodiments, the multiple color includes at least three kinds colors.In some embodiments
In, the multiple color includes at least four colors.In some embodiments, the multiple color includes at least five kinds face
Color.
In some embodiments, at least one described excitaton source includes light emitting diode (LED).In some embodiments
In, the LED transmitting boundaries are at 390 nanometers (nm) to the light in 700 nanometer ranges.
In some embodiments, at least one described excitaton source includes radiator.In some embodiments, it is described to dissipate
Hot device is fin.
In some embodiments, at least one described excitaton source includes one or more optical units, for by described in
Exciting light is guided into and/or focused in the given detection zone.In some embodiments, one or more of optics lists
Member includes condenser lens.In some embodiments, one or more of optical units include directional mirror.In some realities
Apply in scheme, the detection unit does not include spectroscope.
In some embodiments, the detection unit further comprises one or more filters, its be used for select by
Given frequency or the light of frequency range that the fluorescence detector is detected.In some embodiments, it is one or many
Individual filter is multiple filters.In some embodiments, the multiple filter includes each filter rotatably selected
Light device.In some embodiments, the fluorescence detector includes charge coupling device (CCD) camera.
In some embodiments, the detection unit is arranged to move along three degree of freedom.In some embodiment party
In case, the detection unit is arranged to along the planar movement parallel to the single plane.In some embodiments, institute
Detection unit is stated to be arranged to along the planar movement for being orthogonal to the single plane.
In some embodiments, the system can further comprise fluid stream unit, and it is arranged to adjacent to institute
Sample holder is stated to provide the multiple droplet.
In some embodiments, at least one described excitaton source, which is oriented to, guides the exciting light into the optical window
Mouthful.In some embodiments, at least one described excitaton source is oriented to is introduced only into the optical window by the exciting light.
In some embodiments, at least one described excitaton source is oriented to guides the exciting light along first axle into, wherein described
Fluorescence detector is oriented to along the second not parallel with first axle axle to detect the subset of the multiple droplet
Or one or more of biological samples.
In some embodiments, the detection unit is arranged to so that the exciting light and the optical window pair
Relatively moved simultaneously in the multiple detection zone.
In one aspect, it is used for the method for droplet or biology sample detection the invention provides a kind of.Methods described can
Including:(a) detecting system is activated, the detecting system includes a. sample holders, it is arranged to detecting multiple small liquid
During one or more of the subset of drop or the subset biological sample, the multiple droplet is kept along single plane;b.
Detection unit, including:(i) at least one excitaton source, it is arranged to guide into exciting light multiple in the single plane
Given detection zone in detection zone, and (ii) fluorescence detector, it is arranged to the edge in the given detection zone
Optical window detects the subset or one or more of biological samples of the multiple droplet;C. at least one is activated
Device, it is arranged to make the optical window relatively move along the multiple detection zone;And (b) is at least one described in
Individual actuator, so as to when the multiple droplet along the single plane adjacent to the sample holder when so that the light
Learn window to relatively move along the multiple detection zone, wherein the optical window is positioned at described give by the relative movement
In detection zone, (c) guides the exciting light into the given detection zone using at least one described excitaton source;And (d)
The multiple droplet in the optical window in the given detection zone is detected using the fluorescence detector
The subset or one or more of biological samples.
In some embodiments, methods described can further comprise that there is provided adjacent to the sample holder before (b)
The multiple droplet.
In some embodiments, one or more of biological samples include DNA (DNA) molecule.One
In a little embodiments, one or more of biological samples are included in the core of the nucleic acid amplification reaction carried out on template nucleic acid molecule
Sour amplified production.
In some embodiments, methods described can further comprise before (b) so that the template nucleic acid molecule experience
It is sufficient for the condition of the nucleic acid amplification reaction.In some embodiments, when the multiple droplet is adjacent to the sample
During product supporter, the nucleic acid amplification reaction is carried out.In some embodiments, the condition is included the multiple droplet
Temperature circulated between at least two temperature of multiple temperature levels.In some embodiments, the condition is included by described in
The temperature of multiple droplets is maintained within given temperature or given temperature range.
In some embodiments, methods described further comprises at least one described actuator of guiding, so that institute
Each detection zone along the multiple detection zone of optical window in order is stated to relatively move.
In some embodiments, methods described further comprises that (i) uses the fluorescence detector from the multiple inspection
Survey region and collect at least one illumination correction chart picture, and (ii) is compensated or corrected using at least one described illumination correction chart picture
Come from the illumination heterogeneity of the multiple droplet in the multiple detection zone.
In some embodiments, methods described further comprises so that the exciting light and the optical window are for institute
Multiple detection zones are stated to relatively move simultaneously.
In some embodiments, methods described further comprises the subset or described for detecting the multiple droplet
Intensity difference in one or more biological samples.
In some embodiments, methods described further comprises so that the optical window is relative according to priority along track
Mobile, the track includes multiple translation vectors along the multiple detection zone.In some embodiments, it is the multiple flat
Moving vector includes second group of vector that first group of vector is orthogonal to first group of vector.
According to following detailed description, other aspects of the present invention and advantage will become to those skilled in the art
It is clear that the illustrative embodiment of the present invention wherein only has shown and described.It will recognize that, present disclosure can be wrapped
Other and different embodiments are included, and its some details can be modified at multiple obvious aspects, it is all these
All without departing from present disclosure.Correspondingly, accompanying drawing and description will be considered to be illustrative and not restrictive naturally.
Quote and be incorporated to
The all publications, patents and patent applications referred in this specification are both incorporated herein by reference, and its degree is such as
It is same specifically and individually to indicate that each single publication, patent or patent application are incorporated by reference into.
Brief description of the drawings
The novel feature of the present invention is specifically explained in the appended claims.By reference to below to wherein using this
The detailed description and the accompanying drawings (also referred to as " scheming " herein) that the illustrated embodiment of inventive principle is illustrated by, it will obtain
The features and advantages of the present invention are better understood from, in the accompanying drawings:
Fig. 1 is the schematic diagram for depicting example system.
Fig. 2 is the photo of the droplet prepared according to the method for the present invention.
Fig. 3 is the photo that HBV viruses are detected according to the method for the present invention.
Fig. 4 is the top view for describing the detection unit in detecting system of the invention.
Fig. 5 is the schematic diagram for describing the detecting system of the present invention.
Fig. 6 is the bottom view for the detection unit for describing Fig. 4 of the present invention.
Fig. 7 is the schematic diagram for the lightray propagation for describing the detecting system of the present invention.
Fig. 8 is the schematic diagram of the motion track for the optical window for describing the detecting system of the present invention.
Detailed description of the invention
It is aobvious for those skilled in the art although each embodiment of the present invention has been illustrated and described herein
And be clear to, these embodiments are only provided in an illustrative manner.Those skilled in the art are in the situation without departing substantially from the present invention
Down it is contemplated that many changes, change and replacement.It should be appreciated that can be replaced using the various of invention as described herein embodiment
For scheme.
As used in the present specification and claims, singulative " one ", " one kind " and "the" include multiple
Several reference things, unless the context.For example, term " cell " includes multiple cells, including its mixing
Thing.
As used in the present specification and claims, when term " about " is before numerical value is placed in, unless up and down
Text is expressly stated otherwise, and referring to the numerical value can fluctuate no more than 10%.It is no more than for example, the numerical value can fluctuate
10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5% etc..
As it is used herein, term " amplification (amplifying) " and " expanding (amplification) " is interchangeable makes
With, and it is often referred to generate the one or more copies or " amplified production " of nucleic acid.Term " DNA cloning " is often referred to generate DNA
One or more copies of molecule or " DNA product of amplification ".Term " reverse transcription amplification " is often referred to the effect through reverse transcriptase
From ribonucleic acid (RNA) template generation DNA (DNA).
As it is used herein, term " cycle threshold " or " Ct " are often referred to the circulation in Thermal Cycling, in the circulation
In due to caused by amplified production detectable signal increase up to the statistically significant level higher than background signal.
As it is used herein, term " denaturation (denaturing) " and " being denatured (denaturation) " is interchangeable makes
With, and be often referred to the helical structure of double-strandednucleic acid and completely or partially untwist, and refer to single-chain nucleic acid in some cases
Secondary structure is untwisted.Denaturation may include the inactivation of pathogen cells wall or virus coat, and inhibitor protein matter inactivation.
The condition that can be denatured includes " denaturation temperature " and " denaturation duration ", and " denaturation temperature " is often referred to allow what is be denatured
Temperature, " denaturation duration " is often referred to occur the time quantum that denaturation is distributed.
As it is used herein, term " incubation " is often referred under conditions of progress or without vibration and stirring so that
Sample, mixture or solution maintain certain constant temperature section time." incubation temperature " is often referred to allow to be incubated the temperature occurred.
" being incubated the duration " is often referred to distribute to the length for being incubated the time occurred.
As it is used herein, term " extension (elongation) " is often referred to mix nucleotides in the way of template-directed
Enter nucleic acid.Extension can be occurred by means of such as enzyme of polymerase or reverse transcriptase.The condition that can extend includes " prolonging
Stretch temperature " and " extension duration ", " elongating temperature " is often referred to the temperature for allowing to extend, and " extension duration " is usual
Refer to occur the time quantum that extension is distributed.
As it is used herein, term " nucleic acid " is often referred to nucleotides (deoxyribonucleotide or the ribose of any length
The polymerized form of nucleotides or its analog.Nucleic acid can have any three-dimensional structure, and executable any known or unknown
Function.The non-limiting examples of nucleic acid include DNA, RNA, gene or the code area of genetic fragment or noncoding region, by chain point
Analyse the one or more locus determined, extron, introne, mRNA (mRNA), transfer RNA, rRNA, short interference
RNA (siRNA), short hairpin RNA (shRNA), Microrna (miRNA), ribozyme, cDNA, recombinant nucleic acid, branching nucleic acid, plasmid,
Carrier, the DNA of the arbitrary sequence of separation, RNA, nucleic acid probe and the primer of the arbitrary sequence of separation.Nucleic acid can comprising a kind of or
The nucleotides of a variety of modifications, such as methylated nucleotide and nucleotide analog.If it exists, the modification to nucleotide structure
It can be carried out before or after nucleic acid assembling.The nucleotide sequence of nucleic acid can be interrupted by non-nucleotide component.Nucleic acid can be poly-
Further modified after conjunction, such as by being coupled or combining with report agent.
As it is used herein, term " primer extension reaction " is often referred to double-strandednucleic acid denaturation, primer and the nucleic acid of denaturation
One or two chain combinations, then extension primer.In some cases, template nucleic acid can be single in the case of without denaturation
(for example, part is single-stranded) of chain, and primer can be combined in the single-chain nucleic acid, then extension primer.
As it is used herein, term " reactant mixture " is often referred to include for completing nucleic acid amplification (for example, DNA expands
Increase, RNA amplification) necessary to reagent composition, the non-limiting examples of these reagents include having target RNA or target DNA
Specific primer sets, the DNA produced by RNA reverse transcription, archaeal dna polymerase, reverse transcriptase are (for example, the reverse for RNA
Record), suitable buffer solution (including zwitterionic buffer), co-factor (for example, divalence and monovalent cation), dNTP and other
Enzyme (for example, uracil-DNA glycosylase (UNG) etc.).In some cases, reactant mixture can also include one or more
Report agent.
As it is used herein, " report agent " is often referred to produce the composition of detectable signal, the presence of the signal or not
It whether there is in the presence of available for detection amplified production.
As it is used herein, term " target nucleic acid " be often referred to it is in the starter population of nucleic acid molecules, with certain seed nucleus
The nucleic acid molecules of nucleotide sequence, its presence, amount and/or sequence or one of which or multinomial change need to be measured.Target
Nucleic acid can be any kind of nucleic acid, including DNA, RNA and their analog.As it is used herein, " target nucleus ribosomal ribonucleic acid
(RNA) " it is often referred to the target nucleic acid as RNA.As it is used herein, " target DNA (DNA) " is often referred to as DNA
Target nucleic acid.
As it is used herein, term " subject " be often referred to can test or detectable hereditary information entity or
Medium.Subject can be people or individual.Subject can be vertebrate, such as mammal.Mammal it is unrestricted
Property example include mouse, ape and monkey, people, domestic animal, sport animals (sport animal) and pet.Other examples of subject include food
Thing, plant, soil and water.
As it is used herein, term " fluid " is often referred to liquid or gas.Fluid is unable to maintain that the shape of restriction, and
It can be flowed in the time range of observable, so as to fill in the container that it is placed in.Therefore, the fluid can have any allow
Its appropriate viscosity flowed.If there is two or more fluids, every kind of fluid can be selected independently by those skilled in the art
From substantially any fluid (liquid, gas etc.).
As it is used herein, term " aqueous fluids " is often referred to water, by water or from the fluid of water preparation, or comprising
The fluid of water.For example, aqueous fluids can be with the aqueous solution of the water as solvent.The aqueous fluids of the present invention, which can be included, to be used to carry out
The reagent of required chemical reaction (such as polymerase chain reaction (PCR)).The non-limiting example of aqueous fluids includes but not limited
In water and other aqueous solution for including water, such as cell or Biomedia, ethanol, salting liquid.
As it is used herein, term " non-aqueous fluid " be often referred to the liquid except water, by the liquid except water or
From the fluid of the liquid preparation except water.The non-limiting example of non-aqueous fluid includes but is not limited to oil, such as hydro carbons, silicone oil,
Fluorocarbon oil, organic solvent etc..
As it is used herein, term " crossover location " is often referred to a passage through another passage, or and another
Point or region that passage converges.
As it is used herein, term " subregion " is often referred to be split into or the part being distributed as or share.The example of subregion
Including droplet and hole.
As it is used herein, term " droplet " is often referred to the part of the separation of first fluid (such as aqueous fluids),
It is surrounded by second fluid (such as non-aqueous fluid).Emulsion may include first fluid (such as liquid) in second fluid
Dispersion.The first fluid is probably immiscible in the second fluid.In some embodiments, described first
Fluid and the second fluid substantially immiscible.The fluid of the present invention can be spherical, or can use any shape, such as example
Shape with oval cross section.For the droplet of aspherical, its a diameter of and described aspherical droplet has same volume
Perfect mathematics spheroid diameter.The droplet of the present invention can be single emulsion, double emulsion or triple emulsion etc..
Droplet can include skin zone (skin).The skin zone can be formed when droplet is heated.The skin zone it is comparable in
There is higher viscosity inside droplet.In some cases, the skin zone can prevent the droplet from melting with other droplets
Close.
As it is used herein, term " microfluidic device " be often referred to comprising at least one having less than about 10mm, 1mm,
Chip, region, product or the system of the fluid passage of 0.5mm or 0.1mm cross sectional dimensions.
As it is used herein, " cross sectional dimensions " of passage can be substantially square relative to the flow of fluid in the passage
To vertically being measured.
As it is used herein, term " passage " is often referred in device or matrix (such as chip) or the feature in it, its
Flow of fluid is guided at least in part.Passage can have any shape of cross section (circle, ring-type, ellipse, triangle, not advise
Then shape, square or rectangle etc.), and can be covering or unlapped.When passage is completely covered, the passage is extremely
A few part can have the cross section encapsulated completely, or whole passage is encapsulated over the whole length, only its import or export
Or opening exception.The passage of the present invention can be any suitable length.The passage can be it is straight, it is substantially straight, or it can
Including one or more bendings or bending etc..For example, the passage can have snakelike or helical configuration.In some embodiments
In, the passage includes one or more branches, and it is partly or entirely connected with one or more of the other passage.When passage exists
When corner or turning point bending or bending, the corner or turning point can have circular contour, so that fluid or subregion
It will not be trapped at the corner or turning point.
Passage can also have at least about 2:1st, at least about 3:1st, at least about 4:1st, at least about 5:1st, at least about 6:1st, at least about
8:1st, at least about 10:1st, at least about 15:1st, at least about 20:1st, at least about 30:1st, at least about 40:1st, at least about 50:1st, at least about
60:1st, at least about 70:1st, at least about 80:1st, at least about 90:1st, at least about 100:(length is to average horizontal stroke for 1 or higher length-width ratio
The ratio between sectional dimension).Open channel would generally have the feature for being easy to control fluid delivery, such as architectural feature (contracting of extension
Enter), and/or physically or chemically feature (hydrophobicity is to hydrophily), or other can be to the spy of fluid applying power (such as confining force)
Levy.The non-limiting example of the power actuator of suitable power, which can be produced, includes piezo-activator, pressure valve, the electricity for applying AC electric fields
Pole etc..Fluid in passage can partially or even wholly be full of the passage., can be for example using surface when using open channel
Tension force (i.e. protrusion or recessed new lunar surface) is kept fluids in passage.
As it is used herein, term " excitaton source " is often referred to produce exciting with multiple different wave lengths or frequency
Device, equipment or the device of signal, light emitting diode used in embodiment of the invention (" LED ").Here, wavelength
Can be discrete wavelength, and excitation signal can be exciting light.In some embodiments, excitaton source can additionally or can
Selection of land includes one or more optical units, for guiding and/or focusing on exciting light in given detection zone into.
As it is used herein, term " fluorescence detector " is often referred to be applicable the unit or device of detection optical signal,
It is for example including one or more optical units or light propagation path.The unit or device generally include one or many
Individual lens, one or more prisms, IMAQ or acquisition equipment, imaging sensor.IMAQ or acquisition equipment are, for example,
All kinds of cameras (such as charge coupling device (" CCD ") camera), it is alternatively supported adjustment resolution ratio, shoots static or move
Motion video, change burnt poly-, camera lens zoom in or out, changes imaging pattern, the adjustment depth of field, change the time for exposure, adjust visual angle or
The functions such as the visual field.In one embodiment of the invention, fluorescence detector be adapted to detect for coming from sample (for example droplet or
Biological sample) excite produced optical signal through excitaton source, such as various fluorescence or other detectable light, so as to utilize
All kinds of optical detecting methods realize the detection to droplet or biological sample, and optical detecting method here includes but is not limited to
Fluorimetry and UV-Visible absorption.
As it is used herein, term " actuator " is often referred to drive one or more destination objects along one or many
Device, equipment or the mechanism of individual direction movement or rotation.Usual actuator drives mesh by the movement (such as rotating) of itself
Mark the movement of object.Actuator can be driven by various forms of energy in itself, for example electric energy, luminous energy, magnetic energy, heat energy, machine
Tool energy, hydraulic pressure or air pressure.In terms of concrete application, actuator can be all kinds of motors or motor.For example, motor can be certainly
Rectification or outside commutating machine.Motor can also be exchange (AC) or direct current (DC) motor.Motor can include direct-drive motor,
Stepper motor, electrodeless motor or servomotor.Motor may be configured to rotate along single direction, or can be to phase
Anti- direction rotates.In some embodiments of the present invention, actuator can be stepper motor, and can be at least partly
Ground is located in detection unit, or is integrated into detection unit.In some embodiments of the present invention, actuator can be with one
Or multiple computer processor couplings, so as to receive the instruction for coming from computer processor, so that optical window
Relatively move in the detection area.
In one aspect, the invention provides a kind of target nucleic acid for being used to identify the biological sample for obtain since subject
The presence or absence of molecule, or relative quantity method.Methods described may include:(a) generate emulsion, the emulsion comprising fluorinated oil,
Electric liquid and the surfactant based on bay ether, wherein the emulsion includes multiple droplets, the droplet includes (i)
Multiple nucleic acid molecules of the biological sample from the subject, and (ii) carry out DNA (DNA) amplification and
Reagent needed for optional reverse transcription amplification;(b) the multiple nucleic acid molecules in the multiple droplet are being enough to produce
The DNA cloning is carried out under conditions of the amplified production of the multiple nucleic acid molecules;And (c) detection comes from the multiple small liquid
The signal of one or more of drop droplet, wherein the target nucleic acid point in the multiple nucleic acid molecules of the signal designation
The presence or absence of son or relative quantity.
In one embodiment, the surface of emulsion of the invention comprising fluorinated oil, electric liquid and based on bay ether is lived
Property agent.The emulsion can include multiple droplets.The droplet can be comprising (i) biological sample from the subject
Multiple nucleic acid molecules, and (ii) carry out the reagent needed for DNA (DNA) amplification and optional reverse transcription amplification.
For example, the emulsion can include fluorinated oil.Any suitable fluorinated oil can be used in the present invention.Suitable fluorinated oil
Non-limiting example includes HFE 7100, HFE 7500, FC-40, FC-43, FC-70, FC-3208, or its combination.
For example, the emulsion can include electric liquid.Any suitable electric liquid can be used in the present invention.Suitable electronics
Liquid can be any electric liquid suitable for electronic application.The electric liquid can have the property of surfactant.It is described
Electric liquid can be electrical conduction liquid, or, the electric liquid can be electrically insulating liquid.The electric liquid may be based on fluorine
For the liquid of hydrocarbon.For example, the electric liquid can include perfluor triamylamine.Or, the electric liquid can include other fluoro
Hydrocarbon, including perfluoro-hydrocarbon.In some embodiments, the electric liquid is Fluorinert electric liquids.For example, the electricity
Sub- liquid may be selected from Fluorinert FC-87, FC-72, FC-84, FC-77, FC3255, FC-3283, FC-40, FC-43, FC-
70、FC-5312.For example, the electric liquid can be Fluorinert FC-70.
For example, the emulsion can include surfactant.Any suitable surfactant can be used in the present invention.For example,
Surfactant of the present invention can be hydrophilic surfactant active or lipophilic surfactant.
Hydrophilic surfactant active can be ionic or non-ionic.Suitable ionic surfactant include but
It is not limited to alkylammonium salt;Fusidic Acid salt;The derivative of fatty acid of amino acid, oligopeptides and polypeptide;Amino acid, oligopeptides and polypeptide
Glyceride ester derivatives;Lecithin and hydrolecithin;Lysolecithin and hydrogenated lyso lecithin;Phosphatide and its derivative;It is molten
Blood phospholipid and its derivative;Carnitine fatty acid ester salt;Alkyl sulfate;Soap;Docusate sodium;Acyl-lactate;Glycerine
The monoacylated and diacetylation tartrate of monoesters and diglyceride;The monoglyceride and diglyceride of succinylation;Glycerine
The citrate of monoesters and diglyceride;And its mixture.
In foregoing group, some ionic surfactants include, for example:Lecithin, lysolecithin, phosphatide, haemolysis
Phosphatide and its derivative;Carnitine fatty acid ester salt;Alkyl sulfate;Soap;Docusate sodium;Acyl-lactate;Glycerine list
The monoacylated and diacetylation tartrate of ester and diglyceride;The monoglyceride and diglyceride of succinylation;Glycerine list
The citrate of ester and diglyceride;And its mixture.
Ionic surface active agent can be lecithin, lysolecithin, phosphatidyl choline, phosphatidyl-ethanolamine, phosphatidyl
Glycerine, phosphatidic acid, phosphatidylserine, lysophosphatidyl choline, lysophosphatidyl ethanolamine, lysophosphatidyl glycerol, haemolysis
Phosphatidic acid, hemolytic phosphatidylserine, PEG- phosphatidyl-ethanolamines, PVP- phosphatidyl-ethanolamines, the lactate of aliphatic acid, tristearin
Acyl -2- lactates, stearoyl lactylates, succinylated monoglycerides, the mono bis acetylation winestone of monoglyceride/diglyceride
Acid esters, the citrate of monoglyceride/diglyceride, cholylsarcosine, capronate, caprylate, decylate, laurate, meat
Myristate, palmitate, oleate, ricinoleate, linoleate, linolenate, stearate, lauryl sulfate ester,
Myristyl sulfate ester (teracecyl sulfate), many storehouse esters, Laurylcarnitine, palmitoyl carnitine, C14 and
The ionized form of its salt and mixture.
Hydrophilic non-ionic surfactant may include but be not limited to APG;Alkylmaltosides;Alkylthio
Glucoside;Lauryl LABRAFIL M 1944CS;Polyoxyalkylene alkyl such as polyethylene glycol alkyl ether;Polyoxyalkylene alkyl phenol is as gathered
Ethylene glycol alkyl phenol;Polyoxyalkylene alkyl phenol fatty acid ester such as polyethylene glycol fatty acid monoesters and polyethylene glycol fatty acid diester;
Polyethylene glycol glycerol fatty acid ester;Polyglyceryl fatty acid ester;Such as polyethylene glycol dehydration of polyoxyalkylene sorbitan fatty acid ester
Span;In polyalcohol and the group being made up of glyceride, vegetable oil, hydrogenated vegetable oil, aliphatic acid and sterol at least
The hydrophily product of transesterification reaction of one member;Polyoxyethylene sterol, its derivative and analog;Oxyethylated vitamin
And its derivative;Polyox-yethylene-polyoxypropylene block copolymer;And its mixture;Polyethylene glycol sorbitan fatty acid esters
And polyalcohol is exchanged with the hydrophilic ester of at least one member in the group being made up of triglycerides, vegetable oil and hydrogenated vegetable oil
Reaction product.The polyalcohol can be glycerine, ethylene glycol, polyethylene glycol, sorbierite, propane diols, pentaerythrite or sugar.
Other hydrophilic non-ionic surfactants include but is not limited to PEG-10 laurates, PEG-12 laurates,
PEG-20 laurates, PEG-32 laurates, PEG-32 dilaurates, PEG-12 oleates, PEG-15 oleates, PEG-
20 oleates, PEG-20 dioleates, PEG-32 oleates, PEG-200 oleates, PEG-400 oleates, PEG-15 stearic acid
Ester, PEG-32 distearates, PEG-40 stearates, PEG-100 stearates, PEG-20 dilaurates, PEG-25 are sweet
Oily trioleate, PEG-32 dioleates, PEG-20 glyceryl laurate esters, PEG-30 glyceryl laurate esters, PEG-20 stearic acid
Glyceride, PEG-20 oleins, PEG-30 oleins, PEG-30 glyceryl laurate esters, PEG-40 lauric acids
Ester, PEG-40 palm-kernel oils, PEG-50 rilanit specials, PEG-40 castor oil, Cremophor ELP, PEG-60 castor oil,
Cremophor RH40 PEG-60 rilanit specials, PEG-60 corn oils, PEG-6 capric acid/glycerol caprylate, PEG-8 capric acid/
Glycerol caprylate, Natrulon H-10-laurate, PEG-30 cholesterol, PEG-25 phytosterols, PEG-30 sojasterols, PEG-
20 trioleates, PEG-40 sorbitan monooleates, PEG-80 anhydrous sorbitols laurate, polysorbate 20, poly- sorb
Ester 80, POE-9 lauryl ethers, POE-20 lauryl ethers, POE-10 oleyl ethers, POE-20 oleyl ethers, POE-20 stearyl ethers, life
Educate phenol PEG-100 succinates, PEG-24 cholesterol, Natrulon H-10-oleate, polysorbate40, polysorbate60, sucrose monostearate
Ester, sucrose monolaurate, sucrose palmitic acid ester, PEG 10-100 nonylphenol series, PEG15-100 octyl phenols series
And poloxamer.
Only for example, suitable lipophilic surfactant includes:Fatty alcohol;Fatty acid glyceride;Acetylated glycerol
Fatty acid ester;Lower alcohol fatty acid esters;Methyl glycol fatty acid ester;Sorbitan fatty acid ester;Polyethylene glycol anhydrous sorbitol
Fatty acid ester;Sterol and sterol derivative;Oxyethylated sterol and sterol derivative;Polyethylene glycol alkyl ether;Sugar ester;Sugar
Ether;The lactic acid derivative of monoglyceride and diglyceride;Polyalcohol with by glyceride, vegetable oil, hydrogenated vegetable oil, aliphatic acid and
The hydrophobicity product of transesterification reaction of at least one member in the group of sterol composition;Fat soluble vitamin/vitamin derivative;And
Its mixture.In the group, some lipophilic surfactants include fatty acid glyceride, methyl glycol fatty acid ester and its mixing
The hydrophobicity of at least one member in thing, or polyalcohol and the group that is made up of vegetable oil, hydrogenated vegetable oil and triglycerides
Product of transesterification reaction.
Conventional use of surfactant also includes such as oleic acid, lecithin, sorbitan trioleate, chlorination 16
Alkyl pyridine, benzalkonium chloride, polyoxyethylene (20) sorbitan mono-laurate, polyoxyethylene (20) anhydrous sorbitol list are hard
Resin acid ester, polyoxyethylene (20) sorbitan monooleate, polyoxypropylene/polyoxyethylene block copolymer, polyoxypropylene/poly-
Oxygen ethene/ethylenediamine block copolymer, ethoxylated castor oil etc..Other suitable surfactants/emulsifiers are for ability
Field technique personnel are known, and in CTFA International Cosmetic Ingredient Dictionary
Listed in and Handbook, Vol.2, the 7th edition (1997).
In some embodiments, the surfactant is the surfactant based on bay ether.For example, the surface
Activating agent is glycolic polyoxyethanyl bay ether.
In some embodiments, the emulsion also includes another surfactant.For example, another surface is lived
Property agent is any another surfactant specifically described herein.In one embodiment, another surfactant
It is polyoxyethylene sorbitan monolaurate (Tween 20).
In some embodiments, the surfactant is fluoro surfactants.For example, the surfactant can
Include hydrophobicity tail groups and hydrophilic head group, tail groups and hydrophilic head group based on polymer, based on polymer
Tail groups and the head group based on polymer, tail groups of fluorination and be hydrophilic head group, or be based on fluorinated polymer
Group and the head group based on hydrophilic polymer.In some embodiments, the surfactant belongs to diblock copolymer
Or triblock copolymers type.For example, the surfactant can be block copolymer, such as by two PFPE blocks and
The triblock copolymer of one polyethylene glycol block composition.In some embodiments, the surfactant is selected from the group:
PFPE-PEG-PFPE (PFPE-polyethylene glycol-PFPE), triblock copolymer EA- surfactants (RainDance
) and DMP (dimorpholino phosphoric acid)-surfactant (Baret, Kleinschmidt etc., 2009) Technologies.Polymer
The length of PEG in species (including polymeric surfactant), can be any suitable length, and can according to it is used not
Change with type of polymer.
In some embodiments, be contained in the multiple droplet the multiple nucleic acid molecules it is un-extracted and/or
Purifying.For example, the multiple nucleic acid molecules are not yet purified when being contained in the multiple droplet.In some embodiments,
The multiple nucleic acid molecules are when being contained in the multiple droplet, and the nucleic acid molecules are un-extracted.For example, the multiple core
Acid molecule can be a part for biological sample, and the multiple nucleic acid molecules are the multiple when being contained in the multiple droplet
Nucleic acid molecules are extracted not from the biological sample.In addition, in some embodiments, the multiple nucleic acid molecules comprising
When the multiple droplet, the target nucleic acid (for example, target RNA or target DNA) being present in the multiple nucleic acid molecules may be not
Concentrated or enrichment.
For example, the emulsion can include emulsifying agent.Any suitable emulsifying agent can be used in the present invention.Described suitable breast
Agent can cause emulsion-stabilizing of the present invention.The emulsifying agent can have the property of surfactant.The emulsifying agent
Can be oil-water emulsifiers or water-in-oil emulsifier.The non-limiting example of emulsifying agent includes fatty glyceride, sucrose ester, mountain
Pears sugar alcohol ester, soybean lecithin, glyceryl laurate ester, propylene glycol ester etc..In some embodiments, the emulsifying agent is sorbose
Alcohol ester.In some embodiments, the emulsifying agent is the emulsifying agent based on monostearate.It is for example described to be based on monostearate
The emulsifying agent of ester can be the serial emulsifying agents of Tween, such as polyoxyethylene sorbitan monostearate (Tween 60).
After the emulsion of the present invention is generated, multiple nucleic acid molecules in multiple droplets in emulsion can be enough
Produce and carry out DNA cloning under conditions of the amplified production of the multiple nucleic acid molecules.The side of any suitable DNA cloning can be used
Method carries out the DNA cloning, DNA cloning method including but not limited to described herein.
In some embodiments, the DNA cloning also includes carry out reverse transcription amplification parallel with the DNA cloning.Can
The reverse transcription amplification, reverse transcription amplification including but not limited to described herein are carried out using the method for any reverse transcription amplification
Method.The parallel DNA cloning of any method progress and reverse transcription amplification can be used, it is including but not limited to described herein parallel
DNA cloning and reverse transcription amplification method.
For example, the DNA cloning includes first the multiple nucleic acid molecules being carried out reverse transcription amplification to produce complementary DNA
(cDNA) molecule, and the DNA cloning parallel with least one subset progress of the reverse transcription amplification to the cDNA molecules with
Produce the amplified production.
In some embodiments, the droplet is stable at a temperature of higher than 95 DEG C, does not deform or closes
And.The droplet can be herein stable in described amplification process, do not deform or merge.For example, institute
Stating droplet can be stable under any temperature herein in described amplification process or in any Thermal Cycling, no
Deform or merge.
In another aspect, the present invention relates to a kind of target nucleic acid for being used to identify the biological sample for obtain since subject
The presence or absence of molecule, or relative quantity system.The system may include:Droplet maker, and controller, its with it is described
Droplet maker is operably connected.
The droplet maker can be any suitable droplet maker, as long as it can the method according to the invention life
Into emulsion.For example, the droplet maker can generate emulsion of the present invention.For example, the emulsion includes fluorinated oil, electricity
Sub- liquid and the surfactant based on bay ether, wherein the emulsion includes multiple droplets, the droplet comes comprising (i)
Carry out DNA (DNA) amplification from multiple nucleic acid molecules of the biological sample of the subject, and (ii) and appoint
Reagent needed for the reverse transcription amplification of choosing.
The controller can be any suitable controller, include but is not limited to the present invention described in controller and can be real
Any device and instrument of existing control function.The controller is programmed to execute the side of the present invention in some embodiments
Method.Such as described controller can be programmed to (i) and the multiple nucleic acid molecules in the multiple droplet are being enough to produce
The DNA cloning is carried out under conditions of the amplified production of the multiple nucleic acid molecules;And (ii) detection is from the multiple small
The signal of one or more of drop droplet, wherein the target nucleic acid in the multiple nucleic acid molecules of the signal designation
The presence or absence of molecule or relative quantity.
In some embodiments, the system further comprises detector, and the detector is used to detect the signal.
The detector can detect the signal, method including but not limited to described herein with any suitable method.Detection
The non-limiting examples of method include optical detection, spectral detection, electrostatic detection, Electrochemical Detection etc..Optical detecting method bag
Include but be not limited to fluorimetry and UV-Visible absorption.Spectral method of detection includes but is not limited to mass spectrography, nuclear magnetic resonance
(NMR) spectral method and infra-red sepectrometry.Electrostatic detection methods include but is not limited to the technology based on gel, for example, gel electrophoresis.
The electrochemistry that electrochemical detection method includes but is not limited to amplified production after the high performance liquid chromatography separation of amplified production is examined
Survey.The detector may include real-time detector device.The non-limiting examples of real-time detector device are followed including various real-time PCR heat
Ring instrument, real-time PCR system, sequence detection system, intelligent circulation system etc..
In some embodiments, the controller is operably coupled to the detector, and manipulates the detector
Detect signal.
In one aspect, the present invention relates to the method for forming subregion.Methods described includes the water that guiding includes nucleic acid samples
Property fluid by first passage, and guiding non-aqueous fluid is by second channel, both is flowed to multiple intersections position in chip
Put, so that multiple subregions are formed in the multiple crossover location when the aqueous fluids and the non-aqueous fluid are in contact,
Each subregion of wherein the multiple subregion is required for nucleic acid amplification including (i) described nucleic acid samples or part thereof, and (ii)
Reagent.In the second channel, the non-aqueous fluid can be substantially free of the sample and the reagent.
Methods described can further comprise the condition of (b) in the amplified production for being enough to produce the nucleic acid samples or part thereof
Under to described nucleic acid samples in each subregion in the multiple subregion or part thereof carry out nucleic acid amplification reaction.In some realities
Apply in scheme, (b) can be carried out in collecting zone.In some embodiments, (b) can be carried out on chip.
In some embodiments, (b) can follow any nucleic acid amplification reaction scheme and carry out, such as described in this specification
Those.
Step (b) may include to carry out thermal cycle to each in the multiple subregion.The thermal cycle may include to make institute
The temperature for stating each subregion in multiple subregions is circulated between the first temperature and the second temperature higher than the first temperature.One
In the case of a little, the thermal cycle may include to make the temperature of each subregion in the multiple subregion more than two different temperatures it
Between circulate.
The aqueous fluids can be comprising nucleic acid samples and for reagent necessary to nucleic acid amplification.
In one aspect, the present invention relates to the method for forming subregion.Methods described, which includes working as, includes the aqueous of nucleic acid samples
When fluid is in contact with non-aqueous fluid, multiple subregions are formed, wherein each subregion of the multiple subregion includes (i) described core
Sour sample or part thereof, and (ii) is for reagent necessary to nucleic acid amplification.
Methods described can further comprise the condition of (b) in the amplified production for being enough to produce the nucleic acid samples or part thereof
Under to described nucleic acid samples in each subregion in the multiple subregion or part thereof carry out nucleic acid amplification reaction.
Methods described can be further after (b), including (c) is when the multiple zone configuration is in substantially planar collection
After region, the signal for indicating the amplified production presence or absence is detected simultaneously in the multiple subregion.
In some embodiments, methods described further comprises guiding the multiple subregion to the collecting zone.
In some embodiments, (b) is carried out in the collecting zone.
The collecting zone may be included in chip.
In some embodiments, the collecting zone includes multiple intervals, and wherein in (c), in the multiple area
Between in given interval detect signal simultaneously.
May be sized to of the collecting zone accommodates the multiple subregion in one layer.In some cases, it is described
The size of collecting zone may be alternatively provided as accommodating the multiple subregion in multilayer.
In some embodiments, (b) is carried out on chip.
In one aspect, the invention provides a kind of method for forming subregion.Methods described, which includes working as, includes nucleic acid samples
Aqueous fluids when being in contact with non-aqueous fluid, multiple subregions are formed, wherein each subregion of the multiple subregion includes (i)
Described nucleic acid samples or part thereof, and (ii) is for reagent necessary to nucleic acid amplification.
Methods described can further comprise the condition of (b) in the amplified production for being enough to produce the nucleic acid samples or part thereof
Under to described nucleic acid samples in each subregion in the multiple subregion or part thereof carry out nucleic acid amplification reaction.
Methods described can further after (b), including (c) when the multiple subregion by hole be fixed on collecting zone it
Afterwards, the signal for indicating the amplified production presence or absence is detected simultaneously in the multiple subregion, wherein the chi that each hole has
Very little (such as length, width, depth) is less than the average diameter of the given subregion in the multiple subregion.
In some embodiments, methods described further comprises guiding the multiple subregion to the collecting zone.
In some embodiments, (b) is carried out in the collecting zone.
The collecting zone may be included in chip.
In some embodiments, the collecting zone includes multiple intervals, and wherein in (c), in the multiple area
Between in given interval detect signal simultaneously.
May be sized to of the collecting zone accommodates the multiple subregion in one layer.In some cases, it is described
The size of collecting zone may be alternatively provided as accommodating the multiple subregion in multilayer.
In some embodiments, (b) is carried out on chip.
In some embodiments, the hole is sized to accommodate the single subregion in the multiple subregion.
The non-aqueous fluid can include hydrophobic liquid.The non-limiting example of hydrophobic liquid include oil, such as hydro carbons,
Silicone oil, fluorocarbon oil, fluorinated oil, organic solvent etc..In some embodiments, the oil is fluorinated oil, such as HFE 7100,
HFE 7500, FC-40, FC-43, FC-70, FC-3208, or its combination.In some embodiments, the oil is mineral oil,
Such as atoleine, light mineral oil, white oil, refined mineral oil, naphthenic oil, aromatic oil, or its combination.The oil can for it is any can
Oil for preparing droplet.
The non-aqueous fluid can include surfactant.The surfactant can include hydrophobicity tail groups and hydrophilic
Property head group, tail groups and hydrophilic head group based on polymer, the tail groups based on polymer and the head based on polymer
Group, tail groups of fluorination and be hydrophilic head group, or the tail group based on fluorinated polymer and based on hydrophilic polymer
Head group.In some embodiments, the surfactant belongs to diblock copolymer or triblock copolymers type.Example
Such as, the surfactant can be block copolymer, for example, be made up of two PFPE blocks and a polyethylene glycol block
Triblock copolymer.In some embodiments, the surfactant is selected from the group:(perfluor gathers PFPE-PEG-PFPE
Ether-polyethylene glycol-PFPE), triblock copolymer EA- surfactants (RainDance Technologies) and DMP
(dimorpholino phosphoric acid)-surfactant (Baret, Kleinschmidt etc., 2009).Type of polymer (including polymer table
Face activating agent) in PEG length, can be any suitable length, and can be become according to used different type of polymer
Change.The surfactant can be with of 0.0001% to 5% (w/w), such as 0.001% to 4% (w/w), 0.01% to
3% (w/w), 0.1% to 2% (w/w), 0.1% to 1% (w/w) concentration is present in non-aqueous fluid.In some embodiment party
In case, the surfactant is with least about, at most about or about about 0.1% (w/w), 0.2% (w/w), 0.3% (w/
W), 0.4% (w/w), 0.5% (w/w), 0.6% (w/w), 0.7% (w/w), 0.8% (w/w), 0.9% (w/w), 1.0% (w/
W), 1.2% (w/w), 1.4% (w/w), 1.6% (w/w), 1.8% (w/w), 2.0% (w/w), 2.5% (w/w), 3.0% (w/
W), 3.5% (w/w), 4.0% (w/w), 4.5% (w/w), 5.0% (w/w), 7.0% (w/w), 10.0% (w/w), 15.0%
(w/w), 20.0% (w/w) or more or less concentration are present in non-aqueous fluid.
The first passage can be any suitable length.The first passage can be substantially straight.Or, it is described
First passage can include one or more bendings or bending etc..The first passage can have snakelike or spiral shape to set.It is described
First passage can have one or more branches.Part or all of the branch can include secondary channel so that first leads to
The main channel in road is connected with one or more second channels.The first passage is also connected to fluid source as described herein.
The first passage can have at least about 1mm, at least about at least about 2mm, at least about 3mm, at least about 5mm, 7mm,
At least about 1cm, at least about 1.5cm, at least about 2cm, at least 2.5cm, at least about 3cm, at least about 5cm, at least about 7cm, at least
About 10cm length.The first passage can have no more than about 10cm, no more than about no more than about 7cm, 5cm, no more than about
3cm, no more than about 2.5cm, no more than about 2cm, no more than about 1.5cm, no more than about 1cm, no more than about 7mm, no more than about
5mm, no more than about 3mm, or no more than about 2mm length.When referring to the length of the first passage, the length also includes
Its all branch and the length of secondary channel.
The cross-sectional area of the first passage can be substantial constant, it is possibility to have be changed.In some implementations
In scheme, the cross-sectional area of the first passage is varied from position of the fluid stream in the first passage.Institute
The cross-sectional area for stating first passage can be average at least about 1,000 μm2, at least about 2,000 μm2, at least about 3,000 μm2, extremely
It is few about 5,000 μm2, at least about 10,000 μm2, at least about 20,000 μm2, at least about 30,000 μm2, at least about 50,000 μm2, extremely
It is few about 100,000 μm2, at least about 200,000 μm2, at least about 300,000 μm2, at least about 500,000 μm2, at least about 1,000,
000μm2Or it is higher.The cross-sectional area of the first passage can be averagely no more than about 1,000,000 μm2, no more than about 500,
000μm2, no more than about 300,000 μm2, no more than about 200,000 μm2, no more than about 100,000 μm2, no more than about 50,000
μm2, no more than about 30,000 μm2, no more than about 20,000 μm2, no more than about 10,000 μm2, no more than about 5,000 μm2, do not surpass
Cross about 3,000 μm2, or is no more than about 2,000 μm2.These cross-sectional area numerical value also can independent assortment.
The cross-sectional area of the first passage can be varied from along the length direction of passage.Such as described first passage
Cross-sectional area can be in average cross sectional area about 75% to about 125%, about 80% to about 120%, about 90% to about
110%, about 95% to about 105%, change in the range of about 97% to about 103% or about 99% to about 101%.Described first leads to
Road can have any suitable shape of cross section, such as circle, annular, ellipse, triangle, irregular shape, square or square
Shape etc..
The first passage can have any suitable cross-sectional dimension.Cross-sectional dimension is often referred to accommodate
Full-size in the cross section of the first passage, wherein the cross section refers to the mean square with fluid stream in first passage
To orthogonal face.For example, the cross-sectional dimension can be no more than 1mm, and no more than about 800 μm, no more than about 600 μm,
No more than about 500 μm, no more than about 400 μm, no more than about 300 μm, no more than about 250 μm, no more than about 200 μm, it is no more than
About 100 μm, no more than about 75 μm, no more than about 50 μm, no more than about no more than about 25 μm, 10 μm etc..For example, described maximum horizontal
Sectional dimension can be at least about 5 μm, at least about 10 μm, at least about 25 μm, at least about 50 μm, at least about at least about 75 μm, 100 μ
M, at least about 200 μm, at least about 250 μm, at least about 300 μm, at least about 400 μm, at least about 500 μm, at least about 600 μm, extremely
It is few about 800 μm etc..
The first passage can be with one or more second channel fluid communications.The second channel can be microfluid dress
Put.However, in some embodiments, the first passage and/or second channel are not microfluidic devices.
The second channel can with first passage at a distance of relative constancy distance.And/or, the first passage and
Second channel can be substantially parallel to each other.In some embodiments, the first passage and second channel are average at a distance of both
About the 75% to about 125% of distance, e.g., from about 80% to about 120%, about 90% to about 110%, about 95% to about 105%, about
97% to about 103% or about 99% to about 101%.
In some embodiments, more than one second channel may be present.Each second channel can lead to described first
Road fluid communication.If more than a second channel, each second channel can with the first passage at a distance of identical or
Different distances.In addition, multiple second channels can have identical or different length, cross-sectional area or other properties.It is described
Second channel also fluid communication or each other not fluid communication each other.
The second channel can have any suitable shape.The second channel can be substantially straight.Described second
Passage can have one or more bendings or bending.The second channel can have the shape substantially the same with the first passage
Shape allows for example described second channel and the first passage at a distance of the distance of substantial constant.The second channel also may be used
There are different shapes from the first passage.
The second channel can have any suitable length.For example, the length of the second channel can be at least about
1mm, at least about 2mm, at least about 3mm, at least about 5mm, at least about 7mm, at least about 1cm, at least about 1.5cm, at least about 2cm,
At least 2.5cm, at least about 3cm, at least about 5cm, at least about 7cm, at least about 10cm etc..For example, the length of the second channel
It can be no more than about 10cm, no more than about no more than about 7cm, no more than about 5cm, no more than about 3cm, 2.5cm, be no more than about
2cm, no more than about 1.5cm, no more than about 1cm, no more than about 7mm, no more than about 5mm, no more than about 3mm, or no more than about
2mm.The length of the second channel may include the length of its any branch or secondary channel.
The cross-sectional area of the second channel can be substantial constant, it is possibility to have be changed.In some implementations
In scheme, the cross-sectional area of the second channel is varied from position of the fluid stream in the second channel.Institute
The cross-sectional area for stating second channel can be average at least about 1,000 μm2, at least about 2,000 μm2, at least about 3,000 μm2, extremely
It is few about 5,000 μm2, at least about 10,000 μm2, at least about 20,000 μm2, at least about 30,000 μm2, at least about 50,000 μm2, extremely
It is few about 100,000 μm2, at least about 200,000 μm2, at least about 300,000 μm2, at least about 500,000 μm2, at least about 1,000,
000μm2Or it is higher.The cross-sectional area of the second channel can be averagely no more than about 1,000,000 μm2, no more than about 500,
000μm2, no more than about 300,000 μm2, no more than about 200,000 μm2, no more than about 100,000 μm2, no more than about 50,000
μm2, no more than about 30,000 μm2, no more than about 20,000 μm2, no more than about 10,000 μm2, no more than about 5,000 μm2, do not surpass
Cross about 3,000 μm2, or no more than about 2,000 μm2.These cross-sectional area numerical value also can independent assortment.
In some embodiments, the cross-sectional area of the second channel can be varied from.For example, the second channel
Cross-sectional area can be varied from along the length direction of passage.The cross-sectional area of such as described second channel can be average
Cross-sectional area about 75% to about 125%, about 80% to about 120%, about 90% to about 110%, about 95% to about 105%, about
Change in the range of 97% to about 103% or about 99% to about 101%.The cross-sectional area of the second channel can with it is described
The cross-sectional area of first passage is identical or different.In addition, the second channel can have any suitable shape of cross section, example
Such as circle, annular, ellipse, triangle, irregular shape, square or rectangle.The shape of cross section of the second channel can
With identical or different with the shape of cross section of the first passage.
The second channel can have any suitable cross-sectional dimension.Cross-sectional dimension is often referred to accommodate
Full-size in the cross section of the second channel, wherein the cross section refers to the mean square with fluid stream in second channel
To orthogonal face.For example, the cross-sectional dimension can be no more than 1mm, and no more than about 800 μm, no more than about 600 μm,
No more than about 500 μm, no more than about 400 μm, no more than about 300 μm, no more than about 250 μm, no more than about 200 μm, it is no more than
About 100 μm, no more than about 75 μm, no more than about 50 μm, no more than about no more than about 25 μm, 10 μm etc..For example, described maximum horizontal
Sectional dimension can be at least about 5 μm, at least about 10 μm, at least about 25 μm, at least about 50 μm, at least about at least about 75 μm, 100 μ
M, at least about 200 μm, at least about 250 μm, at least about 300 μm, at least about 400 μm, at least about 500 μm, at least about 600 μm, extremely
It is few about 800 μm etc..The cross-sectional dimension of the second channel can be with the first passage cross-sectional dimension phase
It is same or different.
The first passage can include main channel and multiple secondary channels.The secondary channel can multiple crossover locations with
The second channel intersects.Flow the aqueous fluids from the main channel of the first passage and may pass through one or more secondary channels,
To enter non-aqueous fluid contained in the second channel.The aqueous fluids can make substantially with the non-aqueous fluid
It is immiscible, and therefore can form the droplet for the aqueous fluids being contained in non-aqueous fluid.In some embodiments,
The secondary channel is substantially of similar shape or size, and/or its cross-sectional area is substantially less than main channel or
The cross-sectional area of two passages so that mainly influenceed on the resistance (resistance) of fluid stream by the size of secondary channel,
This may be such that the droplet to be formed is substantially monodispersed.
In some embodiments, during mean resistance of the secondary channel to fluid stream is first passage and/or second channel
Resistance it is at least about 3 times high, it is at least about 10 times high for example, at least about 5 times are high, it is at least about 20 times high, it is at least about 30 times high,
It is at least about 50 times high, it is at least about 75 times high, it is at least about 100 times high, it is at least about 200 times high, it is at least about 300 times high, at least about 500
It is high again, or at least about 1, it is 000 times high.In some embodiments, mean resistance of the secondary channel to fluid stream is no more than first
Resistance in passage and/or second channel it is about 1,000 times high or 500 times high.The secondary channel can have substantially the same
Mean resistance.For example, mean resistance of the secondary channel to fluid stream can be averaged in all secondary channels to fluid stream
About the 75% to about 125% of resistance, about 80% to about 120%, about 90% to about 110%, about 95% to about 105%, about 97%
Change in the range of to about 103% or about 99% to about 101%.
In some embodiments, using with relatively small cross-sectional area or relatively small minimum or maximum transversal
The secondary channel of face size produces the high-drag to fluid stream.Or, it is in some embodiments, described transversal except controlling
Outside face area or cross sectional dimensions, using other technologies produce high-drag, for example the secondary channel is coated and/or
Build relatively sinuous secondary channel.Correspondingly, the secondary channel can be to be substantially straight, or the secondary channel can be wrapped
Containing one or more bendings or bending etc..If there is multiple secondary channels, these secondary channels can each have identical or not
Same shape.For example, part or all of secondary channel can make it is substantially straight.Appoint in addition, the secondary channel can have
What suitable shape of cross section, such as circle, annular, ellipse, triangle, irregular shape, square or rectangle.Described time
Level passage can independently have identical or different shape of cross section.The shape of cross section of the secondary channel can be with the master
The shape of cross section of passage and/or second channel is identical or different.
The secondary channel can have any suitable cross-sectional dimension.Cross-sectional dimension is often referred to accommodate
Full-size in the cross section of the secondary channel, wherein the cross section refers to the mean square with fluid stream in secondary channel
To orthogonal face.For example, the cross-sectional dimension can be no more than 1mm, and no more than about 800 μm, no more than about 600 μm,
No more than about 500 μm, no more than about 400 μm, no more than about 300 μm, no more than about 250 μm, no more than about 200 μm, it is no more than
About 100 μm, no more than about 75 μm, no more than about 50 μm, no more than about no more than about 25 μm, 10 μm etc..For example, described maximum horizontal
Sectional dimension can be at least about 5 μm, at least about 10 μm, at least about 25 μm, at least about 50 μm, at least about at least about 75 μm, 100 μ
M, at least about 200 μm, at least about 250 μm, at least about 300 μm, at least about 400 μm, at least about 500 μm, at least about 600 μm, extremely
It is few about 800 μm etc..The height of the secondary channel can be identical or different with the height of described first or second channel.
In some embodiments, cross sectional dimensions minimum in secondary channel is to the ratio of maximum cross sectional dimensions
At least about 1:1.1, at least about 1:1.5, at least about 1:2, at least about 1:3, at least about 1:5, at least about 1:7, at least about 1:10, extremely
Few about 1:15, at least about 1:20, at least about 1:25, at least about 1:30, at least about 1:35, at least about 1:40, at least about 1:50, extremely
Few about 1:60, at least about 1:70, at least about 1:80, at least about 1:90, at least about 1:100 etc..For example, the ratio is can be for not
More than about 1:100, no more than about 1:90, no more than about 1:80, no more than about 1:70, no more than about 1:60, no more than about 1:50,
No more than about 1:40, no more than about 1:35, no more than about 1:30, no more than about 1:25, no more than about 1:20, no more than about 1:
15, no more than about 1:10, no more than about 1:7, no more than about 1:5, no more than about 1:3, no more than about 1:2, no more than about 1:1.5
Deng.
The secondary channel can have any suitable length.In some embodiments, the length of the secondary channel
Determined by the distance between main channel and second channel.For example, the average length of the secondary channel can be at least about 10 μm, extremely
It is few about 20 μm, at least about 30 μm, at least about 50 μm, at least about 100 μm, at least about 200 μm, at least about at least about 300 μm, 500 μ
M, at least about 1,000 μm, or at least about 2,000 μm etc..For example, the length of the secondary channel can be no more than about 2,000 μm,
No more than about 1,000 μm, no more than about 500 μm, no more than about 300 μm, no more than about 200 μm, no more than about 100 μm, do not surpass
Cross about 50 μm, no more than about 30 μm, no more than about 20 μm, or no more than about 10 μm.The length of the secondary channel can be basic
Upper identical, or the length can all secondary channels average length (or the spacing of the first passage and second channel
From) about 75% to about 125%, about 80% to about 120%, about 90% to about 110%, about 95% to about 105%, about 97% to
Change in the range of about 103% or about 99% to about 101%.
The cross-sectional area of the secondary channel can be average at least about 20 μm2, at least about 30 μm2, at least about 50 μm2, extremely
It is few about 75 μm2, at least about 100 μm2, at least about 300 μm2, at least about 400 μm2, at least about 500 μm2, at least about 750 μm2, at least
About 1,000 μm2, at least about 1,600 μm2, at least about 2,000 μm2, at least about 3,000 μm2, at least about 4,000 μm2, at least about 5,
000μm2, at least about 6,000 μm2, at least about 6,400 μm2, at least about 7,000 μm2, at least about 8,000 μm2, at least about 9,000 μ
m2, at least about 10,000 μm2Deng.The cross-sectional area of the secondary channel can be averagely no more than about 10,000 μm2, it is no more than
About 9,000 μm2, no more than about 8,000 μm2, no more than about 7,000 μm2, no more than about 6,400 μm2, no more than about 6,000 μm2,
No more than about 6,000 μm2, no more than about 5,000 μm2, no more than about 4,000 μm2, no more than about 3,000 μm2, no more than about 2,
000μm2, no more than about 1,600 μm2, no more than about 1,000 μm2, no more than about 750 μm2, no more than about 500 μm2, no more than about
400μm2, no more than about 300 μm2, no more than about 100 μm2, no more than about 75 μm2, no more than about 50 μm2, no more than about 30 μm2,
No more than about 20 μm2Deng.
In some embodiments, the cross-sectional area of the secondary channel can all secondary channels average cross-section
About the 75% to about 125% of area, about 80% to about 120%, about 90% to about 110%, about 95% to about 105%, about 97%
Change in the range of to about 103% or about 99% to about 101%.The cross-sectional area of the secondary channel can be substantial constant
Or be varied from.For example, the cross-sectional area of the secondary channel can be varied from along the length direction of passage.Such as institute
The cross-sectional area for stating secondary channel can be in average cross sectional area about 75% to about 125%, about 80% to about 120%, about
90% to about 110%, about 95% to about 105%, change in the range of about 97% to about 103% or about 99% to about 101%.
In some embodiments, the volume of the secondary channel can be in the volume of all secondary channels about 75% to about
125%, about 80% to about 120%, about 90% to about 110%, about 95% to about 105%, about 97% to about 103% or about 99%
Change in the range of to about 101%.
In some embodiments, the cross-sectional area of the main channel and/or the second channel is described secondary logical
It is at least about 10 times of minimum cross-sectional area high in the cross-sectional area in road, it is for example, at least about 15 times high, it is at least about 20 times high,
It is at least about 30 times high, it is at least about 40 times high, it is at least about 50 times high, it is at least about 75 times high, it is at least about 100 times high, at least about 200 times
Height, at least about 300 times high, at least about 500 times high, at least about 1,000 times high, at least about 2,000 times high, at least about 3,000 times
Height, or at least about 5, it is 000 times high.In some embodiments, the cross-sectional area of the main channel and/or the second channel
Be the secondary channel cross-sectional area in minimum cross-sectional area it is no more than about 5,000 times high, no more than about 3,000
It is high again, no more than about 2, it is 000 times high, no more than about 1, it is 000 times high, it is no more than about 500 times high, it is no more than about 300 times high, do not surpass
Cross about 200 times high, it is no more than about 100 times high, it is no more than about 75 times high, it is no more than about 50 times high, it is no more than about 40 times high, do not surpass
Cross about 30 times high, or it is no more than about 20 times high.
Any appropriate number of secondary channel may be present.In some embodiments, substantial amounts of secondary channel can be used for
Higher rate produces droplet.If in addition, secondary channel to the resistance of fluid stream relative to first and/or second channel convection current
The resistance of body stream is relatively large, then greater number of secondary channel may not substantially influence droplet produce speed and/or
The monodispersity of droplet.Therefore, in some embodiments, there is connection main channel and the second channel of of a relatively high quantity
Secondary channel.In some embodiments, have at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least
50, at least 75, at least 100, at least 200, at least 300, at least 400, at least 500, at least 600, at least 800, at least 1,000,
At least 1,200, at least 1,500, at least 2,000, at least 2,500 connection main channels and second channel secondary channel.
The multiple secondary channel can be into any suitable angle relative to main channel and/or second channel.For example, secondary
Level passage can be into about 90 ° of intersecting angle relative to main channel and/or second channel.Each secondary channel can be with substantially
Identical angle intersects with the main channel and/or second channel, or the intersecting angle can be independently identical or different
's.In addition, the intersecting angle between main channel and second channel can also be identical or different.In some embodiments,
The secondary channel it is each with the main channel and/or second channel into about 45 ° to about 135 °, about 45 ° to about 100 °, about
70 ° to about 100 °, about 80 ° to about 100 °, about 85 ° to about 95 °, about 88 ° to about 92 ° of angle.In some embodiments, it is secondary
Level passage and main channel and/or second channel are at least about 10 °, about 15 °, about 20 °, about 25 °, about 30 °, about 35 °, about 40 °, about
45 °, about 50 °, about 55 °, about 60 °, about 65 °, about 70 °, about 75 °, about 80 °, about 85 °, about 90 °, about 95 °, about 100 °, about
105 °, about 110 °, about 115 °, about 120 °, about 125 °, about 130 °, about 135 °, about 140 °, about 145 °, about 150 °, about 155 °, about
160 °, about 165 °, the angle (e.g., from about 90 ° to about 170 °) of the scope between about 170 ° of angle, or these any numerical value.
The secondary channel can be arranged between main channel and second channel with any suitable configuration.For example, secondary
Passage can be equidistant arrangement so that the distance between neighboring secondary passage is substantially the same, or in all adjacency channels
About the 75% to about 125% of average distance, about 80% to about 120%, about 90% to about 110%, about 95% to about 105%, about
Change in the range of 97% to about 103% or about 99% to about 101%.When the cross-sectional area of secondary channel is substantial constant
When, the spacing between secondary channel can be used for the size for determining droplet.
Chip can include multigroup first passage, second channel and multiple crossover locations.For example, the chip can include 2,3,
4,5,6,7,8,9,10 or more first passages and/or second channel.Each first passage can comprising main channel and one or
Multiple secondary channels.
The quantity of crossover location can be 2 or more, 3 or more, 4 or more, 5 or more, 10 or more,
15 or more, 20 or more, 25 or more, 30 or more, 35 or more, 40 or more, 50 or more,
60 or more, 70 or more, 80 or more, 90 or more, 100 or more.Crossover location can be logical first
Between the main channel in road and second channel, between the secondary channel and second channel of first passage, and/or first passage secondary
Formed between passage and main channel.Multiple crossover locations can be arranged linearly or nonlinearly.For example, multiple crossover locations can be arranged
Configured for two-dimensional array.
The subregion of the present invention can be the separate section of first fluid (such as aqueous fluids), and it has second fluid (example completely
Such as non-aqueous fluid) surround.In some embodiments, subregion is droplet.Subregion (such as droplet) can be any shape
Shape, and be not necessarily spherical.In aspherical subregion, its a diameter of and described aspherical droplet has same volume
The diameter of perfect mathematics spheroid.
The present invention multiple subregions can first fluid (such as aqueous fluids) a part it is (such as non-by second fluid
Aqueous fluids) around when formed.As it is used herein, enclosed when closure can be drawn around first fluid, and the closure circle only leads to
When crossing second fluid, it is believed that a part for first fluid " is surrounded " by second fluid.It is first-class when that can surround in any direction
Body draw closure circle, and the closure circle only by second fluid when, it is believed that a part for first fluid " is enclosed completely by second fluid
Around ".When can be dependent on direction around first fluid draw closure circle, and the closure circle only by second fluid when, it is believed that first
A part for fluid is by second fluid " substantially around ".
As described herein, the multiple subregion can be in the main channel of first passage, second channel and/or first passage
Formed at the one or more crossover locations formed between secondary channel.It is multiple that the multiple subregion can be formed from them
Expel or deflect from by one or more power at crossover location, for example, putting on the one or more imports and/or outlet of passage
Power.The power such as can apply as pump, gravity, capillarity, surface tension, electro-osmosis, centrifugal force, by subregion from it
Expel and/or deflect from multiple crossover locations for being formed.Vacuum be it is also possible to use (such as by vavuum pump or other are suitable
Vacuum source).The non-limiting example of pump includes syringe pump, peristaltic pump, pressure stream pump etc..In some embodiments, it is the multiple
Subregion can be formed between the main channel by first passage and multiple secondary channels of first passage.In some embodiments,
The multiple passage is located at the same side of the first passage.
The average-size of subregion (such as droplet) may depend on one or more properties (such as flow velocity, viscosity) of fluid
And/or the size of chip, (such as spacing, passage between the length and width of passage, adjacency channel exist for configuration or geometry
Pore size of crossover location etc.).
The chip of the present invention can include passage and multiple crossover locations.One or more passages are in some embodiments
Microfluidic channel.In some embodiments, at least part passage is not microfluidic device.
The chip can include any amount of passage, including microfluidic channel.The passage can be arranged as any suitable
Configuration.All passages can homogeneously connect, or the network of more than one passage may be present.Passage can be independently straight
, bending, bending etc..In some embodiments, in chip passage (when being added together) is micro- with least about 100
Rice, at least about 300 microns, at least about 500 microns, at least about 1mm, at least about 3mm, at least about 5mm, at least about 10mm, at least
About 30mm, at least 50mm, at least about 100mm, at least about 300mm, at least about 500mm, at least about 1m, at least about 2m, or at least
About 3m total length.In some embodiments, chip of the invention has at least two passage, at least three passage, at least four
Passage, at least five passage, at least ten passage, at least 20 passages, at least 30 passages, at least 40 passages, at least 50
Passage, at least 60 passages, at least 70 passages, at least 80 passages, at least 90 passages, at least 100 passages etc..
In some embodiments, at least some of the passage in the chip are microfluidic channels.For example, the chip
In fluid in all or part of cross-sectional dimension be less than about 2mm, in some cases, less than about 1mm.One
In the case of a little, all fluid passages in chip are microfluidic channels.In some embodiments, passage in the chip
Cross-sectional dimension is less than about 500 microns, less than about 200 microns, less than about 100 microns, less than about 50 microns, or is less than
About 25 microns.
Passage in chip can be arranged with any suitable configuration.Different passages can be used to arrange manipulate fluid,
Other key elements in subregion (such as droplet) and/or passage.For example, the passage in device can be configured to generation subregion (for example
Discrete droplet, single emulsion, double emulsion, multiple emulsion etc.), fluid and/or subregion or other key elements are mixed, screening
Or sort fluid and/or subregion or other key elements, fluid and/or subregion are separated, cause reaction occur (such as two fluids it
Between, or between the material and second fluid of first fluid carrying, or the reaction between two kinds of materials of two fluids carryings) etc.
Deng.
Fluid can be delivered to the passage in chip via one or more fluid sources.Any suitable fluid can be used
Source, and in some embodiments, more than one fluid source can be used.Pump, gravity, capillarity, surface tension, electricity can be used
The fluid of the fluid source in future such as infiltration, centrifugal force is delivered into one or more of chip passage.It it is also possible to use vacuum (for example
By vavuum pump or other suitable vacuum sources).The non-limiting example of pump includes syringe pump, peristaltic pump, pressure stream pump etc..Fluid
Source can be the bank comprising corresponding fluids, and the bank can be with one or more of chip passage fluid communication.Bank can
Comprising one or more outlets, and the passage in chip can include one or more entrances.The outlet and entrance can flow each other
Body UNICOM.In some cases, hydrodynamic resistance device (hydrodynamic can be set at bank outlet and/or feeder connection
Resistor), fluid stream is controlled such as valve, filter, sieve, coiled pipe.The hydrodynamic resistance device can be comprising total length
0.1mm, 0.5mm, 1mm, 1.5mm, 2mm, 2.5mm snakelike tube passage.The snakelike tube passage can turn back repeatedly, for example, 2,
3,4,5,6,7,8 times or more times.
The chip can have associated any amount of fluid source, such as 1,2,3,4,5,6,7,8,9,10,
Or more fluid source.The fluid source is without fluid is delivered into identical passage.Different fluid sources can deliver fluid
Enter different passages.For example, can deliver aqueous fluids into first passage, and non-aqueous fluid is delivered into second channel.
The invention further relates to after the multiple zone configuration is in collecting zone, detected simultaneously in the multiple subregion
Indicate the signal of the amplified production presence or absence.The collecting zone can be in the downstream of multiple crossover locations.In some implementations
In scheme, detected simultaneously in all subregions in the multiple subregion or partial-partition indicate the amplified production exist with
No signal.In some cases, the collecting zone includes multiple intervals, therefore can be in the multiple interval given area part
Detect the signal simultaneously.
The method of the present invention also includes guiding the multiple subregion to the collecting zone.Third channel for example can be used
The multiple subregion is guided to the collecting zone from multiple crossover locations.The diameter of the third channel can be more than described many
The cross sectional dimensions of each in individual subregion.
One or more first passages and/or second channel can be connected by the third channel with collecting zone.Herein
In description and restriction to first passage and/or second channel, unless clearly contradicted, be otherwise applied to the third channel.
The third channel can join with one or more first passages, second channel, and/or the collecting zone fluid
It is logical.
The collecting zone may be included in the chip.Or, the collecting zone can be separated with the chip.Work as receipts
When collection region is not included in the chip, it can be with the chip fluid UNICOM.Can by multiple crossover locations formed it is multiple
One or more passages that subregion is included by the chip and/or the collecting zone are guided to the collecting zone.
The collecting zone can have suitable shape and/or configuration.For example, the collecting zone can be substantially planar
's.In one embodiment, the collecting zone tool curved surface.In some embodiments, the collecting zone can be annular
's.In some embodiments, the collecting zone is inclined.The collecting zone can be separated with chip.The collecting region
Domain can be rotatable.
In some embodiments, it can be included in the side of rotatable supporting construction (such as rotatable symmetrical disk)
Multiple chips.Each chip in the multiple chip can be comprising passage (such as first passage and second channel) for generation institute
State multiple subregions and collecting zone.In some embodiments, the rotatable supporting construction includes multiple collecting zone (examples
The collecting zone such as separated with chip).The rotation of the supporting construction can be driven by the motor that can adjust the speed of rotation.It is described many
Individual chip or multiple collecting zones can be placed relative to the Central Symmetry of the supporting construction.In some embodiments, it is described
Multiple chips or the insertion of the multiple collecting zone are integrated into the rotatable support structure.
May be sized to of the collecting zone accommodates the multiple subregion in simple layer.For example, the collecting region
The mode of the stacking that may be sized to avoid or do not have or hardly have the multiple subregion in domain.In some embodiment party
In case, the collecting zone is surrounded by two layers of parallel plane, and two layers of parallel planes bound collecting zone is flat
Equal distance.In some embodiments, the height of the collecting zone is the average diameter of the subregion about or less than about generation.Example
Such as, the height of the collecting zone may be less than about 2000 μm, less than about 1000 μm, small less than about 500 μm less than about 750 μm
In about 400 μm, less than about 300 μm, less than about 200 μm, less than about 100 μm, less than about 90 μm, less than about 80 μm, less than about 70 μ
M, less than about 60 μm, less than about 50 μm, less than about 45 μm, less than about 40 μm, less than about 35 μm, less than about 30 μm, less than about 25 μ
M, less than about 20 μm, less than about 15 μm, less than about 10 μm, less than about 5 μm, less than about 1 μm, less than about 0.1 μm, less than about 0.01
μm or it is smaller.The diameter of the collecting zone (or when applied, the plane that the collecting zone is included) can be at least or about
0.01 μm, 0.1 μm, 1 μm, 5 μm, 10 μm, 20 μm, 30 μm, 40 μm, 50 μm, 60 μm, 70 μm, 80 μm, 90 μm, 100 μm, 150 μ
M, 200 μm, 250 μm, 300 μm, 350 μm, 400 μm, 450 μm, 500 μm, 550 μm, 600 μm, 700 μm, 800 μm, 900 μm,
1mm, 2mm, 3mm, 4mm, 5mm, 6mm, 7mm, 8mm, 9mm, 10mm, or it is bigger.However, in some cases, the collecting region
The size in domain also may be configured as accommodating the multiple subregion in multiple layers.
The collecting zone can include hole, and being dimensioned so as to of the hole accommodates the single subregion in the multiple subregion.
The size (such as width, length, depth) in each hole can be the average diameter less than the given subregion in the multiple subregion.Example
Such as, the size in each hole is smaller than about 500 μm, less than about 400 μm, less than about 300 μm, less than about 200 μm, less than about 100 μm,
Less than about 90 μm, less than about 80 μm, less than about 70 μm, less than about 60 μm, less than about 50 μm, less than about 45 μm, less than about 40 μm,
Less than about 35 μm, less than about 30 μm, less than about 25 μm, less than about 20 μm, less than about 15 μm, or less than about 10 μm, or it is smaller.
Hole can accommodate whole droplet, or single droplet a part.Or, hole can accommodate multiple droplets, such as extremely
Few 2,3,4,5 or 10 droplets, or more.
In some embodiments, in collecting zone, each region in the multiple subregion is in addressable alone
Position.For example, each subregion in the multiple subregion may correspond to structure or the space limited, these structures and space are with energy
Enough identifications are present in the structure of any such restriction or the mode of the subregion in space is encoded, arranges or arranged.In some realities
Apply in scheme, the structure of restriction or space can be the hole for being sized to accommodate single subregion.
Can be used for the chip is that outside source of thermal power is followed to each subregion progress heat in the multiple subregion
Ring.For example, the source of thermal power can be infrared power source.In some embodiments, it can be used and be incorporated into the chip
Source of thermal power carries out thermal cycle to each subregion in the multiple subregion.For example, the source of thermal power be thermoelectric element (for example
Peltier elements) or stratie.Or, the source of thermal power can be inductive heating element.
In some embodiments, thermoelectric element (such as Peltier elements) attaches to the side (example of the collecting zone
Such as downside).The thermoelectric element can be in close contact with the collecting zone, and its area can be as big as at least whole collecting region of covering
Domain.
In some embodiments, the side (such as bottom side) of the collecting zone can be prepared by heat absorption material, described
Material can convert light energy into heat.For example, the collecting zone with can be by by the relative side (such as top side) of heat absorption material
The material (such as transparent material) for being transmissive to light is made.Therefore, light is (such as from the infrared lamp above the collecting zone
The light of transmitting) side is may pass through, and available for the temperature (for example, changing the temperature in subregion) for improving collecting zone.
In some embodiments, in collecting zone can comprising one or more temperature sensors with monitoring temperature (for example
Real-time monitoring temperature).The temperature sensor can provide anti-to the control system of the control power source (such as described IR lamps)
Feedforward information.After temperature sensor receive information, the control system can be compiled then by one or more independent or entirety
Journey is controlled by the computer processor of the adjustment power source.
When multiple chips or control area are contained in or are integrated in the rotatable supporting construction, the power source
(such as one or more infrared lamps) can be arranged such that the multiple chip or collecting zone with the rotation of the supporting construction
Turn to be evenly exposed to the power source (such as light source), so that it is guaranteed that different chips or collecting zone in the supporting construction
It is heated properly.
The chip can include one or more entrances and one or more outlets.Each entrance can with it is one or more
Bank fluid communication.Bank can be filled with fluid (aqueous fluids or non-aqueous fluid), and the fluid is to be supplied in one or many
The passage included in individual chip.Thick mouth can be located at an end for including passage in chip and/or collecting zone.One can be driven
Or multiple subregions, fluid or waste flow through outlet and flow to and the bank for exporting fluid communication.In some embodiments, institute
State entrance and/or outlet can be comprising elastic ring such as rubber ring or connector such as rubber tube with the inlet/outlet and institute
State formation sealedly connection between bank.In some cases, first passage and/or second channel and the outlet can be used
Between pressure drop the aqueous fluids and non-aqueous fluid are flowed.The pressure drop can be at least about 0.1psi, extremely
Few about 0.5psi, at least about at least about 1psi, at least about 5psi, at least about 10psi, at least about 15psi, 20psi, at least about
30psi, at least about 40psi, at least about 50psi, at least about 60psi, at least about 70psi, at least about 80psi, at least about
90psi, at least about 100psi, at least about 150psi, at least about 200psi, at least about 250psi, at least about 300psi, at least about
350psi, at least about 400psi, at least about 450psi, at least about 500psi, at least about 750psi or bigger.The pressure drop can
At most about 750psi, at most about 500psi, at most about 450psi, at most about 400psi, at most about 350psi, at most about
300psi, at most about 250psi, at most about 200psi, at most about 150psi, at most about 100psi, at most about 90psi, at most about
80psi, at most about 70psi, at most about 60psi, at most about 50psi, at most about 40psi, at most about 30psi, at most about
20psi, at most about 15psi, at most about 10psi, at most about 5psi, at most about 1psi, at most about 0.5psi, at most about 0.1psi
Or it is smaller.In some embodiments, by controlling the import, the first passage and/or second channel and the outlet
Between pressure drop substantial constant, generate it is multiple be substantially monodispersed subregions.
The chip and/or one or more banks can include filter or enriching apparatus and come from nucleic acid sample to remove
Desired composition in the undesirable material of product, and/or the enrichment nucleic acid samples.Filter or enriching apparatus it is non-limiting
Property example include filter membrane, such as nitrocellulose, cellulose acetate, makrolon, polypropylene and polyvinylidene fluoride micropore
Film, and milipore filter (for example, those prepared by polysulfones, polyvinylidene fluoride, cellulose).In some embodiments, drive
Dynamic stream is from the aqueous fluids and/or non-aqueous fluid of one or more of banks by one or more filters to enter
State the entrance of chip.In some embodiments, permeate is collected in single bank.
In order to detect the signal for indicating the amplified production presence or absence, inspection of the present invention simultaneously in multiple subregions
Survey can further comprise guiding excitation energy to the multiple subregion, and detect the signal launched from the multiple subregion.It is described
The detector integrated with the chip can be used to detect for signal.In some cases, the chip exterior can be used in the signal
Detector detection.For example, the detector can be charge coupling device (CCD) camera.
The excitation energy can be by providing with the excitation energy source that the chip is integrated.In some cases, it is described to excite
Energy can be provided by the excitation energy source of the chip exterior.For example, the excitation energy source can be by light emitting diode or laser
There is provided.The signal can be optical signalling (such as fluorescence signal), photochemistry signal, and/or electrostatic signal.In some embodiment party
In case, provided in the side (such as collecting zone above) of the chip optical image capturing apparatus (such as CCD camera) and
Adjoint fluorescence excitation light source.
In detection of the present invention, the flow velocity that the multiple subregion flows through the collecting zone is smaller than about 10ml/
H, for example, less than about 9ml/h, less than about 8ml/h, less than about 7ml/h, less than about 6ml/h, less than about 5ml/h, less than about 4ml/
H, less than about 3ml/h, less than about 2ml/h, less than about 1ml/h, less than about 0.5ml/h, 0.1ml/h, 0.01ml/h or smaller.
In some embodiments, in detection of the present invention, the multiple subregion is substantially static.
The method of the present invention can further comprise after the detection has been carried out (for example, indicating described expand have detected
After the signal for the presence or absence for increasing production thing), guide the multiple subregion to leave the collecting zone, flow direction outlet.It is described go out
Mouth can be under negative pressure.In some cases, the negative pressure may be less than or about -5 bars, -4 bars, -3 bars, -2 bars, -1 bar, -0.9
Bar, -0.8 bar, -0.7 bar, -0.6 bar, -0.5 bar, -0.4 bar, -0.3 bar, -0.2 bar, -0.1 bar, -0.05 bar, -0.04 bar, -
0.03 bar, -0.02 bar, -0.01 bar, -0.005 bar, -0.001 bar, -0.0001 bar, or it is smaller.The first passage and/or
Two passages can be in direct draught relative to the outlet.In some cases, first passage and/or second channel and institute can be used
The pressure drop between outlet is stated so that the aqueous fluids, non-aqueous fluid and/or the subregion (such as droplet) flow
It is dynamic.The pressure drop can be at least about 0.1psi, at least about at least about 0.5psi, at least about 1psi, at least about 5psi, 10psi,
At least about 15psi, at least about 20psi, at least about 30psi, at least about 40psi, at least about 50psi, at least about 60psi, at least
About 70psi, at least about 80psi, at least about 90psi, at least about 100psi, at least about 150psi, at least about 200psi, at least about
250psi, at least about 300psi, at least about 350psi, at least about 400psi, at least about 450psi, at least about 500psi, at least
About 750psi or bigger.The pressure drop can be up to about 750psi, at most about at most about 500psi, 450psi, at most about
400psi, at most about 350psi, at most about 300psi, at most about 250psi, at most about 200psi, at most about 150psi, at most
About 100psi, at most about 90psi, at most about 80psi, at most about 70psi, at most about 60psi, at most about 50psi, at most about
40psi, at most about 30psi, at most about 20psi, at most about 15psi, at most about 10psi, at most about 5psi, at most about 1psi,
At most about 0.5psi, at most about 0.1psi or smaller.
The amplified production can be detected with least about 90% susceptibility.For example, the amplified production can be down to
Few 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least
98%, at least 99% or higher susceptibility is detected.As it is used herein, susceptibility is often referred to correctly be accredited as the positive
Signal accounts for measuring for positive signal ratio.
The amplified production can be gone out with least about 90% specific detection.For example, the amplified production can be down to
Few 60%, at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least
98%, at least 99% or higher specific detection goes out.As it is used herein, specificity is often referred to correctly be accredited as feminine gender
Signal accounts for measuring for negative signal ratio.
The chip or its component (for example, the passage, described collecting zone etc.), can use multiple material and method system
It is standby.For example, the chip or its component can be formed from solid material, wherein the passage can pass through micro manufacturing, thin film deposition work
Skill such as spin coating and chemical vapors deposition, physical vapor deposition, laser manufacture, photoetching technique, engraving method (including wet-chemical or are waited
Ion processes), electro-deposition etc. formed.A variety of manufacturing process (such as soft lithographic, hot moulding, injection molding and laser ablation) can
For producing chip and its component.
In some embodiments, the chip or its component are prepared by polymer.The polymer can be flexible polymer
Thing such as dimethyl silicone polymer (" PDMS "), polytetrafluoroethylene (PTFE) (" PTFE " or) etc..For example, passage (such as miniflow
Body passage) it can be realized by using the separately fabricated microfluid system of PDMS or other soft lithographies.Other potential conjunctions
The example of suitable polymer includes but is not limited to PET (PET), polyacrylate, polymethylacrylic acid
Ester, makrolon, polystyrene, polyethylene, polypropylene, polyvinyl chloride, cyclenes copolymer (COC), polytetrafluoroethylene (PTFE), fluoro gather
Compound, siloxanes (such as dimethyl silicone polymer), polyvinylidene chloride, dibenzo cyclobutane (BCB), polyimides, polyamides are sub-
Fluoro derivatives of amine etc..In addition, combination, copolymer or the blend of above-mentioned polymer be may also include.
In some embodiments, the chip or its component are by polymeric material and/or flexible material and/or elastomeric material
Prepare, and can be manufactured in order to isomorphism molding easily by hardenable fluid preparation (for example duplicating molded, injection molding,
Cast molding etc.).The hardenable fluid substantially can be induced solidification to be any, or spontaneous solid turns to solid
Fluid, the solid can accommodate or transport the fluid for fluid network.In one embodiment, the hardenable stream
Body includes polymeric liquid or liquid polymer precursor (i.e. prepolymer).Suitable polymeric liquid includes, such as thermoplasticity
Polymer, thermosetting polymer, wax, metal, or its mixture or compound, it is heated to more than fusing point.In some implementations
In scheme, suitable polymeric liquid includes the solution of one or more polymer in a suitable solvent, and the solution is being gone
Solid polymer is formed during except solvent (such as by evaporation).Such polymeric material can evaporate from molten condition or by solvent
Solidification.There are a variety of suitable polymeric materials is used to form molding.The non-limiting example of such a polymeric material includes
Siloxanes, epoxy polymer and polyacrylate.
The invention further relates to the method for amplification of nucleic acid.
In one aspect, it is present in directly from the target in the biological sample that subject obtains the invention provides a kind of amplification
The method of ribonucleic acid (RNA).This method includes:(a) provide comprising biological sample and for expanding with DNA (DNA)
Increase the reaction vessel of reagent necessary to abreast carrying out reverse transcription amplification, to obtain reactant mixture, the reagent is inverse comprising (i)
Transcriptase, (ii) archaeal dna polymerase, and (iii) are directed to target RNA primer sets;And (b) passes through the reactant mixture in reaction vessel
The primer extension reaction of multiple circulations is gone through, to generate the DNA amplification product for indicating there is target RNA, each circulation includes:(i) will
Reactant mixture is incubated the denaturation duration less equal than 60 seconds under denaturation temperature, and subsequent (ii) exists reactant mixture
The extension duration less equal than 60 seconds is incubated under elongating temperature, so as to expand target RNA.
On the other hand, it is present in directly from the target in the biological sample that subject obtains the invention provides a kind of amplification
The method of ribonucleic acid (RNA).This method includes:(a) biological sample obtained from subject is received;(b) provide comprising life
Thing sample and the reaction for expanding necessary reagent for progress reverse transcription amplification and optional DNA (DNA) are held
Device, to obtain reactant mixture, the reagent is directed to target RNA primer sets comprising (i) reverse transcriptase and (ii);(c) mix reaction
Compound undergoes the primer extension reaction of multiple circulations, to produce the expansion for the detectable amount for indicating to exist in biological sample target RNA
Increase DNA product;(d) amount of the DNA amplification product of detection (c);And (e) by the information on the amount of DNA amplification product export to
Recipient, wherein for completing (a)-(e) time quantum less than or equal to about 30 minutes.
In one aspect, it is present in the invention provides a kind of amplification from the target nucleic acid in the biological sample that subject obtains
Method.This method includes:(a) provide comprising biological sample and the reaction of reagent necessary to for carrying out nucleic acid amplification is held
Device, to obtain reactant mixture, the reagent includes (i) DNA (DNA) polymerase and optional reverse transcriptase, and
(ii) primer sets of target nucleic acid are directed to;And (b) makes the multiple serial primer extends of reactant mixture experience in reaction vessel anti-
It should indicate there is the amplified production of target nucleic acid in biological sample to generate, each series following is followed including two or more
Ring:(i) the incubation reaction mixture under with denaturation temperature and the Denaturing that is characterized of denaturation duration, subsequent (ii) with
Incubation reaction mixture under the conditions of the extension that elongating temperature and extension duration are characterized, wherein with regard to Denaturing and/or prolonging
Stretch for condition, single series is different from least one other single series in the multiple series.
In one aspect, the invention provides a kind of method for being used to detect the target nucleic acid molecule in biological sample.It is described
Method may include:A) biological sample is mixed to obtain mixture with lysis buffer;B) by the mixture higher than
The incubation duration of no more than about 15 minutes is incubated under 15 DEG C of incubation temperature, or without being incubated;C) will be from b) it is mixed
Compound is added to reaction vessel, and the reaction vessel includes the reagent needed for carrying out nucleic acid amplification, and the reagent includes:(i) take off
Oxygen ribonucleic acid (DNA) polymerase, and (ii) are directed to the primer sets of the target nucleic acid molecule, to obtain reactant mixture;And
D) reactant mixture in the reaction vessel is undergone the primer extension reaction of multiple circulations, indicated with generating described
There is the amplified production of the target nucleic acid molecule in sample, each circulation includes:(i) reaction is incubated under denaturation temperature mixed
Compound is less equal than denaturation duration of 60 seconds, then (ii) be incubated under elongating temperature the reactant mixture be less than or
The extension duration equal to 60 seconds, so as to expand the target nucleic acid molecule.The amplified production can be DNA product.
In one aspect, the invention provides a kind of method for being used to detect the target nucleic acid molecule in biological sample.It is described
Method may include:A) biological sample is mixed to obtain mixture with lysis buffer;B) by the mixture higher than
The incubation duration of no more than about 15 minutes is incubated under 15 DEG C of incubation temperature, or without being incubated;C) will be from b) it is mixed
Compound is added to reaction vessel, and the reaction vessel includes the reagent needed for carrying out nucleic acid amplification, and the reagent includes:(i) take off
Oxygen ribonucleic acid (DNA) polymerase, and optionally, reverse transcriptase, and (ii) are directed to the primer sets of the target nucleic acid, it is anti-to obtain
Answer mixture;And the reactant mixture in the reaction vessel is undergone multiple serial primer extension reactions, with
Generation indicates there is the amplified production of the target nucleic acid in the sample, and each series following is followed including two or more
Ring:(i) reactant mixture is incubated under the Denaturing being characterized with denaturation temperature and denaturation duration, subsequent (ii)
The reactant mixture is incubated under the conditions of the extension being characterized with elongating temperature and extension duration, wherein the just denaturation
For condition and/or the extension condition, single series is different from least one other single series in the multiple series.
The biological sample can include fecal specimens.The biological sample can include milk sample.The amplified production can be DNA productions
Thing.
In one aspect, the invention provides a kind of method for being used to detect the target nucleic acid molecule in biological sample.It is described
Method may include:A) biological sample is mixed to obtain mixture with lysis buffer;B) by the mixture higher than
The incubation duration of no more than about 15 minutes is incubated under 15 DEG C of incubation temperature, or without being incubated;C) will be from b) it is mixed
Compound is added to reaction vessel, and the reaction vessel includes the reagent needed for carrying out nucleic acid amplification, and the reagent includes:(i) take off
Oxygen ribonucleic acid (DNA) polymerase, and optionally, reverse transcriptase, and (ii) are directed to the primer sets of the target nucleic acid, it is anti-to obtain
Answer mixture;And the reactant mixture in the reaction vessel is undergone multiple serial primer extension reactions, with
Generation indicates there is the amplified production of the target nucleic acid in the sample, and each series following is followed including two or more
Ring:(i) reactant mixture is incubated under the Denaturing being characterized with denaturation temperature and denaturation duration, subsequent (ii)
The reactant mixture is incubated under the conditions of the extension being characterized with elongating temperature and extension duration, wherein the just denaturation
For condition and/or the extension condition, single series is different from least one other single series in the multiple series.
The biological sample can include fecal specimens.The biological sample can include milk sample.The amplified production can be DNA productions
Thing.
Any aspect in many aspects of the present invention, " incubation temperature " can be greater than about 15 DEG C, for example, in height
It is high in about 20 DEG C, greater than about 25 DEG C, greater than about 30 DEG C, greater than about 35 DEG C, greater than about 40 DEG C, greater than about 45 DEG C, greater than about 50 DEG C
It is high in about 55 DEG C, greater than about 60 DEG C, greater than about 65 DEG C, greater than about 70 DEG C, greater than about 75 DEG C, greater than about 80 DEG C, greater than about 85 DEG C
It is high in about 90 DEG C, greater than about 91 DEG C, greater than about 92 DEG C, greater than about 93 DEG C, greater than about 94 DEG C, greater than about 95 DEG C, greater than about 96 DEG C
It is incubated at a temperature of about 97 DEG C, greater than about 98 DEG C, greater than about 99 DEG C, greater than about 100 DEG C, or, at about 20 DEG C to about
Be incubated at a temperature of 90 DEG C, for example, about 25 DEG C to about 85 DEG C, about 30 DEG C to about 80 DEG C, about 40 DEG C to about 70 DEG C, about 40
DEG C to about 95 DEG C, about 45 DEG C to about 90 DEG C, about 50 DEG C to about 85 DEG C, about 55 DEG C to about 80 DEG C, about 60 DEG C to about 75 DEG C, about 65 DEG C
To being incubated at a temperature of about 75 DEG C or about 65 DEG C to about 70 DEG C.
Any aspect in many aspects of the present invention, described " being incubated the duration " can be not more than 20 minutes.Example
Such as, described " be incubated duration " can be not more than 19 minutes, not more than 18 minutes, not more than 17 minutes, not more than 16 minutes,
Not more than 15 minutes, not more than 14 minutes, not more than 13 minutes, not more than 12 minutes, not more than not more than 11 minutes, 10 points
Clock, not more than 9 minutes, not more than 8 minutes, not more than 7 minutes, not more than 6 minutes, not more than 5 minutes, not more than 4 minutes, no
More than 3 minutes, not more than 2 minutes, not more than 1 minute, not more than 50 seconds, not more than not more than 40 seconds, 30 seconds, not more than 20
Second, not more than 15 seconds, or not more than 10 seconds.In some embodiments, the incubation duration can be zero, i.e., without incubating
Educate.
Any aspect in many aspects of the present invention, the lysis buffer can comprising NaCl, PBS and/or
HEPES.Conventional buffer solution may include but be not limited to about 0.9% sodium chloride solution, phosphate buffer, Lactated Lin Ge
Family name's solution, acetylizad Ringer's solution, phosphate buffered saline (PBS), citrate buffer, sodium carbonate buffer, sodium acid carbonate
Buffer solution, borate buffer solution, Tris buffer solutions, histidine buffering liquid, HEPES buffer solution, MOPOS buffer solutions, glycine delay
Fliud flushing, L-Glycylglycine buffer solution etc..
Any aspect in many aspects of the present invention, it is being mixed by the biological sample with the lysis buffer
Before, the biological sample can in the solution be suspended, to obtain the homogeneous prepared product for including the biological sample.The solution can
For buffer suspension liquid.The buffer suspension liquid can include NaCl, PBS and/or HEPES.The buffer solution according to workable for the present invention
May include but be not limited to about 0.9% sodium chloride solution, phosphate buffer, Lactated Ringer's solution, acetylizad woods
Grignard solution, phosphate buffered saline (PBS), citrate buffer, sodium carbonate buffer, sodium bicarbonate buffer liquid, boric acid salt buffer
Liquid, Tris buffer solutions, histidine buffering liquid, HEPES buffer solution, MOPOS buffer solutions, glycine buffer, the sweet ammonia of N- glycyl
Acid buffer etc..
Any aspect in many aspects of the present invention, the homogeneous prepared product can be at a temperature of greater than about 40 DEG C
It is incubated, for example, can be at greater than about 45 DEG C, greater than about 50 DEG C, greater than about 55 DEG C, greater than about 60 DEG C, greater than about 65 DEG C, greater than about
70 DEG C, greater than about 75 DEG C, greater than about 80 DEG C, greater than about 85 DEG C, greater than about 90 DEG C, greater than about 91 DEG C, greater than about 92 DEG C, greater than about
93 DEG C, greater than about 94 DEG C, greater than about 95 DEG C, greater than about 96 DEG C, greater than about 97 DEG C, greater than about 98 DEG C, greater than about 99 DEG C, greater than about
It is incubated at a temperature of 100 DEG C.
Any aspect in many aspects of the present invention, the homogeneous prepared product can be incubated not more than 20 minutes, example
Such as, not more than 19 minutes, not more than 18 minutes, not more than 17 minutes, not more than not more than 16 minutes, 15 minutes, not more than 14
Minute, not more than 13 minutes, not more than 12 minutes, not more than 11 minutes, not more than not more than 10 minutes, 9 minutes, not more than 8
Minute, not more than 7 minutes, not more than 6 minutes, not more than 5 minutes, not more than 4 minutes, not more than 3 minutes, not more than 2 minutes,
Not more than 1 minute, not more than 50 seconds, not more than 40 seconds, not more than 30 seconds, not more than 20 seconds, not more than 15 seconds, or not more than 10
Second.
In some embodiments, can be to the life before the biological sample is mixed with the lysis buffer
Thing sample is centrifuged, to obtain the supernatant and precipitation comprising biological sample.In some embodiments, in the biological sample
Before product are mixed with the lysis buffer, the biological sample can be centrifuged, to obtain supernatant and comprising biological sample
The precipitation of product.
In some embodiments, can be to institute after the mixture of the biological sample and lysis buffer is incubated
Mixture is stated to be centrifuged to obtain supernatant.The supernatant can include biological sample.Then, the supernatant can be used as
Mixture in subsequent reactions.For example, the supernatant can be added to comprising for carrying out the reagent needed for nucleic acid amplification
In reaction vessel.
In some cases, before the primer extension reaction is carried out, can make the target nucleic acid molecule undergo one or
Multiple Denaturings.One or more of Denaturings may be selected from denaturation temperature distribution and denaturant.
In some cases, can be by the biological sample at 90 DEG C to 100 DEG C before the primer extension reaction is carried out
Preheating temperature under preheating be not more than the pre- thermal endurance of 10 minutes.In some embodiments, the pre- thermal endurance
Not more than 1 minute.
Any aspect in many aspects of the present invention, can be in the case where not carrying out DNA or RNA extractions by the life
The mixture of thing sample and lysis buffer is added to reaction vessel, and the reaction vessel includes the examination needed for carrying out nucleic acid amplification
Agent.In some cases, can in the case where not purified by the mixture be added to the reaction vessel.In some feelings
Under condition, the mixture is added to the reaction vessel under conditions of can concentrating or be enriched with not carrying out DNA or RNA.
Any aspect in many aspects of the present invention, has expanded the nucleic acid from the biological sample derived from subject.
In some embodiments, the biological sample can be obtained directly from source.For example, the biological sample can be directly from it
Source is obtained, and without preculture, non-selective enrichment, selective enrichment, be plated on differentiation culture medium, and/or the life of expected property
Thing medical verification." preculture " is often referred to before the method for the present invention is carried out, to one or more target kind (examples in sample
Such as microorganism) expanded, or increase the method for its quantity." non-selective enrichment " is often referred to non-selectively in population mixture
The method of the middle all or most of species (such as microorganism) of increase." selective enrichment " is often referred in population mixture increase by one
The ratio and/or amount of kind or a variety of particular species (such as microorganism), and suppress the method for other species.This suppression can be
Due to the selective toxicity of medium component such as compound, and organism by the use of medium component when be used as microbial metabolism
End-product and the selective toxicity of material produced." differentiation culture medium " is often referred to include the indicant of one or more additions,
Allow to distinguish the culture medium of the specified chemical reaction occurred in growth course." it is expected that the identification of property biomedicine " is often referred to
Microorganism is made based on the observation of growth, Gram's staining result etc. to colony characteristicses, on primary isolation medium
The Preliminary Identification gone out.
In some embodiments, the biological sample increases bacterium through culture.For example, before being mixed with lysis buffer,
Biological sample can be made to undergo the culture duration under the conditions of enrichment culture.The enrichment culture condition may include suitably training
Support base (such as Tryptic Soy nutrient solution (TBS), modified Tryptic Soy nutrient solution, tryptone, nutrient medium, bacteriolyze culture
Liquid (LB), Gram-negative nutrient solution, peptone, Tryptic Soy nutrient solution or salmonella culture medium containing yeast) in close
At suitable temperature (for example, about 23 DEG C to about 40 DEG C, such as about 25 DEG C, about 30 DEG C, about 35 DEG C or about 37 DEG C etc.) vibration or not
Biological sample is cultivated under conditions of vibration.In some embodiments, the culture medium is salmonella culture medium, its relative to
Other bacteriums, are more beneficial for salmonella propagation.Exemplary salmonella culture medium includes bismuth sulfite agar (BS), xylose
Lysine deoxycholic acid agar (XLD), selenium bright green sulfanilamide (SN) nutrient solution (SBG) etc., but not limited to this.When the culture continues
Between can be about 0.5 hour to 10 hours, for example, about 1 hour, about 1.5 hours, about 2 hours, about 2.5 hours, about 3 hours, about
3.5 hours, about 4 hours, about 4.5 hours, about 5 hours, about 5.5 hours, about 6 hours, about 6.5 hours, about 7 hours, it is about 7.5 small
When, about 8 hours, about 8.5 hours, about 9 hours, about 9.5 hours or about 10 hours.In some embodiments, the culture is held
The continuous time is no more than about 7 hours, for example, no more than about 6.5 hours, no more than about 6 hours, no more than about 5.5 hours, do not surpass
Cross about 5 hours, be no more than about 4.5 hours, be no more than about 4 hours, be no more than about 3.5 hours, be no more than about 3 hours, be no more than
About 2.5 hours, no more than about 2 hours, no more than about 1.5 hours, no more than about 1 hour or no more than about 0.5 hour.
In some embodiments, before the biological sample experienced the culture duration under the conditions of enrichment culture
And/or afterwards, the biological sample can be centrifuged, to obtain the supernatant and precipitation comprising biological sample.In some realities
Apply in scheme, the biological sample was experienced under the conditions of enrichment culture before or after the culture duration, can be to described
Biological sample is centrifuged, to obtain supernatant and precipitation comprising biological sample.
In some embodiments, the biological sample experienced under the conditions of enrichment culture culture the duration it
Afterwards, the biological sample can be mixed with lysis buffer, and do not suffer from selective enrichment, be plated on differentiation culture medium, and/or
It is expected that the biomedical identification of property.
In some embodiments, the biological sample experienced under the conditions of enrichment culture culture the duration it
Afterwards, lysis buffer can be added to the mixture.The lysis buffer can be alkaline.For example, the cracking buffering
Liquid can include NaOH.The pH of the lysis buffer can be about 7 to about 14, such as about 8 to about 13, about 9 to about 12, about 10 to about
11.For example, the pH of the lysis buffer can be about 7,7.5,8,8.5,9,9.5,10,10.5,11,11.5,12,12.5,13,
13.5 or 14.
Any aspect in the multiple aspect, the present invention relates to obtain biological sample from subject.In certain situation
Under, the biological sample is directly obtained from subject.The biological sample directly obtained from subject is often referred to such biological sample:
It does not enter after subject obtains in addition to any means further handled for gathering biological sample from subject
Row further processing.For example, directly obtaining blood from subject by following steps:Into the circulatory system of subject, from by
Blood (for example, by pin) is taken out in examination person, and the blood of taking-up is entered in storage.The storage can be comprising reagent (for example, anti-
Coagulant), to cause blood sample to can be used for further analysis.In another example, swab can be used to obtain subject's
Epithelial cell on oralpharyngeal surfaces.In another example, swab can be used to obtain the fecal specimens of subject.Obtained from subject
Obtain after biological sample, the swab containing biological sample can be made to be contacted with fluid (for example, buffer solution), to collect biological from swab
Fluid.
In some embodiments, the biological sample is fecal specimens.In some embodiments, the fecal specimens
For solid manure sample.In some embodiments, the fecal specimens are liquid manure sample.In some embodiments,
The solid-like fecal specimens can be suspended in appropriate buffer solution, as suspension fecal specimens.In some embodiments, institute
It can be watery diarrhea thing to state liquid fecal specimens.
In some embodiments, the biological sample is obtained by swab.For example, the available swab scraping solid excrement
Just sample surfaces, to obtain fecal specimens.Or, the swab can be immersed liquid manure sample or suspension fecal specimens, with
Obtain fecal specimens.The swab can be sterile swab.The swab can be sterile flocking swab.
Also fecal specimens can be obtained with other methods, for example, pipette, microsyringe, syringe, pipette can be used
Pipe, pipettor etc. obtain liquid manure sample or suspension fecal specimens.For example, small spoon, liquid relief point, tweezers etc. can be used to obtain
Solid manure sample.
Any aspect in many aspects of the present invention, the weight of the biological sample can be about 50mg to about 5g, example
Such as, the weight of the biological sample can be about 50mg, 100mg, 150mg, 200mg, 250mg, 300mg, 350mg, 400mg,
450mg、500mg、550mg、600mg、650mg、700mg、750mg、800mg、850mg、900mg、950mg、1.0g、1.1g、
1.2g, 1.3g, 1.4g, 1.5g, 1.6g, 1.7g, 1.8g, 1.9g, 2.0g, 2.5g, 3.0g, 3.5g, 4.0g, 4.5g or 5.0g,
Or can be any value or scope between any of the above-described numerical value.
Any aspect in many aspects of the present invention, the volume of liquid biological sample or the suspension biological sample can
It is about 50 μ l to about 5ml, for example, the volume of the biological sample can be about 50 μ l, 100 μ l, 150 μ l, 200 μ l, 250 μ l, 300
μl、350μl、400μl、450μl、500μl、550μl、600μl、650μl、700μl、750μl、800μl、850μl、900μl、
950μl、1.0ml、1.1ml、1.2ml、1.3ml、1.4ml、1.5ml、1.6ml、1.7ml、1.8ml、1.9ml、2.0ml、
2.5ml, 3.0ml, 3.5ml, 4.0ml, 4.5ml or 5.0ml, or can be any value or scope between any of the above-described numerical value.
In some embodiments, biological sample is not yet purified when being provided in reaction vessel.In some embodiments
In, when biological sample is provided into reaction vessel, the nucleic acid of biological sample is not yet extracted.Biological sample is provided for example, working as
During into reaction vessel, RNA or DNA in biological sample may be extracted not from biological sample.In addition, in some embodiments
In, before biological sample is provided into reaction vessel, it is present in the target nucleic acid in biological sample (for example, target RNA or target
DNA) may be not concentrated.
The present invention many aspects any one in, the mixture of the biological sample and the lysis buffer can be
Do not undergo under conditions of DNA or ribonucleic acid (RNA) are extracted and be added in reaction vessel.In some cases, the mixture
It can be added under conditions of not undergoing purifying in reaction vessel.In some cases, the mixture can not undergo DNA or
It is added under conditions of RNA concentrations in reaction vessel.The reaction vessel can be to include the examination needed for for carrying out nucleic acid amplification
The reaction vessel of agent.
For example, the mixture of the biological sample and the lysis buffer is incubated as described in other parts herein
Afterwards, can be not purified added to reaction vessel by the mixture.For example, can be by the mixture without DNA or ribose core
Sour (RNA) is extracted and is added to reaction vessel.For example, the mixture can be concentrated without DNA or ribonucleic acid (RNA) and added
Add to reaction vessel.The reaction vessel can be to include the reaction vessel of the reagent needed for for carrying out nucleic acid amplification.
For example, after supernatant can be produced mixture specifically described herein is centrifuged, by the supernatant not
It is purified to be added to reaction vessel.For example, after supernatant can be produced mixture specifically described herein is centrifuged, will
The supernatant extracts without DNA or ribonucleic acid (RNA) and is added to reaction vessel.For example, can be will be specifically described herein
Mixture is centrifuged after producing supernatant, the supernatant to be concentrated without DNA or ribonucleic acid (RNA) and is added to
Reaction vessel.The reaction vessel can be to include the reaction vessel of the reagent needed for for carrying out nucleic acid amplification.
Any suitable biological sample comprising nucleic acid can be obtained from subject.Biological sample can be solid matter (example
Such as, biological tissue), or can be fluid (for example, biofluid).Generally, biofluid may include related to live organism
Any fluid.The non-limiting examples of biological sample include any anatomical location from subject (for example, tissue, circulation
System, marrow) obtain blood (or the composition of blood-for example, leucocyte, red blood cell, blood platelet), from any of subject
Cell that anatomical location is obtained, skin, heart, lung, kidney, expiratory air, marrow, excrement, seminal fluid, vaginal secretion, from swollen
It is the tissue fluid of tumor tissue, mammary gland, pancreas, cerebrospinal fluid, tissue, brush,throat, biopsy article, placental fluids, amniotic fluid, liver, muscle, flat
Sliding flesh, bladder, gall-bladder, colon, intestines, brain, chamber liquid, phlegm, purulence, micropopulation (microbiota), meconium, milk, prostate, food
Road, thyroid gland, serum, saliva, urine, gastric juice and digestive juice, tear, ocular fluids, sweat, mucus, earwax, oil, body of gland point
Secretion, spinal fluid, hair, nail, Skin Cell, blood plasma, nose swab or nasopharynx washing lotion, spinal fluid, Cord blood, lymph
(lymphatic fluid) and/or other excretas or bodily tissue.
In other cases, the biological sample may be from soil or food.For example, the foodstuff samples can be dairy products
Sample.In some cases, the dairy products sample may include milk.
From subject biological sample can be obtained by a variety of methods.Means for directly obtaining biological sample from subject
Non-limiting examples include:Into the circulatory system (for example, through syringe or other pins be intravenous or intra-arterial entrance), collect
The biological sample (for example, excrement, urine, phlegm, saliva etc.) of secretion, surgical operation (for example, biopsy), wipe (for example, oral cavity is wiped
Son, oropharynx swab, procto swab), liquid relief and breathing.In addition, any solution that can be from subject residing for desired biological sample
Cut open position and obtain biological sample.In some embodiments, the biological sample can be obtained from its packing material, for example, including food
The packing material of thing (such as milk) or soil.Soil can be life under mineral matter, organic substance, gas, liquid and certain situation
The mixture of object.
Any aspect in the multiple aspect, is expanded to generate amplified production to target nucleic acid.Target nucleic acid can be with
It is target RNA or target DNA.Target nucleic acid be target RNA in the case of, target RNA can be any kind of RNA, including herein other
RNA types described in place.In some embodiments, target RNA is viral RNA.In some embodiments, viral RNA can
Can be pathogenic for subject.Causative virus RNA non-limiting examples include human immunodeficiency virus I (HIV I), people
HIV II (HIV II), orthomyxovirus, Ebola virus, dengue virus, influenza virus (for example, H1N1, H3N2,
H7N9 or H5N1), hepatitis viruse, hepatitis A virus, hepatitis type B virus, HCV (for example, tool first RNA-
HCV virus), Hepatitis D virus, HEV, HGV RNA, Epstein-Barr virus, monocytosis,mononucleosis it is viral, huge
Cell virus, SARS virus, west nile fever virus, poliovirus, measles virus, enterovirus (such as Coxsackie virus,
Such as coxsackie virus A 16) and norovirus (such as norovirus GI or norovirus GII).
In the case where target nucleic acid is target DNA, target DNA can be any kind of DNA, including described in elsewhere herein
DNA types.In some embodiments, target DNA is viral DNA.In some embodiments, viral DNA may for by
Examination person is pathogenic.The non-limiting examples of DNA virus include herpes simplex virus, variola virus, adenovirus (for example, 55
Type adenovirus, 7 type adenovirus) and varicella virus (for example, fowl pox).
In some cases, target DNA can be DNA of bacteria.DNA of bacteria may be from being pathogenic bacterium to subject,
For example, the pathogenic bacteria can be Gram-positive or Gram-negative pathogenic bacteria.For example, the pathogenic bacteria can
Selected from staphylococcus aureus (Staphylococcus aureus), Listeria monocytogenes (Listeria
Monocytogenes), Escherichia coli (Escherichia coli), Enterobacter sakazakii (Enterobacter sakazakii),
Vibrio parahaemolytious (Vibrio Parahemolyticus), Shigella (Shigella spp.) and mycobacterium tuberculosis ---
One kind, which has been notified, causes phthisical bacterium.In some cases, target DNA can be (for example, a kind of from pathogenic protozoa
Or the protozoan of a variety of plasmodium types for causing malaria) DNA.
Any aspect in many aspects of the present invention, when the biological sample is mixed to obtain with the buffer suspension liquid
When obtaining homogeneous prepared product, the biological sample can be about 5 to the ratio of the buffer suspension liquid:1 (wt/vol) to about 1:500
(wt/vol), for example, about 1:1 (wt/vol) to about 1:100(wt/vol).For example, the biological sample is to the buffer suspension
The ratio of liquid can be about 5:1 (wt/vol), about 4:1 (wt/vol), about 3:1 (wt/vol), about 2:1 (wt/vol), about 1:1(wt/
Vol), about 1:2 (wt/vol), about 1:3 (wt/vol), about 1:4 (wt/vol), about 1:5 (wt/vol), about 1:6 (wt/vol), about
1:7 (wt/vol), about 1:8 (wt/vol), about 1:9 (wt/vol), about 1:10 (wt/vol), about 1:20 (wt/vol), about 1:30
(wt/vol), about 1:40 (wt/vol), about 1:50 (wt/vol), about 1:60 (wt/vol), about 1:70 (wt/vol), about 1:80
(wt/vol), about 1:90 (wt/vol), about 1:100 (wt/vol), about 1:110 (wt/vol), about 1:120 (wt/vol), about 1:
130 (wt/vol), about 1:140 (wt/vol), about 1:150 (wt/vol), about 1:160 (wt/vol), about 1:170 (wt/vol),
About 1:180 (wt/vol), about 1:190 (wt/vol), about 1:200 (wt/vol), about 1:250 (wt/vol), about 1:300(wt/
Vol), about 1:350 (wt/vol), about 1:400 (wt/vol), about 1:450 (wt/vol), or about 1:500(wt/vol).
Any aspect in many aspects of the present invention, when lysis buffer is added into the homogeneous prepared product,
The lysis buffer can be about 50 to the ratio of the homogeneous prepared product:1 (vol/vol) to about 1:50 (vol/vol), for example
About 5:1 (vol/vol) to about 1:5(vol/vol).For example, the lysis buffer can be to the ratio of the homogeneous prepared product
About 50:1 (vol/vol), 40:1 (vol/vol), 30:1 (vol/vol), 20:1 (vol/vol), 10:1 (vol/vol), 9:1
(vol/vol), 8:1 (vol/vol), 7:1 (vol/vol), 6:1 (vol/vol), 5:1 (vol/vol), about 4:1 (vol/vol),
About 3:1 (vol/vol), about 2:1 (vol/vol), about 1:1 (vol/vol), about 1:2 (vol/vol), about 1:3 (vol/vol), about
1:4 (vol/vol), about 1:5 (vol/vol), about 1:6 (vol/vol), about 1:7 (vol/vol), about 1:8 (vol/vol), about 1:
9 (vol/vol), about 1:10 (vol/vol), about 1:20 (vol/vol), about 1:30 (vol/vol), about 1:40 (vol/vol), or
About 1:50(vol/vol).
Any aspect in many aspects of the present invention, the biological sample obtained from subject or from described herein
Mixture, supernatant, suspension or homogeneous prepared product derived from biological sample with for carrying out nucleic acid amplification institute in reaction vessel
Required reagent provides to obtain reactant mixture together.Besides or furthermore, any mixture obtained from biological sample, supernatant
Liquid, suspension or homogeneous prepared product can with for carrying out providing together with reagent to obtain necessary to nucleic acid amplification in reaction vessel
Reactant mixture.Any suitable reaction vessel can be used.In some embodiments, reaction vessel includes main body, the main body
It may include inner surface, outer surface, openend and relative blind end.In some embodiments, reaction vessel may include lid.Institute
Stating lid can be configured as in its openend and body contact so that the openend closing of the reaction vessel when being contacted.
Under certain situation, the lid is for good and all associated with reaction vessel so that it remains attached to anti-under opening and closing configuration
Answer container.In some cases, the lid is removable, so that when reaction vessel is opened, lid is separated with reaction vessel.
In some embodiments, reaction vessel can be sealed, in some cases to be gas-tight seal.
Reaction vessel can have different sizes, shape, weight and configuration.In some instances, reaction vessel can be
Circular or ellipse tubulose.In some embodiments, reaction vessel can be rectangle, square, rhombus, circle, ellipse
Shape or triangle.Reaction vessel can be regular shape or irregular shape.In some embodiments, the closing of reaction vessel
End can have taper, circular or flat surface.The non-limiting examples of type of reaction vessel include pipe, hole, capillary, cylinder, ware,
Centrifuge tube or head of pipette.Reaction vessel can be constructed by any suitable material, and the non-limiting examples of these materials include glass
Glass, metal, plastics and combinations thereof.
In some embodiments, reaction vessel is a part for reaction vessel array.Reaction vessel array is especially useful
Multiple samples are handled in automatic mode and/or simultaneously.For example, the microwell plate that reaction vessel can be made up of many holes
Hole.In another example, reaction vessel may be housed in the hole of hot block of thermal cycler, and wherein thermal cycle block includes each can
Receive multiple holes of shuttle.The array being made up of reaction vessel may include any an appropriate number of reaction vessel.For example, battle array
Row may include at least 2,4,6,8,10,12,14,16,18,20,25,35,48,96,144,384 an or more reaction vessels.
The reaction vessel part of reaction vessel array can also individually be addressed by fluid treating device so that the fluid treating device can be just
Really identification reaction vessel, and appropriate fluent material is assigned in reaction vessel.Fluid treating device can be used for fluid material
Expect the addition automation into reaction vessel.
In some embodiments, reaction vessel can include multiple hot-zones.Hot-zone in reaction vessel can be by making reaction
The different zones of container are realized exposed to different Thermal cycling conditions.For example, reaction vessel may include top hot-zone with
Portion hot-zone.Top hot-zone can receive biological sample and examination necessary to for obtaining the reactant mixture for nucleic acid amplification
Agent.The reactant mixture can then undergo the first thennocycling protocols.After the circulation of desired number, for example, reactant mixture
Slowly but continuously lower hotspot can be leaked into from top hot-zone.In lower hotspot, reactant mixture is then subjected to and top
The circulation of the desired number of the second different thennocycling protocols of the scheme of hot-zone.These strategies are when using nested PCR amplification DNA
May be particularly useful.In some embodiments, in reaction under the auxiliary for the temperature-sensitive layered material that hot-zone can be in reaction vessel
Produced in container.In tiiese cases, reactant mixture is discharged into from a hot-zone using the heating of temperature-sensitive layered material
In next hot-zone.In some embodiments, reaction vessel include 2,3,4,5,6,7,8,9,10,11,12,13,14,15
Or more hot-zone.
In some embodiments, the reaction vessel comprising hot-zone can be used for handling biological sample before nucleic acid amplification.Example
Such as, decomposition agent can be added to the first of reaction vessel before addition biological sample and for reagent necessary to nucleic acid amplification
Hot-zone.When in the reaction vessel that biological sample and reagent are added to comprising decomposition agent, acquisition can crack the biological sample
The reactant mixture of interior species (for example, cell or virion).Or, can be by decomposition agent and biological sample and reagent simultaneously
It is added in the first hot-zone of reactant mixture.The temperature conditionss for making the first hot-zone be subjected to being suitable for decomposition agent effect can be used to
The cell and virion in biological sample are cracked in first hot-zone so that the nucleic acid in the biological sample is discharged into reaction mixing
In thing.After cracking, reactant mixture can be then set to enter the second hot-zone of reaction vessel, for using amplification as described herein
Method is expanded to the nucleic acid of release.
The lysis buffer can include any suitable decomposition agent, including commercially available decomposition agent.The non-limit of decomposition agent
Property example processed includes Tris-HCl, EDTA, detergent (for example, Triton X-100, SDS), lysozyme, glucolase
(glucolase), protease E, viral endolysin, outer lysin (exolysin), zymolase (zymolose), lyticase
(Iyticase), Proteinase K, endolysin and outer lysin from bacteriophage, the endolysin from bacteriophage PM2, from withered grass
Bacillus (B.subtilis) bacteriophage PBSX endolysin, from lactobacillus prophage Lj928, Lj965, bacteriophage
15Phiadh endolysin, the endolysin from streptococcus pneumonia bacteriophage Cp-I, Streptococcusagalactiae bacteriophage B30's is difunctional
Peptide glycan lysin, endolysin and outer lysin from prophage bacterium, from the interior of Listeria (Listeria) bacteriophage
Lysin, cave albumen (holin)-endolysin, the lysis genes of cell 20, holWMY walsh staphylococcuses (Staphylococcus
Wameri) M bacteriophages varphiWMY, walsh staphylococcus M bacteriophages varphiWMY Iy5WMY, Tween 20, PEG,
KOH, NaCl, and combinations thereof.In some cases, buffer solution can include decomposition agent (for example, lysis buffer).Lysis buffer
An example be sodium hydroxide (NaOH).In some embodiments, the biological sample is without detergent-treatment.For example,
The lysis buffer can be free of any detergent.
The pH of the lysis buffer is about 7 to about 14, such as about 8 to about 13, about 9 to about 12, about 10 to about 11.Example
Such as, the pH of the lysis buffer can be about 7,7.5,8,8.5,9,9.5,10,10.5,11,11.5,12,12.5,13,13.5,
Or 14.
Any aspect in many aspects of the present invention, when the biological sample is mixed with the lysis buffer to obtain
When obtaining mixture, the biological sample can be about 5 to the ratio of the lysis buffer:1 (wt/vol) to about 1:10(wt/
Vol), for example, about 1:1 (wt/vol) to about 1:10(wt/vol).For example, ratio of the biological sample to the buffer suspension liquid
Example can be about 5:1 (wt/vol), about 4:1 (wt/vol), about 3:1 (wt/vol), about 2:1 (wt/vol), about 1:1 (wt/vol),
About 1:2 (wt/vol), about 1:3 (wt/vol), about 1:4 (wt/vol), about 1:5 (wt/vol), about 1:6 (wt/vol), about 1:7
(wt/vol), about 1:8 (wt/vol), about 1:9 (wt/vol), or about 1:10(wt/vol).
In some embodiments, the reaction vessel includes the reagent needed for carrying out nucleic acid amplification.For example, the reagent
It may include to carry out the reagent needed for reverse transcription amplification and/or DNA (DNA) amplification.
Any kind of nucleic acid amplification reaction is used equally for amplification target nucleic acid and generates amplified production.In addition, the expansion of nucleic acid
Increasing can be linear, exponential form or its combination.Amplification can be emulsion-based or can be with right and wrong emulsion-based.Nucleic acid
The non-limiting examples of amplification method include reverse transcription, primer extend, polymerase chain reaction, ligase chain reaction, unwindase according to
Bad amplification, non-symmetric amplification, rolling circle amplification and multiple displacement amplification (MDA).In some embodiments, amplified production can be with
It is DNA.In the case where being expanded to target RNA, DNA can be obtained by RNA reverse transcription and using subsequent DNA
Expand to generate the DNA product of amplification.The DNA product of amplification can indicate there is target RNA in biological sample.Enter to DNA
In the case of row amplification, a variety of DNA cloning methods can be used.The non-limiting examples of DNA cloning method include polymerase chain
React (PCR), PCR modification (for example, in real time PCR, ApoE gene, assembling PCR, asymmetric pcr, digital pcr,
Emulsion-based PCR, PCR, nest-type PRC, heat start PCR, inverse PCR, the methyl for transfering to PCR (dial-out PCR), unwindase to rely on
Change the asymmetric friendship of specific PCR, micro- primer PCR (miniprimer PCR), multiplex PCR, nest-type PRC, overlapping-extension PCR, heat
Wrong PCR (thermal asymmetric interlaced PCR), fall progressively PCR) and ligase chain reaction (LCR).At some
In the case of, DNA cloning is linear.In some cases, DNA cloning is exponential.In some cases, DNA cloning is adopted
Realized with nest-type PRC, it can improve the sensitivity of the DNA product of detection amplification.In some embodiments, it is specifically described herein
Amplification can refer to primer extension reaction.
In many aspects, these nucleic acid amplification reactions as described herein parallel can be carried out.Generally, parallel amplified reaction is
The amplified reaction occurred simultaneously in same reaction vessel.Parallel nucleic acid amplification reaction can be carried out as follows:For example, in reaction
Container is included for reagent necessary to each nucleic acid amplification reaction to obtain reactant mixture, and makes the reactant mixture
It is subjected to for condition necessary to each nucleic acid amplification reaction.For example, reverse transcription amplification and DNA cloning can abreast be entered as follows
OK:There is provided for reagent necessary to both amplification methods to form and obtain reactant mixture, and make in reaction vessel
The reactant mixture is subjected to being adapted for the condition of the two amplified reactions.The DNA produced by RNA reverse transcription can be abreast
Expanded to produce the DNA product of amplification.Any suitable number of nucleic acid amplification reaction can be carried out abreast.In some feelings
Under condition, abreast carry out at least 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 or more
Individual nucleic acid amplification reaction.
The parallel advantage for carrying out nucleic acid amplification reaction may include the rapid translating between the nucleic acid amplification reaction of coupling.Example
Such as, target nucleic acid (for example, target RNA, target DNA) can be extracted or discharged from biological sample in the heating period of parallel nucleic acid amplification.
In the case of target RNA, for example, the biological sample comprising target RNA can be heated and target RNA is discharged from biological sample.Released
The target RNA put can immediately begin to reverse transcription (via reverse transcription amplification) to produce complementary DNA.Then the complementation can be expanded immediately
DNA, generally in the magnitude of several seconds.Target RNA discharged from biological sample and target RNA reverse transcriptions be complementary DNA between in short-term
Between interval can help to make to may interfere with reverse transcription in biological sample and/or the influence of the inhibitor of DNA cloning is minimized.
Any aspect in these many aspects, can be used the primer sets for target nucleic acid anti-to carry out nucleic acid amplification
Should.For example, the reagent needed for the progress nucleic acid amplification may include one or more primer sets.Primer sets generally comprise it is a kind of or
A variety of primers.For example, primer sets can include about 1,2,3,4,5,6,7,8,9,10 kind or more kind primer.In some cases,
Primer sets can include the primer for different amplified production or different nucleic acid amplification reactions.For example, primer sets can be comprising the
One primer and second primer complementary with nucleic acid chains product, the first primer are the generation core complementary with least a portion of target nucleic acid
Necessary to first chain of acid product, the second primer is that generation is produced with the complementary nucleic acid of at least a portion of the chain of nucleic acid product first
Necessary to second chain of thing.
For example, primer sets can be directed to target RNA.Primer sets, which can be included, can be used for generation and target RNA at least a portion complementary
The chain of nucleic acid product first the first primer.In the case of reverse transcription reaction, the first chain of nucleic acid product can be DNA.Draw
Thing group can also include the second of the chain of nucleic acid product second that can be used for generation complementary with least a portion of the chain of nucleic acid product first
Primer.In the case of the reverse transcription reaction of progress parallel with DNA cloning, the second chain of nucleic acid product can be with from RNA moulds
One chain of nucleic acid (for example, DNA) product for the DNA complementation that plate is produced.
If it is desired, any suitable number of primer sets can be used.It is, for example, possible to use about 1,2,3,4,5,6,7,8,
9th, 10 or more primer sets.When using multiple primer sets, one or more primer sets can respectively correspond to specific core
Sour amplified reaction or amplified production.
In any aspect of many aspects, the reagent can include forward primer.The reagent can be included and is adapted for
The forward primer of any amount of nucleic acid amplification.For example, the reagent can include about less than 0.01 μM, 0.01 μM, 0.05 μM, 0.06
μM、0.07μM、0.08μM、0.09μM、0.1μM、0.2μM、0.3μM、0.4μM、0.5μM、0.6μM、0.7μM、0.8μM、0.9μ
M、1.0μM、1.1μM、1.2μM、1.3μM、1.4μM、1.5μM、1.6μM、1.7μM、1.8μM、1.9μM、2.0μM、2.5μM、3.0
μM、3.5μM、4.0μM、4.5μM、5.0μM、6.0μM、7.0μM、8.0μM、9.0μM、10.0μM、11.0μM、12.0μM、13.0μ
M, 14.0 μM, 15.0 μM, more than 15.0 μM dNTP, or between any of the above-described numerical value range of concentrations forward primer, for example, about
0.01 to 10.0 μM, 0.05 to 5.0 μM, 0.05 to 4.0 μM, 0.05 to 3.0 μM, 0.05 to 2.0 μM, 0.05 to 1.0 μM, 0.05
To 0.5 μM, 0.1 to 5.0 μM, 0.1 to 4.0 μM, 0.1 to 3.0 μM, 0.1 to 2.0 μM, 0.1 to 1.0 μM, 0.1 to 0.9 μM, 0.1
To 0.8 μM, 0.1 to 0.7 μM, 0.1 to 0.6 μM, 0.1 to 0.5 μM of forward primer.In one aspect, the reagent can include about
0.1 to 1.0 μM of forward primer.
In any aspect of many aspects, the reagent can include reverse primer.The reagent can be included and is adapted for
The reverse primer of any amount of nucleic acid amplification.For example, the reagent can include about less than 0.01 μM, 0.01 μM, 0.05 μM, 0.06
μM、0.07μM、0.08μM、0.09μM、0.1μM、0.2μM、0.3μM、0.4μM、0.5μM、0.6μM、0.7μM、0.8μM、0.9μ
M、1.0μM、1.1μM、1.2μM、1.3μM、1.4μM、1.5μM、1.6μM、1.7μM、1.8μM、1.9μM、2.0μM、2.5μM、3.0
μM、3.5μM、4.0μM、4.5μM、5.0μM、6.0μM、7.0μM、8.0μM、9.0μM、10.0μM、11.0μM、12.0μM、13.0μ
M, 14.0 μM, 15.0 μM, more than 15.0 μM dNTP, or between any of the above-described numerical value range of concentrations reverse primer, for example, about
0.01 to 10.0 μM, 0.05 to 5.0 μM, 0.05 to 4.0 μM, 0.05 to 3.0 μM, 0.05 to 2.0 μM, 0.05 to 1.0 μM, 0.05
To 0.5 μM, 0.1 to 5.0 μM, 0.1 to 4.0 μM, 0.1 to 3.0 μM, 0.1 to 2.0 μM, 0.1 to 1.0 μM, 0.1 to 0.9 μM, 0.1
To 0.8 μM, 0.1 to 0.7 μM, 0.1 to 0.6 μM, 0.1 to 0.5 μM of reverse primer.In one aspect, the reagent can include about
0.1 to 1.0 μM of reverse primer.
In some embodiments, using archaeal dna polymerase.Any suitable archaeal dna polymerase can be used, including it is commercially available
Archaeal dna polymerase.Archaeal dna polymerase is often referred to the enzyme that can be incorporated into nucleotides in the way of template is combined in DNA.DNA
The non-limiting examples of polymerase include Taq polymerase, Tth polymerases, Tli polymerases, Pfu polymerase, VENT polymerases,
DEEPVENT polymerases, EX-Taq polymerases, LA-Taq polymerases, Expand polymerases, Sso polymerases, Poc polymerases, Pab
Polymerase, Mth polymerases, Pho polymerases, ES4 polymerases, Tru polymerases, Tac polymerases, Tne polymerases, Tma polymerases,
Tih polymerases, Tfi polymerases, Platinum Taq polymerases, Hi-Fi polymerases, Tbr polymerases, Tfl polymerases,
Pfutubo polymerases, Pyrobest polymerases, Pwo polymerases, KOD polymerases, Bst polymerases, Sac polymerases, Klenow pieces
Section, and their variant, the product and derivative of modification.For certain thermal starting polymerase, it may be necessary at 94 DEG C -95 DEG C
The denaturing step of lower 2 minutes to 10 minutes, this may change heat distribution according to different polymerases.
In some embodiments, the reagent needed for the progress nucleic acid amplification may include reverse transcriptase.In some implementations
In scheme, reagent described in the present invention can include reverse transcriptase.For example, any suitable reverse transcriptase can be used.Reverse
Record enzyme is often referred to that nucleotides can be incorporated into the enzyme in DNA when being combined with RNA templates.The non-limiting reality of reverse transcriptase
Example include HIV1-RT, M-MLV reverse transcriptases, AMV reverse transcriptases, reverse transcriptase of telomere, and they variant,
The product and derivative of modification.DNA and RNA polymerase many specifically described herein or known in the art can draw in template
Nucleotide analog is utilized in the primer extension reaction led.Broad category of nucleotide analog known in the art.Ucleotides
Include ribonucleotide and deoxyribonucleotide analogs like the non-limiting examples of thing.Generally, the analog include adenosine,
Thymidine, uridine, cytidine, the analog of uridine and these bases.The analog may include ribonucleoside triphosphote, or it may also include
Extra phosphate group, such as four phosphoric acid, five phosphoric acid, six phosphoric acid, seven phosphoric acid or more.The example of some in these analogs is retouched
It is set forth in, for example U.S. Patent Application Publication 2003-0124576 and 2007-0072196, and U.S. Patent number 7,223,541
With 7,052,839, its full text is incorporated herein with regard to all purposes by quoting.
In many aspects, amplified production is generated using primer extension reaction.Primer extension reaction generally includes following
Circulation:Reactant mixture is incubated to one section of denaturation duration under denaturation temperature, and by reactant mixture in elongating temperature
It is lower to be incubated one section of extension duration.
In some cases, before the primer extension reaction is carried out, can make the target nucleic acid molecule undergo one or
Multiple Denaturings.One or more of Denaturings may be selected from denaturation temperature distribution and denaturant.
In some cases, before the primer extension reaction is carried out, by the biological sample at about 90 DEG C to about 100
DEG C pre-heating temperature under the preheating no more than about pre-add thermal endurance of 10 minutes.In some embodiments, it is described pre-
The duration of heat is no more than 1 minute.
Denaturation temperature can be according to the particular organisms sample, the particular source (example of biological sample target nucleic acid for example analyzed
Such as, virion, bacterium), used reagent and/or desired reaction condition and change.For example, denaturation temperature can be about
80 DEG C to about 110 DEG C.In some instances, denaturation temperature can be about 90 DEG C to about 100 DEG C.In some instances, denaturation temperature
It can be about 90 DEG C to about 97 DEG C.In some instances, denaturation temperature can be about 92 DEG C to about 95 DEG C.In other other examples
In, denaturation temperature can be about 80 DEG C, 81 DEG C, 82 DEG C, 83 DEG C, 84 DEG C, 85 DEG C, 86 DEG C, 87 DEG C, 88 DEG C, 89 DEG C, 90 DEG C, 91 DEG C,
92 DEG C, 93 DEG C, 94 DEG C, 95 DEG C, 96 DEG C, 97 DEG C, 98 DEG C, 99 DEG C or 100 DEG C.
Being denatured the duration can be according to the particular organisms sample, the particular source of biological sample target nucleic acid for example analyzed
(for example, virion, bacterium), used reagent and/or desired reaction condition and change.For example, when denaturation continues
Between can less equal than 300 seconds, 240 seconds, 180 seconds, 120 seconds, 90 seconds, 60 seconds, 55 seconds, 50 seconds, 45 seconds, 40 seconds, 35 seconds, 30
Second, 25 seconds, 20 seconds, 15 seconds, 10 seconds, 5 seconds, 2 seconds or 1 second.For example, denaturation the duration can no more than 120 seconds, 90 seconds, 60
Second, 55 seconds, 50 seconds, 45 seconds, 40 seconds, 35 seconds, 30 seconds, 25 seconds, 20 seconds, 15 seconds, 10 seconds, 5 seconds, 2 seconds or 1 second.
Elongating temperature can be according to the particular organisms sample, the particular source (example of biological sample target nucleic acid for example analyzed
Such as, virion, bacterium), used reagent and/or desired reaction condition and change.For example, elongating temperature can be about
30 DEG C to about 80 DEG C.In some instances, elongating temperature can be about 35 DEG C to about 72 DEG C.In some instances, elongating temperature can
It is about 45 DEG C to about 65 DEG C.In some instances, elongating temperature can be about 35 DEG C to about 65 DEG C.In some instances, temperature is extended
Degree can be about 40 DEG C to about 60 DEG C.In some instances, elongating temperature can be about 50 DEG C to about 60 DEG C.In other other examples
In, elongating temperature can be about 35 DEG C, 36 DEG C, 37 DEG C, 38 DEG C, 39 DEG C, 40 DEG C, 41 DEG C, 42 DEG C, 43 DEG C, 44 DEG C, 45 DEG C, 46 DEG C,
47℃、48℃、49℃、50℃、51℃、52℃、53℃、54℃、55℃、56℃、57℃、58℃、59℃、60℃、61℃、62
℃、63℃、64℃、65℃、66℃、67℃、68℃、69℃、70℃、71℃、72℃、73℃、74℃、75℃、76℃、77
DEG C, 78 DEG C, 79 DEG C or 80 DEG C.
Extending the duration can be according to the particular organisms sample, the particular source of biological sample target nucleic acid for example analyzed
(for example, virion, bacterium), used reagent and/or desired reaction condition and change.For example, when extension continues
Between can less equal than 300 seconds, 240 seconds, 180 seconds, 120 seconds, 90 seconds, 60 seconds, 55 seconds, 50 seconds, 45 seconds, 40 seconds, 35 seconds, 30
Second, 25 seconds, 20 seconds, 15 seconds, 10 seconds, 5 seconds, 2 seconds or 1 second.For example, extension the duration can no more than 120 seconds, 90 seconds, 60
Second, 55 seconds, 50 seconds, 45 seconds, 40 seconds, 35 seconds, 30 seconds, 25 seconds, 20 seconds, 15 seconds, 10 seconds, 5 seconds, 2 seconds or 1 second.
Any aspect in the multiple aspect, can carry out the primer extension reaction of multiple circulations.It can carry out any suitable
When the circulation of number.For example, the period carried out can with less than about 100,90,80,70,60,50,40,30,20,10 or 5 follow
Ring.The period of progress may depend on, for example, obtaining detectable amplified production (for example, indicating there is target in biological sample
The DNA amplification product of RNA detectable amount) necessary to period (for example, cycle threshold (Ct)).For example, can detect
Amplified production (for example, indicate exist in biological sample target RNA detectable amount DNA product) necessary to period can
With less than about or be about 100 circulation, 75 circulation, 70 circulation, 65 circulation, 60 circulation, 55 circulation, 50 follow
Ring, 40 circulations, 35 circulations, 30 circulations, 25 circulations, 20 circulations, 15 circulations, 10 circulations or 5 circulations.This
Outside, in some embodiments, the amplified production of detectable amount is (for example, indicate there is the detectable of target RNA in biological sample
The DNA product of amount) can be with the circulation less than 100,75,70,65,60,55,50,45,40,35,30,25,20,15,10 or 5
Threshold value (Ct) is obtained.
Amplification produce indicate exist expanded target nucleic acid detectable amount amplified production needed for time can according to from
The particular cycle of the middle biological sample for obtaining target nucleic acid, the specific nucleic acid amplified reaction that will be carried out and desired amplified reaction
Count and change.For example, the amplification of target nucleic acid can be at 120 minutes or shorter, 90 minutes or shorter, 60 minutes or shorter, 50 minutes
Or it is shorter, 45 minutes or shorter, 40 minutes or shorter, 35 minutes or shorter, 30 minutes or shorter, 25 minutes or shorter, 20 points
Clock or it is shorter, 15 minutes or shorter, the period of 10 minutes or shorter or 5 minutes or shorter produces and indicates there is target nucleic acid
The amplified production of detectable amount.
In some embodiments, target RNA amplification can at 120 minutes or shorter, 90 minutes or shorter, 60 minutes or more
It is short, 50 minutes or shorter, 45 minutes or shorter, 40 minutes or shorter, 35 minutes or shorter, 30 minutes or shorter, 25 minutes or
It is shorter, 20 minutes or shorter, 15 minutes or shorter, the period of 10 minutes or shorter or 5 minutes or shorter produces and indicates exist
The DNA amplification product of target RNA detectable amount.
In some embodiments, reactant mixture can be made to undergo multiple serial primer extension reactions.The multiple system
Single series in row may include the specific primer extension of multiple circulations, and the reaction is characterised by, for example, as herein its
Specific denaturation and extension condition described in his place.Generally, for example, for Denaturing and/or extension condition, Mei Gedan
Individual series is different from least one other single series in the multiple series.For example, with regard to oblique variable Rate, denaturation temperature, change
Property duration, elongating temperature and in the extension duration any one, two, three, four or all for five, it is single
Individual series may differ from another single series in the multiple series.In addition, multiple series may include any number of list
Individual series, for example, at least about or about 2,3,4,5,6,7,8,9,10 or more a single series.
For example, multiple serial primer extension reactions may include First Series and second series.First Series, for example, can
Primer extension reaction including more than ten circulations, wherein each circulation of First Series include (i) by reactant mixture about
It is incubated and is no more than 30 seconds at 92 DEG C to about 95 DEG C, reactant mixture is incubated by subsequent (ii) at about 35 DEG C to about 65 DEG C is no more than
About one minute.Second series, for example, it may include more than the primer extension reaction of ten circulations, wherein each of second series follows
Ring includes (i) and is incubated reactant mixture no more than 30 seconds at about 92 DEG C to about 95 DEG C, and subsequent (ii) exists reactant mixture
It is incubated at about 40 DEG C to about 60 DEG C no more than about 1 minute.In this instantiation, the first and second series are in their extension
It is different in temperature conditionss.However, the example is not intended to limit, because any group of different extensions and Denaturing can be used
Close.
In each series in multiple serial primer extension reactions, any an appropriate number of circulation can be carried out.For example,
In each series in multiple serial primer extension reactions the period that carries out can with less than about 100,90,80,70,60,
50th, 40,30,20,10 or 5 circulations.
The advantage for carrying out multiple serial primer extension reactions may is that, and under the conditions of similar denaturation and extension
Single a series of primer extension reaction is compared, and multiple serial methods are produced with relatively low cycle threshold and indicated in biological sample
There is the amplified production of the detectable amount of target nucleic acid.Compared with the single series under the conditions of similar denaturation and extension, use
Multiple serial primer extension reactions can by these cycle thresholds reduce at least about or about 1%, 5%, 10%, 15%, 20%,
25%th, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95%.
In some embodiments, tiltedly become the time (that is, thermal cycler from a temperature transition to another temperature spent when
Between) and/or tiltedly variable Rate is the key factor in amplification.For example, amplification produces the expansion for the detectable amount for indicating to exist target nucleic acid
Temperature and time needed for volume increase thing can change according to oblique variable Rate and/or oblique change time.Oblique variable Rate can influence to be used to expand
The temperature and time of increasing.
In some cases, oblique change time and/or oblique variable Rate can be different between cycles.But in some feelings
Under condition, oblique change time and/or oblique variable Rate between circulation can be identicals.Oblique change time and/or oblique variable Rate can be based on
The sample handled is adjusted.
In some cases, the oblique change between different temperatures can be for example determined according to the property and reaction condition of sample
Time.Also accurate temperature and incubation time can be determined according to the property and reaction condition of sample.In some embodiments,
It can be used multiple thermal cycles that single sample is handled into (for example, being subjected to amplification condition) repeatedly, each thermal cycle is for example oblique
It is different on change time, temperature and/or incubation time.Best or optimal thermal cycle can be then selected for the specific sample.This is carried
The efficient method for tested specific sample or sample combination tailoring thermal cycle sane is supplied.
In some embodiments, target nucleic acid can be subjected to Denaturing before primer extension reaction startup.In multiple systems
In the case of the primer extension reaction of row, target nucleic acid can be subjected to Denaturing before the multiple series is performed, or can be
Denaturing is subjected between the multiple series.For example, target nucleic acid can First Series and the second series in multiple series it
Between be subjected to Denaturing.The non-limiting examples of these Denaturings include denaturation temperature and are distributed (for example, one or more denaturation
Temperature) and denaturant.
The advantage for carrying out multiple serial primer extension reactions may is that, and under the conditions of similar denaturation and extension
Single a series of primer extension reaction is compared, and multiple serial methods are produced with relatively low cycle threshold and indicated in biological sample
There is the amplified production of the detectable amount of target nucleic acid.Compared with the single series under the conditions of similar denaturation and extension, use
Multiple serial primer extension reactions can by these cycle thresholds reduce at least about or about 1%, 5%, 10%, 15%, 20%,
25%th, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95%.
In some embodiments, biological sample can be preheated before primer extension reaction is carried out.The biological sample of preheating
The temperature (for example, preheating temperature) of product and duration (for example, pre- thermal endurance) can be according to the specific lifes for example analyzed
Thing sample and change.In some instances, can be no more than about 60 minutes, 50 minutes, 40 minutes, 30 points by biological sample preheating
Clock, 25 minutes, 20 minutes, 15 minutes, 10 minutes, 9 minutes, 8 minutes, 7 minutes, 6 minutes, 5 minutes, 4 minutes, 3 minutes, 2 points
Clock, 1 minute, 45 seconds, 30 seconds, 20 seconds, 15 seconds, 10 seconds or 5 seconds.In some instances, can be in about 80 DEG C to about 110 DEG C of temperature
Lower preheating biological sample.In some instances, biological sample can be preheated at a temperature of about 90 DEG C to about 100 DEG C.One
In a little examples, biological sample can be preheated at a temperature of about 90 DEG C to about 97 DEG C.In some instances, can be at about 92 DEG C to about
Biological sample is preheated at a temperature of 95 DEG C.In other other examples, can about 80 DEG C, 81 DEG C, 82 DEG C, 83 DEG C, 84 DEG C,
85 DEG C, 86 DEG C, 87 DEG C, 88 DEG C, 89 DEG C, 90 DEG C, 91 DEG C, 92 DEG C, 93 DEG C, 94 DEG C, 95 DEG C, 96 DEG C, 97 DEG C, 98 DEG C, 99 DEG C or
Biological sample is preheated at a temperature of 100 DEG C.
In some embodiments, it is described carry out nucleic acid amplification needed for reagent (including for carry out parallel nucleic acid amplification
Required reagent) it may also include report agent.The report agent can produce detectable signal.The detectable signal may indicate that amplification
Product whether there is.For example, the existence or non-existence of detectable signal may indicate that amplified production whether there is.Detectable signal
Intensity can be proportional to the amount of amplified production.In some cases, when amplified production is by the target nucleic acid inhomogeneity with initially expanding
When the nucleic acid of type is generated, the intensity of detectable signal can be proportional to the amount of the target nucleic acid initially expanded.For example, by flat
Row ground reverse transcription and the DNA that is obtained from reverse transcription of amplification are come in the case of expanding target RNA, for being tried necessary to the two reactions
Agent, which may also include, can produce the report agent of detectable signal, and the detectable signal indicates the DNA product of amplification and/or the target of amplification
RNA presence.The intensity of detectable signal can be proportional to the amount of the DNA product of amplification and/or the initial target RNA of amplification.Report
Accuse using for agent and also make it possible real-time amplification method, including the real-time PCR for DNA cloning.
Report agent can be connected by covalently or non-covalently interacting with the nucleic acid including amplified production.It is non-covalent
The non-limiting examples of interaction include ionic interaction, Van der Waals force, hydrophobic interaction, hydrogen bonding and its group
Close.In some embodiments, report agent can be combined with initial reactant, and report that the change of agent level can be used for detection to expand
Increase production thing.In some embodiments, report agent can only be detectable (or undetectable) when nucleic acid amplification is carried out.
In some embodiments, the available agent of giving a report of optical activity dyestuff (for example, fluorescent dye).The non-limiting examples bag of dyestuff
Include SYBR green, SYBR is blue, DAPI, propidium iodide (propidium iodine), Hoeste, SYBR gold, ethidium bromide, acridine,
Proflavin, acridine orange, acridine yellow, fluorescent coumarin (fluorcoumanin), ellipticine, daunomycin, chloroquine are held mould partially
Plain D, chromomycin, Homidium Bromide (homidium), mithramycin, many pyridine rutheniums (ruthenium polypyridyl) pacify aspergillus
Plain (anthramycin), phenanthridines and acridine, ethidium bromide, propidium iodide, the own pyridine of iodate (hexidium iodide), dihydro second
Ingot, second ingot homodimer -1 and second ingot homodimer -2, single Azide second ingot (ethidium monoazide) and ACMA,
Hoechst 33258, Hoechst 33342, Hoechst 34580, DAPI, acridine orange, 7-AAD, actinomycin D, LDS751,
Hydroxystilbamidine (hydroxystilbamidine), SYTOX is blue, and SYTOX is green, SYTOX oranges, POPO-1, POPO-3, YOYO-1,
YOYO-3, TOTO-1, TOTO-3, JOJO-1, LOLO-1, BOBO-1, BOBO-3, PO-PRO-1, PO-PRO-3, BO-PRO-1,
BO-PRO-3, TO-PRO-1, TO-PRO-3, TO-PRO-5, JO-PRO-1, LO-PRO-1, YO-PRO-1, YO-PRO-3,
PicoGreen, OliGreen, RiboGreen, SYBR gold, SYBR green I, SYBR green II, SYBR DX, SYTO-40, -41, -
42nd, -43, -44, -45 (indigo plant), SYTO-13, -16, -24, -21, -23, -12, -11, -20, -22, -15, -14, -25 (green),
SYTO-81, -80, -82, -83, -84, -85 (orange), SYTO-64, -17, -59, -61, -62, -60, -63 (red), fluorescein are different
Thiocyanic acid fluorescein (FITC), tetramethylrhodamine isothiocyanates (TRITC), rhodamine, tetramethylrhodamine, R- algae red eggs
In vain, VIC, NED, PET, Cy-2, Cy-3, Cy-3.5, Cy-5, Cy5.5, Cy-7, texas Red (Texas Red), Phar-
Red, allophycocyanin (APC), Sybr green I, Sybr green II, Sybr gold, CellTracker is green, 7-AAD, second ingot homodimeric
Body I, second ingot homodimer II, second ingot homodimer III, ethidium bromide, umbelliferone, eosin, green fluorescent protein, red moss
It is red, cumarin, methylcoumarin, pyrene, peacock green, Stilbene, fluorescein, cascade blue (cascade blue), dichlorotriazine amine fluorescence
Element, dansyl Cl, fluorescence Lanthanide Complexes (such as those include complex compounds of europium and terbium), carboxyl tetrachlorofluorescein (TET), 5 and/
Or 6- Fluoresceincarboxylic acids (FAM), 5- (or 6-) iodacetyl amido fluorescein, 5- { [2 (and 3) -5- (acetyl group sulfydryl)-succinyls
Base] amino fluorescein (SAMSA- fluoresceins), Sulforhodamine B sulfonic acid chloride, 5 and/or 6 carboxyrhodamines (ROX), 5- and/
Or 6- carboxyls tetramethylrhodamine (TAMRA), 6- carboxyls -4 ', 5 '-two chloro- 2 ', 7 '-dimethoxyfluoresceins (JOE), 6- carboxylics
Base -2', 4,4', 5', 7,7'- chlordene fluoresceins (HEX), 7- amino-methyls-cumarin, 7- amino -4- methylcoumarins -3-
Acetic acid (AMCA), BODIPY fluorogens, 8- methoxyl group pyrenes -1,3,6- trisulfonic acid trisodium salts, 3,6- disulfonic acid -4- amino-naphthalene two
Carboximide, phycobniliprotein, AlexaFluor 350,405,430,488,532,546,555,568,594,610,633,635,
647th, 660,680,700,750 and 790 dyestuff, DyLight 350,405,488,550,594,633,650,680,755 and 800
Dyestuff, or other fluorogens.
In some embodiments, report agent can have optically active sequence specific when hybridizing with amplified production
Property oligonucleotide probe.Because probe is combined with the sequence-specific of amplified production, the use of oligonucleotide probe can improve inspection
The specificity of survey and sensitivity.Probe may be connected to any optical activity report agent (for example, dyestuff) as described herein, and also
It may include the optically active quencher that can block associated dyestuff.The non-limiting examples of the probe for agent of giving a report can be used
Including TaqMan probe, TaqMan Tamara probes, TaqMan MGB probes or Lion probes.
In some embodiments, report agent can be optically active sequence with blocking when hybridizing with amplified production
Row specific oligonucleotide probe.In some embodiments, the oligonucleotide probe shows optical activity in fracture.Example
Such as, the report agent can be oligonucleotide probe, and it is comprising optical activity dyestuff (for example, fluorescent dye) and is adjacently located on
Quencher on probe.Dyestuff and quencher in close proximity to can blocked dye optical activity.Probe can be with target to be amplified
Sequence is combined.Once the exonuclease activity of archaeal dna polymerase is broken probe during expanding, then quencher and dyestuff point
From, and free dyestuff regains its optical activity, the activity can be then detected.The oligonucleotide probe can be
RNA oligonucleotide probe or DNA oligonucleotide probe.
In some embodiments, report agent can be molecular beacon (molecular beacon).Molecular beacon includes,
For example, the quencher connected on one end of the oligonucleotides of hairpin conformation.It is optical activity in the other end of the oligonucleotides
Dyestuff, for example, fluorescent dye.In hairpin structure, optical activity dyestuff and quencher are tightly enough approached so that quencher
It is capable of the optical activity of blocked dye.However, once with amplified production hybridize, the oligonucleotides be linear conformation and with the expansion
Increase production the target sequence hybridization on thing.The linearisation of oligonucleotides causes the separation of optical activity dyestuff and quencher, so that
Optical activity is recovered, and can be detected.Molecular beacon can improve inspection to the sequence-specific of the target sequence on amplified production
The specificity of survey and sensitivity.
In any aspect of many aspects, the reagent can include one or more oligonucleotide probes or molecule letter
Mark.The reagent can include the one or more oligonucleotide probes or molecular beacon of any amount for being adapted for nucleic acid amplification.
For example, the reagent can include about less than 0.01 μM, 0.01 μM, 0.05 μM, 0.06 μM, 0.07 μM, 0.08 μM, 0.09 μM, 0.1
μM、0.2μM、0.3μM、0.4μM、0.5μM、0.6μM、0.7μM、0.8μM、0.9μM、1.0μM、1.1μM、1.2μM、1.3μM、
1.4μM、1.5μM、1.6μM、1.7μM、1.8μM、1.9μM、2.0μM、2.5μM、3.0μM、3.5μM、4.0μM、4.5μM、5.0μ
M, 6.0 μM, 7.0 μM, 8.0 μM, 9.0 μM, 10.0 μM, 11.0 μM, 12.0 μM, 13.0 μM, 14.0 μM, 15.0 μM, more than 15.0 μ
The one or more oligonucleotide probes or molecular beacon of range of concentrations between M dNTP, or any of the above-described numerical value, for example, about
0.01 to 10.0 μM, 0.05 to 5.0 μM, 0.05 to 4.0 μM, 0.05 to 3.0 μM, 0.05 to 2.0 μM, 0.05 to 1.0 μM, 0.05
To 0.5 μM, 0.1 to 5.0 μM, 0.1 to 4.0 μM, 0.1 to 3.0 μM, 0.1 to 2.0 μM, 0.1 to 1.0 μM, 0.1 to 0.9 μM, 0.1
To 0.8 μM, 0.1 to 0.7 μM, 0.1 to 0.6 μM, 0.1 to 0.5 μM of one or more oligonucleotide probes or molecular beacon.
On one side, the reagent can include about 0.1 to 0.5 μM of one or more oligonucleotide probes or molecular beacon.
In some embodiments, report agent can be radioactive species.The non-limiting examples of radioactive species include14C、123I、124I、125I、131I、Tc99m、35S or3H。
In some embodiments, report agent can produce the enzyme of detectable signal.Detectable signal can pass through
Enzyme is produced to its substrate, or in the case where enzyme has multiple substrates to the activity of specific substrates.The enzyme of agent of giving a report can be used
Non-limiting examples include alkaline phosphatase, horseradish peroxidase, I2- galactosidases, alkaline phosphatase, beta galactose
Glycosides enzyme, acetylcholinesterase and luciferase.
In the amplified reaction of parallel progress, a variety of report agent can be used to detect a variety of amplified productions.A variety of reports
Each accused in agent can produce detectable signal, and the detectable signal that a variety of report agent are produced is different from each other.It is described
Each in a variety of detectable signals may indicate that its corresponding amplified production whether there is.In a variety of detectable signals
The intensity of each can corresponding amplified production amount it is proportional.For example, a kind of corresponding detectable signal of amplified production can
For FAM fluorescence, and the corresponding detectable signal of another amplified production can be ROX fluorescence.The different detectable letter of Parallel testing
Number it may be such that the presence or absence that can compare different amplified productions and amount.Or or the moreover, different detectable letter of Parallel testing
Number may be such that can determine the amount of amplified production for internal reference thing.
In any aspect of many aspects, the reagent can further include MgCl2.The reagent can comprising be suitable into
The MgCl of any amount of row nucleic acid amplification2.For example, the reagent can include about less than 0.01mM, 0.01mM, 0.05mM,
0.06mM、0.07mM、0.08mM、0.09mM、0.1mM、0.2mM、0.3mM、0.4mM、0.5mM、0.6mM、0.7mM、0.8mM、
0.9mM、1.0mM、1.1mM、1.2mM、1.3mM、1.4mM、1.5mM、1.6mM、1.7mM、1.8mM、1.9mM、2.0mM、
2.5mM、3.0mM、3.5mM、4.0mM、4.5mM、5.0mM、6.0mM、7.0mM、8.0mM、9.0mM、10.0mM、11.0mM、
12.0mM, 13.0mM, 14.0mM, 15.0mM, more than 15.0mM MgCl2, or range of concentrations between any of the above-described numerical value
MgCl2, for example, about 0.01 to 15.0mM, 0.05 to 14.0mM, 0.1 to 13.0mM, 0.2 to 12.0mM, 0.3 to 11.0mM,
0.4 to 10.0mM, 0.5 to 9.0mM, 0.6 to 8.0mM, 0.7 to 7.0mM, 0.8 to 6.0mM, 0.9 to 5.0mM, 1.0 to
4.0mM, 1.1 to 3.0mM, 1.2 to 2.5mM, 1.3 to 2.0mM, 1.4 are to 1.6mM MgCl2.In one aspect, the reagent can
Include about 1.5mM MgCl2。
In any aspect of many aspects, the reagent can include dNTP.The reagent can include and be adapted for nucleic acid
The dNTP of any amount of amplification.For example, the reagent can include about less than 0.01mM, 0.01mM, 0.05mM, 0.06mM,
0.07mM、0.08mM、0.09mM、0.1mM、0.2mM、0.3mM、0.4mM、0.5mM、0.6mM、0.7mM、0.8mM、0.9mM、
1.0mM、1.1mM、1.2mM、1.3mM、1.4mM、1.5mM、1.6mM、1.7mM、1.8mM、1.9mM、2.0mM、2.5mM、
3.0mM、3.5mM、4.0mM、4.5mM、5.0mM、6.0mM、7.0mM、8.0mM、9.0mM、10.0mM、11.0mM、12.0mM、
13.0mM, 14.0mM, 15.0mM, the dNTP more than range of concentrations between 15.0mM dNTP, or any of the above-described numerical value, for example, about
0.01 to 10.0mM, 0.05 to 5.0mM, 0.05 to 4.0mM, 0.05 to 3.0mM, 0.05 to 2.0mM, 0.05 to 1.0mM, 0.05
To 0.5mM, 0.1 to 5.0mM, 0.1 to 4.0mM, 0.1 to 3.0mM, 0.1 to 2.0mM, 0.1 to 1.0mM, 0.1 to 0.9mM, 0.1
To 0.8mM, 0.1 to 0.7mM, 0.1 to 0.6mM, 0.1 to 0.5mM dNTP.In one aspect, the reagent can include about 0.1
To 0.5mM dNTP.
In many aspects, amplified production (for example, the DNA product of amplification, RNA products of amplification) can detect.Amplified production
The detection of (DNA for including amplification) can be realized using any suitable detection method.The concrete kind of used detection method
Type be may depend on, for example, specific amplified production, for the type of the reaction vessel of amplification, other in reactant mixture are tried
Whether agent, report agent includes in the reactive mixture, and the used particular type for reporting agent when using report agent.Inspection
The non-limiting examples of survey method include optical detection, spectral detection, electrostatic detection, Electrochemical Detection etc..Optical detecting method
Including but not limited to fluorimetry and UV-Visible absorption.It is common that spectral method of detection includes but is not limited to mass spectrography, nuclear-magnetism
Shake (NMR) spectral method and infra-red sepectrometry.Electrostatic detection methods include but is not limited to the technology based on gel, for example, gel is electric
Swimming.Electrochemical detection method includes but is not limited to the electrochemistry after the high performance liquid chromatography separation of amplified production to amplified production
Detection.
In some embodiments, amplified production can be detected in the primer extension reaction.In some embodiments,
Amplified production can be detected in multiple serial primer extension reactions.In some embodiments, can be in multiple serial primers
Amplified production is detected in each single series in extension.In some embodiments, it can prolong in multiple serial primers
Some single series in reaction are stretched, but do not detect amplified production in other single series.For example, the multiple serial draws
Thing extension may include First Series and second series.Amplified production can not be detected in First Series, and in second series
Middle detection amplified production.Or, amplified production can be detected in First Series, and amplified production is not detected in second series.
Or, amplified production can be detected in First Series and second series, or do not detected in First Series and second series
Amplified production.
In some embodiments, the detectable signal produced by report agent can be detected in the primer extension reaction.
In some embodiments, the detectable signal produced by report agent can be detected in multiple serial primer extension reactions.
In some embodiments, detect what is produced by report agent in each single series that can be in multiple serial primer extension reactions
Detectable signal.In some embodiments, some single series that can be in multiple serial primer extension reactions, but do not exist
The detectable signal produced by report agent is detected in other single series.For example, the multiple serial primer extension reaction can
Including First Series and second series.The detectable signal produced by report agent can not be detected in First Series, and second
The detectable signal produced by report agent is detected in series.Or, it can be detected in First Series by examining that report agent is produced
Signal is surveyed, and does not detect the detectable signal produced by report agent in second series.Or, can be in First Series and second
The detectable signal produced by report agent is detected in row, or does not detect and is produced by report agent in First Series and second series
Raw detectable signal.
Any aspect in the multiple aspect, the time needed for the key element of Method Of Accomplishment can be according to the specific of this method
Step and change.For example, the time quantum for the key element of Method Of Accomplishment can be about 5 minutes to about 120 minutes.In other examples
In, the time quantum for the key element of Method Of Accomplishment can be about 5 minutes to about 60 minutes.In other instances, for Method Of Accomplishment
The time quantum of key element can be about 5 minutes to about 30 minutes.In other instances, the time quantum for the key element of Method Of Accomplishment can
With less than or equal to 120 minutes, less than or equal to 90 minutes, less than or equal to 75 minutes, less than or equal to 60 minutes, be less than or
Equal to 45 minutes, less than or equal to 40 minutes, less than or equal to 35 minutes, less than or equal to 30 minutes, less than or equal to 25 points
Clock, less than or equal to 20 minutes, less than or equal to 15 minutes, less than or equal to 10 minutes, or less than or equal to 5 minutes.
In some embodiments, can be by the presence of the amplified production DNA product of amplification (for example) and/or amount
Information is exported to recipient.Information on amplified production can be exported via a variety of methods.In some embodiments, these are believed
Breath can be verbally provided to recipient.In some embodiments, these information can be provided in report.Report may include any number
The desired element of purpose, the non-limiting examples of the element are included on subject (for example, sex, age, race, health
Situation etc.) initial data, processed data (for example, figure shows (for example, figure, chart, tables of data, data summarization), really
Fixed cycle threshold, the calculated value of target polynucleotide initial amount) information, about whether the conclusion that there is target nucleic acid, diagnosis letter
Breath, prognosis information, disease information, etc., and combinations thereof.This report can be provided as the report (for example, hard copy) of printing, or
Person can provide as electronic report.In some embodiments (including wherein providing the situation of electronic report), these information can
Via such as monitor or television, operationally with for obtaining screen, tablet PC screen that the unit of amplified production is connected, moving
Electronic console (for example, electronic display) output such as dynamic device screen.The report of printing and electronic report can be stored respectively in
In file or database so that they can be accessed for being compared with later report.
In addition, can be used any suitable communication media (including, for example, network connection, wireless connection or internet connect
Connect) transmission will be reported to the recipient of Local or Remote position.In some embodiments, report can be sent to recipient's
Device, such as personal computer, phone, flat board or other devices.This report can online be watched, is stored on the device of recipient
Or printing.Can also be by transmitting report for transmitting any other means of information, the non-limiting examples of the means include postal
Hard copy report is posted to check for reception and/or recipient.
In addition, these information can be exported to various types of recipient.The non-limiting examples of these recipients
Including therefrom obtain the subject of biological sample, doctor, the doctor for treating subject, the clinical monitor for clinical test,
Nurse, researcher, Laboratory Technician, the representative of drugmaker, health care companies, biotech company, hospital, the mankind
Aid organization, health care management person, electronic system are (for example, one or more meter of the medical records of storage such as subject
Calculation machine and/or one or more computer server), Public Health Practice person, other medical workers and other medical facilities.
In one aspect, the invention provides a kind of system for implementing the method according to any method disclosed herein.
In another aspect, it is present in directly from the target nucleus in the biological sample that subject obtains for expanding the invention provides a kind of
The system of ribosomal ribonucleic acid (RNA).The system includes:(a) input module, its user for receiving the target RNA in amplification biological sample please
Ask;(b) module is expanded, it is asked in response to the user:Reactant mixture is received in reaction vessel, the reactant mixture is included
Biological sample and reagent, the reagent necessary to for abreast carrying out reverse transcription amplification with DNA (DNA) amplification
Comprising (i) reverse transcriptase, (ii) archaeal dna polymerase, and (iii) are directed to target RNA primer sets;And, make the reaction in reaction vessel
Mixture undergoes the primer extension reaction of multiple circulations, to generate the DNA amplification product for indicating there is target RNA, each circulation bag
Include:(i) reactant mixture is incubated to the denaturation duration less equal than 60 seconds under denaturation temperature, subsequent (II) will react
Mixture is incubated the extension duration less equal than 60 seconds under elongating temperature, so as to expand target RNA;And (c) is operable
Ground is coupled to the output module of the amplification module, and the wherein output module exports the information on target RNA or DNA product to connecing
Receipts person.
In another aspect, the invention provides a kind of biological sample for being used to expand and being present in and directly being obtained from subject
In target nucleus ribosomal ribonucleic acid (RNA) system.The system includes:(a) input module, it receives the target RNA in amplification biological sample
User request;(b) module is expanded, it is asked in response to the user:(i) reactant mixture is received in reaction vessel, this is anti-
Mixture is answered comprising the biological sample obtained from subject and for carrying out reverse transcription amplification and optional deoxyribose core
Reagent necessary to sour (DNA) amplification, the reagent includes (1) reverse transcriptase, and (2) are directed to target RNA primer sets;And (ii) makes
Reactant mixture undergoes the primer extension reaction of multiple circulations, indicates there is the detectable of target RNA in biological sample to produce
The DNA amplification product of amount;(iii) amount of the DNA amplification product of detection (iii);And (iv) is by the amount of DNA amplification product
Information is exported to recipient, wherein for completing (i)-(iv) time quantum less than or equal to about 30 minutes;And (c) is operationally
Coupled to the output module of the amplification module, described information is sent to recipient by the wherein output module.
In another aspect, it is present in the invention provides a kind of for expanding from the biological sample that subject obtains
The system of target nucleic acid.The system includes:(a) input module, it receives user's request of the target RNA in amplification biological sample;(b)
Module is expanded, it is asked in response to the user:Reactant mixture is received in reaction vessel, the reactant mixture includes biological sample
Product and reagent necessary to for carrying out nucleic acid amplification, the reagent include (i) archaeal dna polymerase and optional reverse transcriptase, and
(ii) primer sets of target nucleic acid are directed to;And, the reactant mixture in reaction vessel is undergone multiple serial primer extension reactions,
Indicate there is the amplified production of target nucleic acid in biological sample to generate, each series following is followed including two or more
Ring:(i) reactant mixture is incubated under the Denaturing being characterized with denaturation temperature and denaturation duration, subsequent (ii) exists
To be incubated the reactant mixture under the conditions of elongating temperature and the extension that is characterized of extension duration, wherein with regard to Denaturing and/
Or for extension condition, single series is different from least one other single series in the multiple series;And (c) is operable
Ground is coupled to the output module of the amplification module, and the wherein output module exports the information on target RNA or DNA product to connecing
Receipts person.
In another aspect, it is used to expand from the target nucleic acid in the biological sample that subject obtains the invention provides a kind of
System.The system may include the electronic display of the user interface with display graphic element, and the graphic element can be by user
Access, to perform to expand the amplification scheme of the target nucleic acid in biological sample.The system may also include computer processor (bag
Include any suitable device with computer processor as described elsewhere herein), it is coupled to the electronic display
And be programmed to perform the amplification scheme when user selects the graphic element.The amplification scheme may include:Make comprising biology
The multiple serial primer extension reactions of reactant mixture experience of sample and reagent necessary to for carrying out nucleic acid amplification, with life
Into amplified production.The amplified production may indicate that the presence of biological sample target nucleic acid.In addition, the primer extension reaction of each series
It may include two or more following circulations:It is incubated under the Denaturing being characterized with denaturation temperature and denaturation duration
Reactant mixture, then the incubation reaction mixture under the conditions of with elongating temperature and the extension that is characterized of extension duration.Just
For Denaturing and/or extension condition, single series may differ from least one other single system in the multiple series
Row.
In addition, any restriction and description of the method to the present invention, unless substantially runed counter to, are otherwise also applied for the present invention's
System.
In one aspect, the present invention relates to a kind of system for being used to detect the target nucleic acid molecule in biological sample.The system
System may include:Input module, biological sample described in its reception processing is asked with the user for detecting the target nucleic acid molecule;And one
Individual or multiple computer processors being operatively connected with the input block.One or more of computer processors can be single
Solely or generally it is programmed for carrying out any method described herein.In one aspect, at one or more of computers
Reason device can individually or generally be programmed for a) mixing to obtain mixture with lysis buffer by the biological sample;B) by institute
The incubation duration that mixture is incubated no more than about 15 minutes under the incubation temperature higher than 15 DEG C is stated, or without being incubated;
C) reaction vessel will be added to from mixture b), the reaction vessel includes the reagent needed for carrying out nucleic acid amplification, described
Reagent includes:(i) DNA (DNA) polymerase, and (ii) are directed to the primer sets of the target nucleic acid molecule, anti-to obtain
Answer mixture;And d) make the primer extension reaction of the multiple circulations of reactant mixture experience in the reaction vessel, with
Generation indicates the amplified production that there is the target nucleic acid molecule in the sample, and each circulation includes:(i) under denaturation temperature
The denaturation duration that the reactant mixture is less equal than 60 seconds is incubated, then (ii) is incubated described anti-under elongating temperature
The extension duration for answering mixture to be less equal than 60 seconds, so as to expand the target nucleic acid molecule.The amplified production can be
DNA product.
In one aspect, the present invention relates to a kind of system for being used to detect the target nucleic acid molecule in biological sample.The system
System may include:Input module, biological sample described in its reception processing is asked with the user for detecting the target nucleic acid molecule;And one
Individual or multiple computer processors being operatively connected with the input block.One or more of computer processors can be single
Solely or generally it is programmed for carrying out any method described herein.In one aspect, at one or more of computers
Reason device can individually or generally be programmed for a) mixing to obtain mixture with lysis buffer by the biological sample;B) by institute
The incubation duration that mixture is incubated no more than about 15 minutes under the incubation temperature higher than 15 DEG C is stated, or without being incubated;
C) reaction vessel will be added to from mixture b), the reaction vessel includes the reagent needed for carrying out nucleic acid amplification, described
Reagent includes:(i) DNA (DNA) polymerase, and optionally, reverse transcriptase, and (ii) is for the target nucleic acid
Primer sets, to obtain reactant mixture;And the reactant mixture in the reaction vessel is undergone multiple serial
Primer extension reaction, to generate the amplified production for indicating there is the target nucleic acid in the sample, each series includes two
Or more following circulation:(i) it is incubated under the Denaturing being characterized with denaturation temperature and denaturation duration described anti-
Mixture is answered, subsequent (ii) is incubated the reaction under the conditions of the extension being characterized with elongating temperature and extension duration and mixed
Thing, wherein for the Denaturing and/or the extension condition, single series is different from the multiple series at least
One other single series.The biological sample can include fecal specimens.The biological sample can include milk sample.It is described to expand
It can be DNA product to increase production thing.
In one aspect, the present invention relates to a kind of system for being used to detect the target nucleic acid molecule in biological sample.The system
System may include:Input module, biological sample described in its reception processing is asked with the user for detecting the target nucleic acid molecule;And one
Individual or multiple computer processors being operatively connected with the input block.One or more of computer processors can be single
Solely or generally it is programmed for carrying out any method described herein.In one aspect, at one or more of computers
Reason device can individually or generally be programmed for a) mixing to obtain mixture with lysis buffer by the biological sample;B) by institute
The incubation duration that mixture is incubated no more than about 15 minutes under the incubation temperature higher than 15 DEG C is stated, or without being incubated;
C) reaction vessel will be added to from mixture b), the reaction vessel includes the reagent needed for carrying out nucleic acid amplification, described
Reagent includes:(i) DNA (DNA) polymerase, and optionally, reverse transcriptase, and (ii) is for the target nucleic acid
Primer sets, to obtain reactant mixture;And the reactant mixture in the reaction vessel is undergone multiple serial
Primer extension reaction, to generate the amplified production for indicating there is the target nucleic acid in the sample, each series includes two
Or more following circulation:(i) it is incubated under the Denaturing being characterized with denaturation temperature and denaturation duration described anti-
Mixture is answered, subsequent (ii) is incubated the reaction under the conditions of the extension being characterized with elongating temperature and extension duration and mixed
Thing, wherein for the Denaturing and/or the extension condition, single series is different from the multiple series at least
One other single series.The biological sample can include fecal specimens.The biological sample can include milk sample.It is described to expand
It can be DNA product to increase production thing.
The system of the present invention may also include biological sample processing module, and it causes the biological sample to be buffered with the cracking
Liquid mixes to obtain the mixture.The biological sample processing module can include the mixture.The biological sample processing
Module can be incubated the mixture.For example, the biological sample processing module may include heat block or incubator, the heat block
Or incubator can be by the mixture of the biological sample and the lysis buffer at greater than about 15 DEG C, for example, greater than about
20 DEG C, greater than about 25 DEG C, greater than about 30 DEG C, greater than about 35 DEG C, greater than about 40 DEG C, greater than about 45 DEG C, greater than about 50 DEG C, greater than about
55 DEG C, greater than about 60 DEG C, greater than about 65 DEG C, greater than about 70 DEG C, greater than about 75 DEG C, greater than about 80 DEG C, greater than about 85 DEG C, greater than about
90 DEG C, greater than about 91 DEG C, greater than about 92 DEG C, greater than about 93 DEG C, greater than about 94 DEG C, greater than about 95 DEG C, greater than about 96 DEG C, greater than about
It is incubated at a temperature of 97 DEG C, greater than about 98 DEG C, greater than about 99 DEG C, greater than about 100 DEG C, or, at about 20 DEG C to about 90 DEG C
At a temperature of be incubated, for example, about 25 DEG C to about 85 DEG C, about 30 DEG C to about 80 DEG C, about 40 DEG C to about 70 DEG C, about 40 DEG C extremely
About 95 DEG C, about 45 DEG C to about 90 DEG C, about 50 DEG C to about 85 DEG C, about 55 DEG C to about 80 DEG C, about 60 DEG C to about 75 DEG C, about 65 DEG C to about
It is incubated at a temperature of 75 DEG C or about 65 DEG C to about 70 DEG C.
The mixture of the biological sample and the lysis buffer can be incubated few by the biological sample processing module
In the incubation time of 20 minutes.For example, the incubation duration can be not more than 19 minutes, not more than 18 minutes, it is not more than
17 minutes, not more than 16 minutes, not more than 15 minutes, not more than 14 minutes, not more than 13 minutes, not more than 12 minutes, seldom
In 11 minutes, not more than 10 minutes, not more than 9 minutes, not more than 8 minutes, not more than not more than 7 minutes, 6 minutes, not more than 5
Minute, not more than 4 minutes, not more than 3 minutes, not more than 2 minutes, not more than 1 minute, not more than 50 seconds, not more than 40 seconds, no
More than 30 seconds, not more than 20 seconds, not more than 15 seconds, or not more than 10 seconds.
The homogeneous prepared product can be incubated by the biological sample processing module at a temperature of greater than about 40 DEG C, for example,
Greater than about 65 DEG C, greater than about 70 DEG C, it can be higher than at greater than about 45 DEG C, greater than about 50 DEG C, greater than about 55 DEG C, greater than about 60 DEG C
About 75 DEG C, greater than about 80 DEG C, greater than about 85 DEG C, greater than about 90 DEG C, greater than about 91 DEG C, greater than about 92 DEG C, greater than about 93 DEG C, it is higher than
About 94 DEG C, greater than about 95 DEG C, greater than about 96 DEG C, greater than about 97 DEG C, greater than about 98 DEG C, greater than about 99 DEG C, greater than about 100 DEG C of temperature
Degree is lower to be incubated.
The homogeneous prepared product can be incubated the incubation time of not more than 20 minutes by the biological sample processing module.Example
Such as, it is described incubation the duration can be not more than 19 minutes, not more than 18 minutes, not more than 17 minutes, not more than 16 minutes, no
More than 15 minutes, not more than 14 minutes, not more than 13 minutes, not more than 12 minutes, not more than 11 minutes, not more than 10 minutes,
Not more than 9 minutes, not more than 8 minutes, not more than 7 minutes, not more than 6 minutes, not more than 5 minutes, not more than 4 minutes, seldom
In 3 minutes, not more than 2 minutes, not more than 1 minute, not more than 50 seconds, not more than 40 seconds, not more than 30 seconds, not more than 20 seconds,
Not more than 15 seconds, or not more than 10 seconds.
The system of the present invention may also include the amplification module being operably connected with the biological sample processing module, wherein
The amplification module (i) adds a certain amount of mixture to reaction vessel from biological sample processing module, and (ii) makes reaction
Reactant mixture experience primer extension reaction in container is to generate amplified production, and the amplified production indicates the target nucleic acid point
The presence of son.
In some embodiments, the mixture of amplification module biological sample in the future processing module is added to reaction
Container, the reaction vessel includes the reagent needed for carrying out nucleic acid amplification, and the reagent includes:(i) DNA (DNA)
Polymerase, and optionally, reverse transcriptase, and (ii) one or more primer sets, each primer sets can specifically bind target nucleus
Acid sequence or its variant, to obtain reactant mixture;And the reactant mixture in the reaction vessel is undergone one
Or multiple serial primer extension reactions, to generate the amplified production for indicating there is the target nucleic acid sequence in the sample,
Each series includes two or more following circulations:(i) in the denaturation being characterized with denaturation temperature and denaturation duration
Under the conditions of be incubated the reactant mixture, subsequent (ii) is under the conditions of the extension being characterized with elongating temperature and extension duration
The reactant mixture is incubated, wherein when carrying out multiple serial primer extension reactions, with regard to the Denaturing and/or described
For extension condition, single series is different from least one other single series in the multiple series.
Or, the mixture can be added to the reaction vessel manually, and the amplification module can hold the reaction
The reactant mixture in device undergoes one or more serial primer extension reactions, there is the target nucleic acid to generate instruction
The amplified production of sequence.
In some embodiments, once identify included in the kit together applied with the system on for
The information of one or more relevant parameters of primer extension reaction is carried out, the amplification module can make the reaction vessel automatically
In the reactant mixture undergo one or more serial primer extension reactions, indicate exist in the sample to generate
The amplified production of the target nucleic acid sequence.Described information can be recognized by the identification module communicated with the amplification module, such as this
In text described in other parts.
The system of the present invention may also include the output module being operably connected with one or more computer processors, its
Described in output module the information on the target nucleic acid molecule or the amplified production is exported to recipient.
In the system of the present invention, it is one or more of to calculate before biological sample is mixed with lysis buffer
Machine processor can individually or be generally programmed in the solution suspend the biological sample, and the biology is included to obtain
The homogeneous prepared product of sample.In some embodiments, one or more of computer processors can individually or generally
It is programmed to centrifuge the biological sample, to obtain the supernatant and precipitation comprising biological sample, or obtains supernatant
With the precipitation comprising biological sample.
In some embodiments, after the mixture of the biological sample and lysis buffer is incubated, described one
Individual or multiple computer processors can individually or generally be programmed to that the mixture is centrifuged to obtain supernatant.
The supernatant can include biological sample.Then, the supernatant can be used as to the mixture in subsequent reactions.For example, can be by
The supernatant is added to comprising in the reaction vessel for carrying out the reagent needed for nucleic acid amplification.
In some embodiments, one or more of computer processors can individually or generally be programmed to make
The biological sample increases bacterium through culture.For example, before being mixed with lysis buffer, one or more of computer processors
It can individually or generally be programmed to make biological sample undergo the culture duration under the conditions of enrichment culture.The enrichment training
Foster condition may include in suitable culture medium (such as Tryptic Soy nutrient solution (TBS), modified Tryptic Soy nutrient solution, tryptose
Peptone, nutrient medium, bacteriolyze nutrient solution (LB), Gram-negative nutrient solution, peptone, the Tryptic Soy nutrient solution containing yeast,
Or salmonella culture medium) at a suitable temperature (for example, about 23 DEG C to about 40 DEG C, such as about 25 DEG C, about 30 DEG C, about 35
DEG C or about 37 DEG C etc.) vibration or it is non-oscillating under the conditions of cultivate biological sample.In some embodiments, the culture medium
It is salmonella special media, it is more beneficial for salmonella propagation relative to other bacteriums.Exemplary salmonella
Special media includes bismuth sulfite agar (BS), xylose lysine deoxycholic acid agar (XLD), the training of selenium bright green sulfanilamide (SN)
Nutrient solution (SBG) etc., but not limited to this.It is described culture the duration can be about 0.5 hour to 10 hours, for example, about 1 hour, about
1.5 hours, about 2 hours, about 2.5 hours, about 3 hours, about 3.5 hours, about 4 hours, about 4.5 hours, about 5 hours, it is about 5.5 small
When, about 6 hours, about 6.5 hours, about 7 hours, about 7.5 hours, about 8 hours, about 8.5 hours, about 9 hours, about 9.5 hours or
About 10 hours.In some embodiments, the culture duration is no more than about 7 hours, for example, no more than about 6.5 is small
When, no more than about 6 hours, no more than about 5.5 hours, no more than about 5 hours, no more than about 4.5 hours, no more than about 4 hours,
No more than about 3.5 hours, no more than about 3 hours, no more than about 2.5 hours, no more than about 2 hours, no more than about 1.5 hours,
No more than about 1 hour or no more than about 0.5 hour.
In some embodiments, before the biological sample experienced the culture duration under the conditions of enrichment culture
And/or afterwards, one or more of computer processors can individually or generally be programmed to enter the biological sample
Row centrifugation, to obtain the supernatant and precipitation comprising biological sample, or obtains supernatant and the precipitation comprising biological sample.
In some embodiments, the biological sample experienced under the conditions of enrichment culture culture the duration it
Afterwards, one or more of computer processors can individually or generally be programmed to buffer the biological sample with cracking
Liquid is mixed, and is not suffered from selective enrichment, is plated on differentiation culture medium, and/or expected property biomedicine identification.
In some embodiments, the biological sample experienced under the conditions of enrichment culture culture the duration it
Afterwards, one or more of computer processors can individually or generally be programmed to mix lysis buffer added to described
Compound.The lysis buffer can be alkaline.For example, the lysis buffer can include NaOH.The lysis buffer
PH can be about 7 to about 14, such as about 8 to about 13, about 9 to about 12, about 10 to about 11.For example, the pH of the lysis buffer can
It is about 7,7.5,8,8.5,9,9.5,10,10.5,11,11.5,12,12.5,13,13.5 or 14.
In some embodiments, one or more of computer processors can individually or generally be programmed to make
The mixture of the biological sample and the lysis buffer adds under conditions of DNA or ribonucleic acid (RNA) extraction is not undergone
Add in reaction vessel.In some cases, one or more of computer processors can individually or be generally programmed
To make the mixture be added under conditions of not undergoing purifying in reaction vessel.In some cases, it is one or many
Individual computer processor can individually or generally be programmed to make the mixture not undergo the condition of DNA or RNA concentrations
It is added in reaction vessel down.The reaction vessel can be to include the reaction vessel of the reagent needed for for carrying out nucleic acid amplification.
In some embodiments, one or more of computer processors can individually or generally be programmed to by
The biological sample obtained from subject or the mixture obtained as described herein from the biological sample, supernatant or homogeneous system
Standby thing with for providing to obtain reactant mixture together with the reagent needed for nucleic acid amplification is carried out in reaction vessel.The reaction
Container can be any reaction vessel specifically described herein.
In the system of the present invention, identification module can also be included, for recognizing that the system with the present invention is used together
The information that kit is included.For example, the kit is marked with unique identifiers.The unique identifiers can be bar code.
The bar code can be one-dimensional bar code or two-dimensional bar.The bar code can allow to extract by scanning on the examination
The information of agent box.The unique identifiers can relate to contactless (contactless) technology.The contactless technology allows to pass through
The kit is placed near Poul Dorset Sheep device to extract the information on the kit.The Poul Dorset Sheep device can
Using radio frequency identification (RFID, radio frequency identification) technology information is extracted from the kit.
In some embodiments, the unique identifiers can be RFID marker.
In some embodiments, the identification module can include bar code scanner module, for scanning on kit
Bar code is to extract information.In some embodiments, the identification module can be comprising RFID module (for example, Poul Dorset Sheep
Device), for extracting information from the kit using REID.In some embodiments, the identification module bag
Containing both the bar code scanner module and the RFID module.
The identification module can be operably connected or communicate with one or more other modules of the present invention, so that
One or more other modules are given by the information transfer extracted.Described information can be the correlation for carrying out primer extension reaction
Parameter.For example, the identification module can communicate with amplification module of the present invention, so that the amplification module to be performed
The relevant parameter of primer extension reaction is transferred to the amplification module.The parameter is upon receipt of, the amplification module can root
The primer extension reaction is performed automatically according to the parameter.The parameter can be, such as the serial number of described primer extension reaction,
Period, Denaturing, extension condition, one or more primer sets, report agent, oligonucleotide probe of each series etc., but
Not limited to this.
In the system of the present invention, one or more of computer processors can individually or generally be programmed to inspection
Survey amount and/or the presence or absence of the amplified production.In some cases, one or more of computer processors can be independent
Ground is generally programmed to indicate that the amount of the amplified production and/or the information of presence or absence are exported to recipient.
In the system of the present invention, detection module, the amount for detecting amplified production can also be included.The detection module
Any detection method specifically described herein can be used to detect amplified production.For example, the detection module can detect amplified reaction
The detectable signal of middle generation.For example, the detection module can detect the detectable signal that report agent specifically described herein is produced.
The detectable signal may indicate that amplified production whether there is.For example, the existence or non-existence of detectable signal may indicate that amplification
Product whether there is.The intensity of detectable signal can be proportional to the amount of amplified production.In some cases, when amplified production by
When being generated with the different types of nucleic acid of target nucleic acid that initially expands, the intensity of detectable signal can be with the target nucleic acid that initially expands
Amount it is proportional.
In some embodiments, the detection module is optical detecting module.The optical detecting module is detectable to be expanded
Increase in reaction and produce optical signalling.The optics letter that the optical signalling can produce for any optical activity dyestuff specifically described herein
Number.Produced and adjoint optical signalling for example, the optical signalling can be due to amplified production.For example, the optical signalling
It can be due to the optical signalling that oligonucleotide probe is produced in fracture.For example, the optical signalling can be molecular beacon
The optical signalling produced when hybridizing with amplified production.
In some embodiments, the optical signalling can be fluorescence signal, and the detection module can be fluoroscopic examination
Module.For example, the detectable fluorescence signal that any fluorescent dye is produced herein of the fluoroscopic examination module.For example, described glimmering
Light detection module can detect the fluorescence signal for the fluorescent dye generation that one or more are selected from the group:FAM, TET, ROX, JOE,
HEX, TAMRA, VIC, NED, PET, texas Red etc..
In some embodiments, the detection module can a variety of detectable signals of Parallel testing.For example, it is described it is a variety of can
Detection signal is produced by a variety of report agent, and the detectable signal that a variety of report agent are produced is different from each other.It is described many
Each planted in detectable signal may indicate that its corresponding amplified production whether there is.It is every in a variety of detectable signals
A kind of intensity can corresponding amplified production amount it is proportional.For example, the detection module can Parallel testing FAM fluorescence and
ROX fluorescence.In the case, a kind of corresponding detectable signal of amplified production can be FAM fluorescence, and another amplified production pair
The detectable signal answered can be ROX fluorescence, so that can the different detectable signal of Parallel testing.Parallel testing it is different can
Detection signal may be such that the presence or absence that can compare different amplified productions and amount.Or, the different detectable letter of Parallel testing
Number may be such that can determine the amount of amplified production for internal reference thing.
Detection module can include an imaging sensor or multiple images sensor.Imaging sensor be able to can be carried out
Optical detection.Imaging sensor can include charge coupling device (CCD) sensor, and it includes cooled CCD.Imaging sensor
CMOS active pixel sensor (APS), such as COMS or NMOS sensors can be included.Detection module can include laser sensor.
Detection module can include photodiode, such as avalanche photodide.Detection module can include photomultiplier
(PMT).Sensor can include single sensor or same type or different types of multiple sensors.
Detection module can be imaged to detection object (detection zone described in other parts such as herein).Detection
Module can in a visual field to it is described detection object at least 10%, 20%, 30%, 40%, 50%, 60%, 70%,
80%th, 90%, 95% or 100% it is imaged.Detection module can herein described in other parts device or system (example
Such as nucleic acid amplifier or system) operation before, during or after detection object is imaged.Detection module can be in dress
Put or be imaged in real time when system is operated, for example, be imaged in real time when carrying out nucleic acid amplification reaction using thermal cycler.
Detection module can record single still image or can record video.Detection module can be with sampling per minute extremely
Few about 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,
28、29、30、31、32、33、34、35、36、37、38、39、40、41、42、43、44、45、46、47、48、49、50、51、52、
53rd, 54,55,56,57,58,59,60,90,120,150,180,210,240,270 or 300 times.Detection module can be with per minute
Sampling at most about 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,
26、27、28、29、30、31、32、33、34、35、36、37、38、39、40、41、42、43、44、45、46、47、48、49、50、
51st, 52,53,54,55,56,57,58,59,60,90,120,150,180,210,240,270 or 300 times.Detection module can be with
It is per minute sampling about 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,
25、26、27、28、29、30、31、32、33、34、35、36、37、38、39、40、41、42、43、44、45、46、47、48、49、
50th, 51,52,53,54,55,56,57,58,59,60,90,120,150,180,210,240,270 or 300 times.Detection module can
With by least about 0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8,0.9,1.0,1.1,1.2,1.3,1.4,1.5,1.6,
1.7、1.8、1.9、2.0、2.1、2.2、2.3、2.4、2.5、2.6、2.7、2.8、2.9、3.0、3.1、3.2、3.3、3.4、3.5、
3.6、3.7、3.8、3.9、4.0、4.1、4.2、4.3、4.4、4.5、4.6、4.7、4.8、4.9、5.0、6、7、8、9、10、15、20、
25th, 30,35,40,45,50,55,60,65,70,75,80,85,90,95,100,105,110,115 or 120Hz speed is carried out
Sampling.Detection module can by most about 0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8,0.9,1.0,1.1,1.2,1.3,
1.4、1.5、1.6、1.7、1.8、1.9、2.0、2.1、2.2、2.3、2.4、2.5、2.6、2.7、2.8、2.9、3.0、3.1、3.2、
3.3、3.4、3.5、3.6、3.7、3.8、3.9、4.0、4.1、4.2、4.3、4.4、4.5、4.6、4.7、4.8、4.9、5.0、6、7、
8th, 9,10,15,20,25,30,35,40,45,50,55,60,65,70,75,80,85,90,95,100,105,110,115 or
120Hz speed is sampled.Detection module can by about 0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8,0.9,1.0,
1.1、1.2、1.3、1.4、1.5、1.6、1.7、1.8、1.9、2.0、2.1、2.2、2.3、2.4、2.5、2.6、2.7、2.8、2.9、
3.0、3.1、3.2、3.3、3.4、3.5、3.6、3.7、3.8、3.9、4.0、4.1、4.2、4.3、4.4、4.5、4.6、4.7、4.8、
4.9、5.0、6、7、8、9、10、15、20、25、30、35、40、45、50、55、60、65、70、75、80、85、90、95、100、
105th, 110,115 or 120Hz speed is sampled.
Detection module can have specific resolution ratio or sensitivity.Detection module can include at least about in one side
100th, 200,500,1000,2000,3000,4000,5000,6000,7000,8000,9000 or 10000 pixels.Detect mould
Block can include at least about 0.5,1.0,1.5,2.0,2.5,3.0,3.5,4.0,4.5,5.0,5.5,6.0,6.5,7.0,7.5,
8.0、8.5、9.0、9.5、10.0、10.5、11.0、11.5、12.0、12.5、13.0、13.5、14.0、14.5、15.0、15.5、
16.0、16.5、17.0、17.5、18.0、18.5、19.0、19.5、20.0、21、22、23、24、25、26、27、28、29、30、
31st, 32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49 or 50,000,000 pixels.Detection module
Can have at least about 10mm, 9mm, 8mm, 7mm, 6mm, 5mm, 4mm, 3mm, 2mm, 1mm, 0.9mm, 0.8mm, 0.7mm,
0.6mm、0.5mm、0.4mm、0.3mm、0.2mm、0.1mm、0.09mm、0.08mm、0.07mm、0.06mm、0.05mm、
0.04mm、0.03mm、0.02mm、0.01mm、0.009mm、0.008mm、0.007mm、0.006mm、0.005mm、0.004mm、
0.003mm、0.002mm、0.001mm、900nm、800nm、700nm、600nm、500nm、400nm、300nm、250nm、200nm
Or 100nm resolution ratio.Detection module can have at most about 10mm, 9mm, 8mm, 7mm, 6mm, 5mm, 4mm, 3mm, 2mm,
1mm、0.9mm、0.8mm、0.7mm、0.6mm、0.5mm、0.4mm、0.3mm、0.2mm、0.1mm、0.09mm、0.08mm、
0.07mm、0.06mm、0.05mm、0.04mm、0.03mm、0.02mm、0.01mm、0.009mm、0.008mm、0.007mm、
0.006mm、0.005mm、0.004mm、0.003mm、0.002mm、0.001mm、900nm、800nm、700nm、600nm、
500nm, 400nm, 300nm, 250nm, 200nm or 100nm resolution ratio.Detection module can have about 10mm, 9mm, 8mm,
7mm、6mm、5mm、4mm、3mm、2mm、1mm、0.9mm、0.8mm、0.7mm、0.6mm、0.5mm、0.4mm、0.3mm、0.2mm、
0.1mm、0.09mm、0.08mm、0.07mm、0.06mm、0.05mm、0.04mm、0.03mm、0.02mm、0.01mm、0.009mm、
0.008mm、0.007mm、0.006mm、0.005mm、0.004mm、0.003mm、0.002mm、0.001mm、900nm、800nm、
700nm, 600nm, 500nm, 400nm, 300nm, 250nm, 200nm or 100nm resolution ratio.
Detection module can include light source.Light source can be integrated into detection module housing or electrophoretic apparatus housing.Light
Source can include lamp, such as incandescent lamp, Halogen lamp LED, fluorescent lamp, gas-discharge lamp, arc lamp or LED.Light source can include swashing
Light device.Light source can produce specific wavelength or wave-length coverage, such as UV.Light source can include filter, for control one or
Multiple output wavelengths.Light source can include the multiple light sources of identical or different type, and it can be used separately or in combination.Light
Source can be by the housing of their own or by electrophoretic apparatus housings close.
Detection module can include various optical elements, including but not limited to filter, lens, collimater, reflective mirror, anti-
Emitter, beam splitter and diffusing globe.Detection zone can be exposed to light, such as light from light source.Light can pass through light source and base
One or more optical elements between matter, or light directly can advance to detection zone from light source.Detection module can connect
Receive the light from detection zone.Light can be through detection zone and detection module one or more optical elements, or
Light directly can advance to detection module from detection zone.Light can be collimation.Light can be evenly distributed in detection zone
One or more dimensions on.One or more dimensions can be illuminated using the light for being substantially identical intensity.Can be by
Light is guided substantially perpendicular to the mode of detection zone upper surface.Can also be according to being not substantially perpendicular in detection zone upper table
The mode in face guides light.Light can be multidirectional.Light can include a wavelength, narrowband wavelength, broad band wavelength or all band
Spectrum.Light can include visible wavelength.Light can include ultraviolet wavelength.Light can include IR wavelength.Light can be by
Lens focus.The image produced by detection module can include bright vision image.The image produced by detection module can include
Dark field image.The image produced by detection module can include fluoroscopic image.
Detection module can include one or more filters, including but not limited to wavelength filter (for example, colour filter,
Ultraviolet filter, infrared filter), dichroic filter and polarizing filter.Filter can include same type or
Different types of multiple filters, it can be used separately or in combination.
Detection module can include one or more lens.Lens can be pack-shot lens or " close-shot " lens.Lens can
To be zoom lens.Lens can be Infrared Lens.Lens can be ultraviolet lens.Lens can be wide-angle lens, including not
It is limited to wide-angle lens, extrawide angle lens and fish-eye lens.Lens can include same type or different types of multiple lens, its
It can be used separately or in combination.
Detection module can include the device for being used to remove pattern distortion or aberration, such as removing barrel distortion or fish
Eye distortion, pincushion distortion, beard shape distort, monochromatic aberration (for example, piston, tilt, defocus, spherical aberration, coma, astigmatism, as
Field bend, pattern distortion) or aberration (for example, axial direction, longitudinal direction, lateral, horizontal aberration) device.Such device
It can include being programmed to realize the computer system for the partially or even wholly instruction of correcting image distortion.For example, can
To use Blang's distortion model (Brown ' s distortion model) or Blang-Joseph Conrad model (Brown-Conrady
Model correct radial distortion and tangential distortion) are come.
Detection module can include communication equipment, and such as wired (for example, USB) or wireless (for example, Wi-Fi, bluetooth) leads to
Believe equipment.Communication equipment can include the equipment for radio.Communication equipment can include being used for Free Space Optics (FSO)
The equipment of communication, such as visible light communication or infrared (IR) communicate.Communication equipment can include the equipment for wire communication, bag
Include but be not limited to USB (USB), optical fiber, Peripheral Component Interconnect (PCI), PCI Express (PCIe) or
Thunderbolt.Communication equipment can include the equipment for Wi-Fi, such as IEEE 802.11a, b, g or n Wi-Fi.It is logical
Believe equipment can include for cellular data service equipment, such as GSM, CDMA, GPRS, 3G (for example, W-CDMA, EDGE and
) or 4G (for example, Long Term Evolution (LTE), mobile WiMAX) CDMA2000.Communication equipment can include being used for mobile satellite communication
Equipment.Communication equipment can include the equipment for Bluetooth communication.Communication equipment can include polytype communication equipment,
Such as USB and Wi-Fi, or bluetooth and Wi-Fi.
Communication equipment can transmit the information for carrying out self-detection module, and the image such as recorded by detection module is (for example, detection
The image in region).Communication equipment can transmit the information of such as image etc in real time.Communication equipment can be with electrophoretic apparatus
And/or the communication of its control system.Communication equipment can communicate with remote computer system, the remote computer system such as
Desktop computer, laptop computer, tablet PC, smart phone device or server.Communication equipment can be with such as hand
Hold the display device communication of formula display device etc.Communication equipment can be transmitted to the user at independent position or facility to be believed
Breath, such as image.
In some embodiments, the detection module can be any of detection module, include but is not limited to herein
Detector described in middle other parts.
In some cases, before the primer extension reaction is carried out, one or more of computer processors can
Individually or generally it is programmed to the target nucleic acid molecule is undergone one or more Denaturings.It is one or more of to become
Property condition may be selected from denaturation temperature distribution and denaturant.
In some cases, before the primer extension reaction is carried out, one or more of computer processors can
Individually or generally it is programmed to preheat the biological sample under about 90 DEG C to about 100 DEG C of pre-heating temperature and does not surpass
The pre-add thermal endurance for spending about 10 minutes.In some embodiments, the pre-add thermal endurance is no more than 1 minute.
Any aspect in the multiple aspect, one or more of computer processors can individually or generally
It is programmed to carry out the primer extension reaction of multiple circulations.Any an appropriate number of circulation can be carried out.For example, the period carried out
Can with less than about 100,90,80,70,60,50,40,30,20,10 or 5 circulations.
In some embodiments, one or more of computer processors can individually or generally be programmed to make
Reactant mixture undergoes multiple serial primer extension reactions.Single series in the multiple series may include multiple circulations
Specific primer extension, the reaction is characterised by, for example, specific denaturation as described elsewhere herein and extension bar
Part.Generally, for example, for Denaturing and/or extension condition, each single series is different from the multiple series extremely
Few other single series.For example, when continuing with regard to oblique variable Rate, denaturation temperature, denaturation duration, elongating temperature and extension
Between in any one, two, three, four or all for five, single series may differ from the multiple series
Another single series.In addition, multiple series may include any number of single series, for example, at least about or about 2,3,4,
5th, 6,7,8,9,10 or more a single series.
For example, one or more of computer processors can individually or generally be programmed to include first and be
Multiple serial primer extension reactions of row and second series.First Series, for example, it may include the primer more than ten circulations prolongs
Reaction is stretched, reactant mixture is incubated and is no more than by wherein each circulation of First Series including (i) at about 92 DEG C to about 95 DEG C
30 seconds, reactant mixture was incubated no more than about one minute by subsequent (ii) at about 35 DEG C to about 65 DEG C.Second series, for example,
It may include the primer extension reaction more than ten circulations, each circulation of wherein second series exists reactant mixture including (i)
It is incubated and is no more than 30 seconds at about 92 DEG C to about 95 DEG C, reactant mixture is incubated by subsequent (ii) at about 40 DEG C to about 60 DEG C is not surpassed
Spend about 1 minute.In this instantiation, the first and second series are different in their elongating temperature condition.However, the reality
Example is not intended to limit, because any combination of different extensions and Denaturing can be used.
In some embodiments, one or more of computer processors can individually or generally be programmed to make
Target nucleic acid is subjected to Denaturing before primer extension reaction startup.In the case of multiple serial primer extension reactions, institute
Stating one or more computer processors can individually or generally be programmed to make target nucleic acid perform the multiple series
Before be subjected to Denaturing, or Denaturing can be subjected between the multiple series.For example, one or more of computers
Processor can individually or generally be programmed to make to pass through between First Series and second series of the target nucleic acid in multiple series
By Denaturing.The non-limiting examples of these Denaturings include denaturation temperature distribution (for example, one or more become warm-natured
Degree) and denaturant.
In some embodiments, one or more of computer processors can individually or be generally programmed to
Carry out preheating biological sample before primer extension reaction.Preheat the temperature (for example, pre-heating temperature) of biological sample and hold
The continuous time (for example, pre-add thermal endurance) can change according to the particular organisms sample for example analyzed.In some instances,
Can by biological sample preheating no more than about 60 minutes, 50 minutes, 40 minutes, 30 minutes, 25 minutes, 20 minutes, 15 minutes, 10
Minute, 9 minutes, 8 minutes, 7 minutes, 6 minutes, 5 minutes, 4 minutes, 3 minutes, 2 minutes, 1 minute, 45 seconds, 30 seconds, 20 seconds, 15
Second, 10 seconds or 5 seconds.In some instances, biological sample can be preheated at a temperature of about 80 DEG C to about 110 DEG C.In some realities
In example, biological sample can be preheated at a temperature of about 90 DEG C to about 100 DEG C.In some instances, can be at about 90 DEG C to about 97
Biological sample is preheated at a temperature of DEG C.In some instances, biological sample can be preheated at a temperature of about 92 DEG C to about 95 DEG C
Product.In other example, can about 80 DEG C, 81 DEG C, 82 DEG C, 83 DEG C, 84 DEG C, 85 DEG C, 86 DEG C, 87 DEG C, 88 DEG C, 89
DEG C, 90 DEG C, 91 DEG C, 92 DEG C, 93 DEG C, 94 DEG C, 95 DEG C, 96 DEG C, 97 DEG C, 98 DEG C, preheat at a temperature of 99 DEG C or 100 DEG C it is biological
Sample.
In some embodiments, system of the invention may include the electronic display of the user interface with display graphic element
Display screen, the graphic element can be accessed by the user, to perform to expand the amplification scheme of the target nucleic acid in biological sample.The system
It may also include computer processor (including any suitable dress with computer processor as described elsewhere herein
Put), it is coupled to the electronic display and is programmed to perform the amplification scheme when user selects the graphic element.The expansion
Increasing scheme may include:Make to undergo multiple systems comprising biological sample and for the reactant mixture of the reagent needed for progress nucleic acid amplification
The primer extension reaction of row, to generate amplified production.The amplified production may indicate that the presence of biological sample target nucleic acid.In addition,
The primer extension reaction of each series may include two or more following circulations:With denaturation temperature and denaturation duration
Incubation reaction mixture under the Denaturing being characterized, then in the extension bar being characterized with elongating temperature and extension duration
Incubation reaction mixture under part.For Denaturing and/or extension condition, single series may differ from the multiple series
At least one other single series.
In some embodiments, target nucleic acid can be related to disease.For example, the disease can be with RNA virus or DNA virus phase
Close.The example of virus is provided in elsewhere herein.In some embodiments, the disease can be with malignant bacteria (e.g., tuberculosis point
Branch bacillus) or pathogenic protozoa (for example, such as plasmodium in malaria) (including these pathogen described elsewhere herein
Example) it is related.In some embodiments, the amplification scheme may point to the presence based on amplified production to determine the disease
Presence.
In some cases, user interface can be graphic user interface.In addition, user interface may include it is one or more
Graphic element.Graphic element may include image and/or text message, such as picture, icon and text.Graphic element is in user interface
On can be of different sizes and direction.In addition, electronic display can be any suitable electronic console, including herein its
The example of his place description.The non-limiting examples of electronic display include monitor, mobile device screen, laptop computer
Screen, TV, portable video game system screen and calculator screen.In some embodiments, electronic display may include to touch
Shield (for example, condenser type or resistive touch screen) so that the graphic element shown in the user interface of electronic display can be through
Selected by user's touch electronic display.
In some embodiments, the amplification scheme can further comprise selecting primer sets for target nucleic acid.Situations such as this
Under, primer sets can be for expand target nucleic acid molecule one or more sequences and specially designed primer sets.In some implementations
In scheme, the amplification scheme can further comprise that selection has specific report to one or more sequences of target nucleic acid molecule
Agent (for example, other kinds of report agent described in oligonucleotide probe or elsewhere herein comprising optical activity species).
In addition, in some embodiments, the reagent may include as described elsewhere herein for appointing necessary to nucleic acid amplification
What suitable reagent, such as DNA (DNA) polymerase, the primer sets for target nucleic acid and (optionally) reverse transcription
Enzyme.
In some embodiments, user interface can show multiple graphic elements.Each graphic element can be with multiple amplifications
Given amplification scheme in scheme is associated.Each scheme in the multiple amplification scheme may include serial primer extension reaction
Various combination.However, in some cases, user interface can show the multiple pattern primitives associated with same amplification scheme
Element.In some embodiments, each graphic element and/or can be associated with disease, and in the multiple amplification scheme
Given amplification scheme may point to determine the presence of the disease of subject.Therefore, in tiiese cases, graphic element may be selected in user
To run an amplification scheme (or a series of amplification scheme) so as to analyze specific disease.In some embodiments,
The disease can be with virus (for example, any RNA virus or DNA virus, including these viral realities described elsewhere herein
Example) it is related.The non-limiting examples of virus include human immunodeficiency virus I (HIV I), human immunodeficiency virus II (HIV
II), orthomyxovirus, Ebola virus, dengue virus, influenza virus (for example, H1N1 is viral, H3N2 virus, H7N9 virus or
H5N1 virus), hepatitis viruse, hepatitis A virus, hepatitis type B virus, HCV (for example, tool first the types of RNA- third
Hepatitis viruse (RNA-HCV)), Hepatitis D virus, HEV, HGV RNA, Epstein-Barr virus, monocytosis
Syndrome virus, cytomegalovirus, SARS virus, west nile fever virus, poliovirus, measles virus, herpes simplex virus,
Variola virus, adenovirus (for example, 55 type adenovirus (ADV 55), 7 type adenovirus (ADV 7)) and varicella virus.In some realities
Apply in scheme, the disease can be with malignant bacteria (for example, mycobacterium tuberculosis) or pathogenic protozoa (for example, the malaria in malaria
Protozoon) (example for including these pathogen described elsewhere herein) correlation.
In many aspects, the system includes input module, and the input module receives amplification and is present in directly from subject
User's request of target nucleic acid (for example, target RNA, target DNA) in the biological sample of acquisition.Can be used can receive these users please
Any suitable module asked.The input module may include, for example, the device comprising one or more processors.Include processing
The non-limiting examples of the device of device (for example, computer processor) include:Desktop computer, laptop computer, flat board meter
Calculation machine (for example, iPad、Galaxy Tab), cell phone, smart phone (for example, iPhone、The phone of support), personal digital assistant (PDA), video game console, TV,
Music player devices (for example,IPod), video playback apparatus, pager and calculator.Processor can with one or
Other units of multiple controllers, computing unit and/or computer system are associated, or when needed in implantation firmware.Such as
Fruit is implemented in software, then routine (or program) can be stored in any computer-readable memory such as RAM, ROM, flash storage
In device, disk, laser disk or other storage mediums.Similarly, the software can be transported to dress via any of transfer approach
Put, this method includes, for example, through communication channel, such as telephone wire, internet, local Intranet, wireless connection, or via
Portable medium, such as computer readable disk, flash disc drives.Each step can be used as various district's groups, operation, instrument, mould
Block or technology are implemented, and the latter can implement in hardware, firmware, software or its any combination again.When implementing within hardware,
Some or all of these district's groups, operation, technology etc. can be in such as customization integrated circuit (IC), application specific integrated circuits
(ASIC), implement in FPGA (FPGA), programmable logic array (PLA) etc..
In some embodiments, input module is configured to receive the user's request for carrying out target nucleic acid amplification.Input mould
Block can directly (for example, by input equipment, the keyboard such as operated by user, mouse or touch-screen) or indirectly (for example,
By wired or wireless connection, including through internet) receive user's request.Input module can be via output electronic device to amplification
Module provides the request of user.In some embodiments, input module may include user interface (UI), such as graphic user interface
(GUI), the user interface is configured to the request for making user provide amplification target nucleic acid.GUI may include text, figure and/
Or audio frequency component.GUI can be provided on an electronic display, and the electronic console includes the aobvious of the device containing computer processor
Show device.These displays may include resistance-type or capacitive touch screen.
The non-limiting examples of user include therefrom obtaining the subject, medical worker, clinician's (example of biological sample
Such as, doctor, nurse, Laboratory Technician), lab assistant (such as hospital laboratory technical staff, Research Scientist, pharmacy
Scientist), the clinical observer of clinical test, or other users in health care industry etc..
In many aspects, the system includes amplification module, and the amplification module is used in response to being received by input module
User asks and carries out nucleic acid amplification reaction to target nucleic acid or part thereof.The amplification module can be able to carry out as described herein
Where method, and can include fluid treating device, one or more thermal cyclers, for receiving one or more reaction vessels
The device in (for example, hole of the hot block of thermal cycle), can detect amplified production detector (for example, fluorescence detector, spectrum examine
Survey device, electrochemical detector) and for recipient export on amplified production (DNA product of amplification) presence and/or
In the device of the information (for example, information of initial data, processed data or any other type as described herein) of amount
Any device.In some cases, the amplification module may include with computer processor as described elsewhere herein
Device, and can with can be analyzed under the auxiliary of Suitable software Autonomous test acquisition initial data.In addition, in some implementations
In scheme, the amplification module may include to input electronic device necessary to receiving instruction from input module and may include and export
Module exports electronic device necessary to being communicated.
In some embodiments, material, amplification of nucleic acid, detection amplified production and output information are provided to reaction vessel
One or more steps can be by amplification module automation mechanized operation.In some embodiments, automation mechanized operation may include to use one
Individual or multiple fluid processors and associated software.These processes can be run using some commercially available fluid handling systems
Automation mechanized operation.The non-limiting examples of these fluid processors include coming from Perkin-Elmer, Caliper Life
Sciences, Tecan, Eppendorf, Apricot Design and Velocity 11 fluid processor.
In some embodiments, amplification module may include real-time detector device.The non-limiting examples bag of these instruments
Include real-time PCR thermal cyclers, ABI7000 sequence detection systems, ABI7700 sequence detection systems,
The real-time PCR systems of Applied Biosystems 7300, the real-time PCR systems of Applied Biosystems 7500, Applied
Biosystems 7900HT Fast real-time PCR systems (are all from Applied Biosystems);LightCyclerTMSystem
(Roche Diagnostics GmbH);Mx3000PTMReal-time PCR system, Mx3005PTMReal-time PCR system and
Multiple quantitative PCR system ( Multiplex Quantitative PCR System)(Stratagene,La
Jolla,Calif.);And intelligent circulation instrument system (Smart Cycler System) (Cepheid, by Fisher
Scientific is distributed).In some embodiments, amplification module may include another self-reacting device, for example, AmpliPrep/System (Roche Molecular Systems),
TIGRIS DTS systems (Hologic Gen-Probe, San Diego, CA), PANTHER systems (Hologic Gen-Probe,
San Diego,CA)、BD MAXTMSystem (Becton Dickinson), GeneXpert systems (Cepheid),(BioFire Diagnostics) system, iCubate systems, IDBox systems (Luminex),
EncompassMDxTM(Rheonix) system, LiatTMAanlyzer (IQuum) system, Biocartis Molecular
Diagnostic Platform systems,ML systems (Enigma Diagnostics),System
(T2Biosystems)、System (NanoSphere), Great Basin Diagnostic System,
UnyveroTMSystem (Curetis), PanNAT systems (Micronics) or SpartanTMRX systems (Spartan
Bioscience)。
In all fields, the system includes the output module for being operably coupled to amplification module.In some embodiment party
In case, the output module can include the device with the processor as described above for input module.The output module can be wrapped
Input equipment as described herein is included, and/or may include the input electronic device for being communicated with amplification module.At some
In embodiment, the output module can be electronic console, in some cases, and the electronic console includes UI.At some
In embodiment, the output module is operably coupled to the communication interface of computer network such as internet.In some implementations
In scheme, any suitable telecommunication media (including computer network, wireless network, local Intranet can be used in the output module
Or internet) by information to being sent to the recipient in Local or Remote position.In some embodiments, the output module
The data received from amplification module can be analyzed.In some cases, the output module includes that report can be generated and will reported
The Report Builder for being sent to recipient is accused, wherein this report includes the amount on amplified production as described elsewhere herein
And/or any information existed.In some embodiments, the output module may be in response to the information received from amplification module
Information is automatically transmitted, such as with initial data or in the form of the data analysis of the software progress included in amplification module.
Or, the output module can transmit information after user instruction is received.The information transmitted by output module can be through electronically
Checked or printed by printer.
One in input module, biological sample processing module, identification module, detection module, amplification module and output module
Kind or it is a variety of can be included in same device, or one or more identical components can be included.For example, amplification module can also be wrapped
Containing input module, biological sample processing module, identification module, detection module, output module, or one or more therein.
In other examples, the device comprising processor, which both can be included in input module, can also reside in output module.User can make
Asked to expand target nucleic acid with the device, and can also use the apparatus as by the information transmission of amplified production extremely
The instrument of recipient.In some cases, the device comprising processor can be included in all six kinds of modules so that should include place
The device of reason device can also be used for instrument of the control included in amplification module or any other module (for example, thermal cycler, incubation
Device, detector, fluid treating device), instruction is provided the instrument, and receives the information returned from the instrument.Six kinds of moulds
Each of block can further include one or more computer processors specifically described herein, and/or can perform described one kind
Or the function that a variety of computer processors are programmed to execute.
Example system for expanding target nucleic acid according to methods described herein is shown in Figure 1.The system includes both filling
When again a part for input module may act as the computer 101 of a part for output module.User will include and be ready for nucleic acid
The reaction vessel 102 of the reactant mixture of amplification is put into amplification module 104.The amplification module includes thermal cycler 105 and inspection
Survey device 106.Input module 107 includes computer 101 and related input equipment 103 (for example, keyboard, mouse etc.), and input is set
Standby 103 can receive the request that user is expanded to the target nucleic acid in reactant mixture.Input module 107 is by the request of user
Amplification module 104 is communicated to, and nucleic acid amplification starts in thermal cycler 105.As amplification is carried out, the detection of module is expanded
Device 106 is detected to amplified production.Information (for example, the initial data obtained by detector) on amplified production is from detection
Device 106 sends back computer 101, and computer 101 also functions as the component of output module 108.Computer 101 is received from amplification mould
The information of block 104, carries out any extra operation to the information, subsequently generates the report for including the information through processing.Once report
Accuse generation, computer 101 then via computer network interface 110 by computer network (for example, Intranet, internet),
It will be reported with hard copy form or via the electronic console 112 for being operably coupled to computer 101 via printer 111
It is sent to its final recipient 109.On the one hand, the invention provides a kind of computer-readable comprising machine executable code
Medium, when it is executed by one or more processors, implements the method according to any method disclosed herein.On the other hand,
The invention provides a kind of computer-readable medium for including machine executable code, it is by one or more computer processors
During execution, implement amplification and be present in the direct method from the target nucleus ribosomal ribonucleic acid (RNA) in the biological sample that subject obtains, the party
Method includes:(a) provide comprising biological sample and for abreast carrying out reverse transcription amplification institute with DNA (DNA) amplification
The reaction vessel of required reagent, to obtain reactant mixture, the reagent include (i) reverse transcriptase, (ii) archaeal dna polymerase, and
(iii) target RNA primer sets are directed to;And (b) makes the primer extend of the multiple circulations of reactant mixture experience in reaction vessel anti-
Should, to generate the DNA amplification product for indicating there is target RNA, each circulation incubates reactant mixture including (i) under denaturation temperature
Educate the denaturation duration less equal than 60 seconds, reactant mixture is incubated by subsequent (ii) under elongating temperature to be less equal than
The extension duration of 60 seconds, so as to expand target RNA.
On the other hand, the invention provides a kind of computer-readable medium for including machine executable code, it is by one
When individual or multiple computer processors are performed, implement amplification and be present in directly from the target nucleus sugar in the biological sample that subject obtains
The method of nucleic acid (RNA), this method includes:(a) biological sample obtained from subject is received;(b) provide comprising biological sample
Product and the reaction vessel that necessary reagent is expanded for progress reverse transcription amplification and optional DNA (DNA), with
Reactant mixture is obtained, the reagent is directed to target RNA primer sets comprising (i) reverse transcriptase and (ii);(c) pass through reactant mixture
The primer extension reaction of multiple circulations is gone through, is produced with the DNA amplification for producing the detectable amount for indicating to exist in biological sample target RNA
Thing;(d) amount of the DNA product of detection (c);And (e) exports the information of the amount on DNA product to recipient, wherein being used for
(a)-(e) time quantum is completed less than or equal to about 30 minutes.
On the one hand, the invention provides a kind of computer-readable medium for including machine executable code, its by one or
When multiple computer processors are performed, implement amplification and be present in from the target nucleus ribosomal ribonucleic acid in the biological sample that subject obtains
(RNA) method, this method includes:(a) provide comprising biological sample and for the anti-of reagent necessary to progress nucleic acid amplification
Container is answered, to obtain reactant mixture, the reagent includes (i) archaeal dna polymerase and optional reverse transcriptase, and (ii) is directed to target nucleus
The primer sets of acid;And (b) makes the reactant mixture in reaction vessel undergo multiple serial primer extension reactions with by target nucleic acid
Amplified production is generated, each series includes two or more following circulations:(i) with denaturation temperature and denaturation duration
Incubation reaction mixture under the Denaturing being characterized, subsequent (ii) is in prolonging for being characterized with elongating temperature and extension duration
Incubation reaction mixture under the conditions of stretching, wherein for Denaturing and/or extension condition, single series is different from the multiple
At least one other single series in series.
Computer-readable medium can take many forms, include but is not limited to, tangible (or non-transitory) storage medium, load
Ripple medium or physical transmission medium.Non-volatile memory medium includes, for example, appointing in CD or disk, such as any computer
What storage device etc., such as available for calculation procedure, process step is implemented.Volatile storage medium includes dynamic memory
The main storage of device, such as computer.Tangible transmission media includes coaxial cable;Wrapped in copper cash and optical fiber, including computer system
Wire containing bus.Carrier wave transmission media can take electric signal or electromagnetic signal or sound wave or light wave such as radio frequency (RF) and infrared
(IR) form of those produced in data communication process.Therefore, the common form of computer-readable medium includes, for example:It is soft
It is disk, flexible disk (flexible disk), hard disk, tape, any other magnetic medium, CD-ROM, DVD or DVD-ROM, any
Other optical mediums, perforated paper tape, any other physical storage medium with hole patterns, RAM, PROM and EPROM,
FLASH-EPROM, any other storage chip or cassette, transmission data or instruction carrier wave, transmit these carrier waves cable or
Link (link) or computer can therefrom program code read and/or data any other medium.These computer-readable Jie
Many in matter form, which may participate in, to be carried one or more sequences of one or more instructions to processor to perform.
Embodiment
Embodiment 1:The amplification and detection of nucleic acid in viral stock sample and biological sample
PCR reagent obtains (Coyote One-Step PCR from Kayoudi Biotechnology (Beijing) Co., Ltd.
Reagent).Virus is detected in artificial synthesized imitated clinical sample using digital pcr and qPCR.The sample includes serum
With HBV analogs (Kayoudi Biotechnology (Beijing) Co., Ltd.).The imitated clinical sample in part uses Qiagen QIAamp
DNA Mini Kit carry out nucleic acid purification, and other imitated clinical samples are without nucleic acid purification.Purified sample is in this experiment
As control.
By the imitated clinical sample (10IU/ reactions) through nucleic acid purification and without nucleic acid purification be placed in different test tubes with
Coyote One-Step PCR Reagent are mixed.Method formation droplet of the reactant mixture according to described in this specification.
Specifically, on the basis of the use HFE7500 and the preparation of surfactant that are known in the art, Tween 60 is with the addition of,
And optional Fluorinert FC-70 (Sigma Aldrich) are used to form droplet.Be on the inside of the droplet comprising
The aqueous solution of the reactant mixture (including HBV viruses), outside is wrapped up by oil reservoir.
After droplet is formed, the droplet is analyzed with quantitative PCR and digital pcr.It is direct with PCR amplifications
As described in this description, wherein denaturation temperature may be up to 100 DEG C to detection HBV method, and period may be up to 80 circulations.
Experimental result is shown in Fig. 2-3.Fig. 2A-D show the droplet prepared using the method for the present invention, and it is right respectively
The droplet that Ying Yu is prepared using following preparations:2%Tween 60, HFE7500,2% glycolic polyoxyethanyl bay ether (A);
0.1%Tween 60, HFE7500,2% glycolic polyoxyethanyl bay ether (A);FC-70, HFE7500,2% glycolic polyoxy
Ethyl Lauroyl ether (C);And FC-70, HFE7500,2% glycolic polyoxyethanyl bay ether (D).
As can be seen, the droplet prepared using the preparation containing Tween 60 has bad droplet stability and small liquid
Uniformity between drop.On the contrary, using containing FC-70 preparation prepare droplet have good droplet stability and
Uniformity between droplet.
The further addition Tween 20, and be optionally followed by being vortexed in reagent so that droplet more stablizes (number
According to not showing).
Quantitative PCR and digital pcr have been carried out using these droplets to react, and find these droplets at high temperature (100
DEG C) keep stable, and be resistant to longer circulation time (up to 80 circulations), and do not deform or droplet each other it
Between merging.
Quantitative PCR and the digital pcr reaction carried out using these droplets successfully detected in imitated clinical sample
Serum in the HBV that contains.Fig. 3 shows the HBV (A containing different potency:High-titer HBV;B:Medium potency HBV;C:It is poorly efficient
Valency HBV;D:Negative control) droplet fluoroscopic examination result.As a result the amplified reaction that display is carried out using these droplets
Virus can delicately be detected.Control sample (purified nucleic acid samples) also by similar method using quantitative PCR and
Digital pcr detected viral (result is not shown).
Therefore, One-Step PCR Reagent are included into electric liquid (such as FC-70) and/or based on list with of the invention
The novel formulation combination of the emulsifying agent (such as Tween 60) of stearate can simplify by PCR method (such as quantitative PCR and numeral
PCR the flow of the infectious disease detection) carried out.
Embodiment 2:For droplet or the system of biology sample detection
Referring to Fig. 4, which depict the top view of the detection unit 400 in the detecting system of the present invention.As illustrated, detection
Unit 400 includes fluorescence detector 401, and it is configured to detect multiple droplets along optical window in given detection zone
Subset or one or more of subset biological sample.In one embodiment, fluorescence detector can be caught including image
Obtain equipment, such as camera.In one embodiment, the fluorescence detector can include CCD camera.In an implementation
In scheme, the CCD camera can be focused light on CCD by camera lens (including camera lens).Then, CCD is filtered
Color, photosensitive (photoelectric conversion) etc. are operated, and reference object has been resolved into pixel one by one with certain arrangement mode.With
Afterwards, the pixel of analog picture signal form is converted into data signal by using analog-digital converter, and be sent at image
Reason device is handled, to obtain real image.These images are possibly stored in storage medium for use as other after compression
Possible application, for example, such as analyze according to the digital pcr of the present invention.
Further, one or more filters 402 are also included according to the detection unit of the present invention.As illustrated, described one
Individual or multiple filters are arranged on filter wheel, and desired optical filtering is selected so as to manually or automatically rotating filtering wheel
Device.In one embodiment, filter can optionally transmit the light in a wavelength range or frequency range, you can with
It is configured to transmit the light of different colours, while stopping the light of undesirable remainder.In other words, the filter can be with
It is configured to select the light of the given frequency or frequency range detected by the fluorescence detector, prevents or filter out optical detection
The frequency of the undesirable detection of device or the light of frequency range.Therefore in this way, there is fluorescence detector detection to expect wavelength
Or the light of frequency, for example detect the exciting light by irradiating droplet or biological sample and obtaining.
In one embodiment, detection unit also include at least one excitaton source, one for example gone out as shown in the figure or
Multiple light emitting diodes (LED) 403 and the radiator 404 being arranged on one or more of LED.In some cases, when
One or more of the subset or the subset of multiple droplets to be detected biological sample is placed on sample holder simultaneously
And along single plane keep when, the exciting light (such as illumination light) that the excitaton source can be arranged to be produced is guided into single
The given detection zone in multiple detection zones in plane, thus to give detection zone in multiple droplets subset or
Biological sample in subset is irradiated, can be by optics to make the biological sample in the subset or subset of multiple droplets launch
The exciting light of detector detection.In some cases, at least one excitaton source can be multiple excitaton sources, so as to produce a variety of face
The light of color, many of color can be at least three kinds, four kinds, five kinds or more kind colors.
In some embodiments of the present invention, excitaton source can include in one or more LED, and the plurality of LED
Each LED launch different frequency light.In some cases, multiple LED can produce white light.In this case, multiple LED
For example it can drive what is lighted with red, yellow, and green, green grass or young crops, five kinds of different colors of blue total, and by the rotation of actuating mechanism
Five LED produce mixed white light.By irradiating white light to droplet or biological sample, fluorescence detector can obtain small liquid
The white image of drop or biological sample.In some embodiments, in the case where not coming from specific LED pseudomorphism, it will can be somebody's turn to do
White image is used for the reference that total droplet is counted, so as to obtain total droplet number.In some embodiments, it is described
One or more LED can have certain transmitting optical range, and such as LED transmitting boundaries can be received at 390 nanometers (nm) to 700
In the range of rice.It is appreciated that transmitting optical range here is merely exemplary that those skilled in the art are according to the present invention
Teaching, the LED with other transmitting optical ranges can also be selected as excitaton source.Unlike the prior art, it is of the invention
Embodiment is imaged by using the LED being circular layout, and without using usually used spectroscope.
In one embodiment, the radiator for being placed on LED (or being attached at LED heating surface) can be radiating
Piece (or radiating fin).The fin is the heat dissipation element of passivity, with good heat conductivility and with compound
Heat exchange pattern radiates, and thus reduces temperature during LED operation, and extend LED working life.
In some embodiments, at least one excitaton source also includes one or more optical units, for swashing described
It is luminous to guide into and/or focus in the given detection zone.In some cases, one or more optical units can be wrapped
Condenser lens or speculum are included, so that exciting light is converged into given detection zone.
In one embodiment, the position of at least one excitaton source can be selected so that at least one excitaton source can be with
It is oriented to and guides or be introduced only into exciting light into optical window, so as to the detection of fluorescence detector.In some cases, at least one
Individual excitaton source is oriented to guides exciting light along first axle into, wherein the fluorescence detector is oriented to along flat not with first axle
The second capable axle detects the subset or one or more of biological samples of the multiple droplet.
In some embodiments, detection unit of the invention includes at least one actuator, such as stepper motor
405.In one embodiment, the stepper motor 405 is electric impulse signal to be transformed into angular displacement to control rotor
The motor of rotation.By the rotation of rotor, shown fluorescence detector can carry out in vertical direction above and below (such as along perpendicular
Straight Z axis) movement so that close to or away from droplet or biological sample to be measured, be achieved in fluorescence detector (for example
Camera) auto-focusing.
In some embodiments, detection unit herein shown also additionally include at least one actuator or with extremely
Few actuator coupling, so that the operation of actuator makes the optical window of fluorescence detector along single planar movement, for example, edge
X-axis and Y-axis movement in plane right-angle coordinate.Using foregoing stepper motor, detection unit of the invention can be in X, Y
Move, moved so as to realize along three degree of freedom under the three-dimensional coordinate constituted with Z axis.In some embodiments, detection unit
Can be along the planar movement parallel to described single plane, so as to the droplet or biological sample that are placed in single plane
Detected.By comparison according in other embodiments, detection unit can be along the plane for being orthogonal to the single plane
It is mobile.
Fig. 5 is the schematic diagram for describing the detecting system 500 of the present invention.As illustrated, the detecting system is included as in Fig. 4
Shown detection unit 400, including fluorescence detector 401, one or more filters 402, one or more luminous
Diode (LED) 403 and the radiator 404 being arranged on one or more of LED.In addition, being further illustrated that optics
The lens or lens group 406 of detector (such as camera), for example, can include convex lens, concavees lens or its combination, to realize
Good light control and imaging.
Further figure 5 illustrates sample holder 407, it can detect the subset or the son of multiple droplets
During one or more of collection biological sample, the multiple droplet 408 is kept along single plane.In some embodiments
In, at least one actuator can also be coupled to sample holder, so as to realize the relative movement of sample holder.
Fig. 6 be describe the present invention Fig. 4 detection unit 400 bottom view, illustrated therein is fluorescence detector 401,
One or more filters 402, one or more light emitting diodes (LED) 403 and it is arranged on one or more of LED
Radiator 404.As shown in FIG., all LED are focused on for fluorescence detector 401.
Fig. 7 is the schematic diagram for the lightray propagation for describing the detecting system of the present invention.As shown in Figure 7, by as sharp
The illumination light that the LED 403 of light emitting source is launched incides the droplet or biological sample 408 positioned at sample holder 407
On, so as to produce reflected light 409 and the exciting light 410 obtained by irradiation droplet or biological sample.In this embodiment,
As fluorescence detector camera will detect the exciting light 410 so that the droplet or biological sample are imaged with
Perform such as dPCR analyses.In the present embodiment, due to the angle theta 1 and reflected light between illumination light 411 and exciting light 410
Angle theta 2 between 409 and exciting light 410 is equal, so that reflected light 409 can't interfere with the imaging of camera.In some realities
Apply in scheme, the angle can be with the range of substantially 30 degree~50 degree, it is therefore preferable to substantially 45 degree.
In some embodiments, detecting system of the invention can be used in two LED of symmetric position as sharp
Light emitting source is imaged to droplet or biological sample, so as to minimizing the distortion of imaging, to avoid to droplet or
The interference of such as dPCR analyses of biological sample.In some embodiments, the excitation source can be that 180 degree is arranged symmetrically,
Five-five ten LED being arranged symmetrically for example in Fig. 4 are shown.
According to embodiment of the present invention, detecting system can use fluorescence detector to be collected from the multiple detection zone
At least one illumination correction chart picture, and come from the multiple inspection using at least one illumination correction chart picture to compensate or correct
The illumination heterogeneity for the multiple droplets surveyed in region.For example, the detecting system of the present invention can collect at least one illumination
Correction chart picture, so as to correct the illumination heterogeneity in dPCR analyses.
Fig. 8 is the schematic diagram of the motion track for the optical window for describing the detecting system of the present invention.As shown in Figure 8
, droplet or biological sample to be detected is divided into 20 sub- droplets or subsample, and according to the square of 5 rows 4 row in figure
Formation formula is placed on sample holder.Then, detecting system of the invention, the specially optical window of fluorescence detector will be
Under the driving of one or more actuators, according to the direction shown in arrow in figure in order from the 1st sub- droplet or subsample
Set out and start detection until sequence detection complete 20th sub- droplet or subsample.In this process, the illumination light sent by LED
The sub- droplet or subsample from the 1st to the 20th will be irradiated according to same order, thus by detection unit Lai
Detect the exciting light launched from droplet.That is, detection unit of the invention can cause exciting light and optical window for many
Individual detection zone is relatively moved simultaneously.Using the track of the relative movement or pattern (i.e. along multiple translations of multiple detection zones
Vector), exciting light can cause the warm-up movement of droplet or biological sample, and the track be also minimize droplet movement and
Optical window moves the optimal path of (or sample holder movement) distance.
According to the detecting system of the present invention, due to the LED illumination light of five kinds of colors can be used, for intensity difference
For digital pcr, very high multiplicity (multiplexing) will be obtained.For example, when droplet or biological sample to be analyzed
During in the presence of 7 kinds of concentration, then the analyte that multiplicity is planted in 35 (5 × 7) can be obtained.
Although the preferred embodiments of the invention have been shown and described herein, to those skilled in the art
It is readily apparent that what these embodiments were only provided in an illustrative manner.Those skilled in the art are without departing substantially from this hair
In the case of bright, a large amount of changes are will now occur, changes and substitutes.It should be appreciated that invention described herein embodiment is each
Alternative solution is planted to can be used for implementing the present invention.Purpose is, limits the scope of the present invention with following claims, thus covers
Method and structure and its equivalent in these rights.
Claims (51)
1. a kind of be used for the system of droplet or biology sample detection, it includes:
Sample holder, it is arranged to detecting one or more of the subset or the subset of multiple droplets biology
During sample, the multiple droplet is kept along single plane;
Detection unit, including:(i) at least one excitaton source, it is arranged to guide exciting light in the single plane into
Given detection zone in multiple detection zones, and (ii) fluorescence detector, it is arranged in the given detection zone
The middle subset or one or more of biological samples that the multiple droplet is detected along optical window;And
At least one actuator, it is arranged to make the optical window relatively move along the multiple detection zone.
2. system according to claim 1, wherein at least one described actuator is a part for the detection unit.
3. system according to claim 1, wherein at least one described actuator is multiple actuators.
4. system according to claim 1, wherein at least one described actuator is coupled to the detection unit.
5. system according to claim 1, wherein at least one described actuator is coupled to the sample holder.
6. the excitaton source of system according to claim 1, wherein energy is arranged to guide into the exciting light
The given detection zone.
7. system according to claim 1, it also includes one or more computer processors, and it is operably coupled to
The detection unit and at least one described actuator, wherein one or more of computer processors are individually or generally
It is programmed for:(i) guide at least one described actuator, so as to when the multiple droplet along the single plane adjacent to
During the sample holder so that the optical window is relatively moved along the multiple detection zone, wherein the relative movement
The optical window is positioned in the given detection zone, (ii) guides at least one described excitaton source by the exciting light
Guide the given detection zone into, and (iii) guides the fluorescence detector described in the given detection zone to detect
The subset or one or more of biological samples of the multiple droplet in optical window.
8. system according to claim 7, wherein one or more of computer processors individually or generally by
Program for guiding at least one described actuator so that the optical window in order along the multiple detection zone
Each detection zone relative movement.
9. system according to claim 7, wherein one or more of computer processors individually or generally by
Programming is used for:(i) at least one illumination correction chart picture is collected from the multiple detection zone using the fluorescence detector, and
(ii) compensate or correct using at least one described illumination correction chart picture come from it is described many in the multiple detection zone
The illumination heterogeneity of individual droplet.
10. system according to claim 1, wherein at least one described excitaton source is multiple excitaton sources.
11. system according to claim 10, wherein the multiple excitaton source is multiple light emitting diodes (LED).
12. system according to claim 11, wherein the multiple LED each LED launches the light of different frequency.
13. system according to claim 11, wherein the multiple LED produces white light.
14. system according to claim 10, wherein the multiple excitaton source produces the light of multiple color.
15. system according to claim 14, wherein the multiple color includes at least three kinds colors.
16. system according to claim 15, wherein the multiple color includes at least four colors.
17. system according to claim 16, wherein the multiple color includes at least five kinds colors.
18. system according to claim 1, wherein at least one described excitaton source includes light emitting diode (LED).
19. system according to claim 18, wherein the LED transmitting boundaries are at 390 nanometers (nm) to 700 nanometer ranges
Interior light.
20. system according to claim 1, wherein at least one described excitaton source includes radiator.
21. system according to claim 20, wherein the radiator is fin.
22. system according to claim 1, wherein at least one described excitaton source includes one or more optical units,
For guiding and/or focusing on the exciting light in the given detection zone into.
23. system according to claim 22, wherein one or more of optical units include condenser lens.
24. system according to claim 22, wherein one or more of optical units include directional mirror.
25. system according to claim 1, wherein the detection unit does not include spectroscope.
26. system according to claim 1, wherein the detection unit further comprises one or more filters, its
For the given frequency or the light of frequency range for selecting to be detected by the fluorescence detector.
27. system according to claim 26, wherein one or more of filters are multiple filters.
28. system according to claim 27, wherein the multiple filter includes each optical filtering rotatably selected
Device.
29. system according to claim 1, wherein the fluorescence detector includes charge coupling device (CCD) camera.
30. system according to claim 1, wherein the detection unit is arranged to move along three degree of freedom.
31. system according to claim 30, wherein the detection unit is arranged to along parallel to described single flat
The planar movement in face.
32. system according to claim 30, wherein the detection unit be arranged to it is described single flat along being orthogonal to
The planar movement in face.
33. system according to claim 1, further comprises fluid stream unit, it is arranged to adjacent to the sample
Product supporter provides the multiple droplet.
34. system according to claim 1, wherein at least one described excitaton source is oriented to and guides the exciting light into
The optical window.
35. system according to claim 34, wherein at least one described excitaton source is oriented to the exciting light only
Guide the optical window into.
36. system according to claim 1, wherein at least one described excitaton source is oriented to the exciting light along
One axle is guided into, wherein the fluorescence detector be oriented to it is the multiple to detect along not parallel with the first axle the second axle
The subset or one or more of biological samples of droplet.
37. system according to claim 1, wherein the detection unit is arranged to so that the exciting light and described
Optical window is relatively moved simultaneously for the multiple detection zone.
38. a kind of method for droplet or biology sample detection, including:
(a) detecting system is activated, the detecting system includes
A. sample holder, it is arranged to detecting that one or more of subset or the subset of multiple droplets are raw
During thing sample, the multiple droplet is kept along single plane;
B. detection unit, including:(i) at least one excitaton source, it is arranged to guide exciting light in the single plane into
Multiple detection zones in given detection zone, and (ii) fluorescence detector, it is arranged in the given detection zone
The subset or one or more of biological samples of the multiple droplet are detected in domain along optical window;
C. at least one actuator, it is arranged to make the optical window relatively move along the multiple detection zone;With
And
(b) using at least one described actuator, so as to when the multiple droplet along the single plane adjacent to the sample
During product supporter so that the optical window is relatively moved along the multiple detection zone, wherein the relative movement will be described
Optical window is positioned in the given detection zone,
(c) exciting light is guided into the given detection zone using at least one described excitaton source;And
(d) detect the multiple small in the optical window in the given detection zone using the fluorescence detector
The subset or one or more of biological samples of drop.
39. the method according to claim 38, further comprises that there is provided adjacent to the sample holder before (b)
The multiple droplet.
40. the method according to claim 38, wherein one or more of biological samples include DNA
(DNA) molecule.
41. the method according to claim 38, wherein one or more of biological samples are included in template nucleic acid molecule
The nucleic acid amplification product of the nucleic acid amplification reaction of upper progress.
42. method according to claim 41, further comprises before (b) so that the template nucleic acid molecule experience foot
To carry out the condition of the nucleic acid amplification reaction.
43. method according to claim 42, wherein when the multiple droplet is adjacent to the sample holder, entering
The row nucleic acid amplification reaction.
44. method according to claim 42, wherein the condition is included the temperature of the multiple droplet multiple
Circulated between at least two temperature of temperature levels.
45. method according to claim 42, wherein the condition includes maintaining the temperature of the multiple droplet
Within given temperature or given temperature range.
46. the method according to claim 38, further comprises at least one described actuator of guiding, so that described
Each detection zone along the multiple detection zone of optical window in order is relatively moved.
47. the method according to claim 38, further comprises that (i) uses the fluorescence detector from the multiple detection
At least one illumination correction chart picture is collected in region, and (ii) is come using at least one described illumination correction chart picture to compensate or correct
From the illumination heterogeneity of the multiple droplet in the multiple detection zone.
48. the method according to claim 38, further comprises so that the exciting light and the optical window are for institute
Multiple detection zones are stated to relatively move simultaneously.
49. the method according to claim 38, further comprises the subset or described for detecting the multiple droplet
Intensity difference in one or more biological samples.
50. the method according to claim 38, further comprises so that the optical window is relative according to priority along track
Mobile, the track includes multiple translation vectors along the multiple detection zone.
51. method according to claim 50, wherein the multiple translation vector is orthogonal to institute including first group of vector
State second group of vector of first group of vector.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710681242.5A CN107287106A (en) | 2017-08-10 | 2017-08-10 | The novel method and system of detection of nucleic acids are carried out using quantitative PCR and digital pcr |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710681242.5A CN107287106A (en) | 2017-08-10 | 2017-08-10 | The novel method and system of detection of nucleic acids are carried out using quantitative PCR and digital pcr |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107287106A true CN107287106A (en) | 2017-10-24 |
Family
ID=60104811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710681242.5A Pending CN107287106A (en) | 2017-08-10 | 2017-08-10 | The novel method and system of detection of nucleic acids are carried out using quantitative PCR and digital pcr |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107287106A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108456622A (en) * | 2018-01-26 | 2018-08-28 | 深圳市博瑞生物科技有限公司 | A kind of date storage method and device |
CN109920474A (en) * | 2019-03-14 | 2019-06-21 | 深圳市检验检疫科学研究院 | Absolute quantification method, device, computer equipment and storage medium |
CN111182972A (en) * | 2017-08-15 | 2020-05-19 | 欧姆尼奥姆股份有限公司 | Scanning device and method for detecting chemical and biological analytes |
CN111270017A (en) * | 2020-04-03 | 2020-06-12 | 深圳华因康基因科技有限公司 | Primer probe combination for detecting novel coronavirus based on digital PCR and application thereof |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1933545A (en) * | 2005-09-12 | 2007-03-21 | 佳能株式会社 | Image processing apparatus and image processing method |
JP2009118798A (en) * | 2007-11-16 | 2009-06-04 | Tokyo Medical & Dental Univ | Apparatus and method for amplifying nucleic acid, and method of culturing cell and amplifying nucleic acid |
CN103501907A (en) * | 2011-01-10 | 2014-01-08 | 伊鲁米那股份有限公司 | Systems, methods, and apparatuses to image a sample for biological or chemical analysis |
US20140045712A1 (en) * | 2010-02-12 | 2014-02-13 | Darren Roy Link | Digital analyte analysis |
CN104081207A (en) * | 2011-12-23 | 2014-10-01 | 雅培医护站股份有限公司 | Integrated test device for optical and electrochemical assays |
CN104198392A (en) * | 2014-08-13 | 2014-12-10 | 中国科学技术大学 | LED-based Multi-window and multi-path detection method of digital polymerase chain reaction PCR |
US20150017648A1 (en) * | 2013-02-22 | 2015-01-15 | Bio-Rad Laboratories, Inc. | Devices, systems and methods for thermal control of droplet detection |
CN105543073A (en) * | 2016-01-08 | 2016-05-04 | 西安交通大学 | Integrated digital nucleic acid amplification detecting system |
CN105969655A (en) * | 2015-03-10 | 2016-09-28 | 松下知识产权经营株式会社 | Method for analyzing multiple nucleic acid targets |
-
2017
- 2017-08-10 CN CN201710681242.5A patent/CN107287106A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1933545A (en) * | 2005-09-12 | 2007-03-21 | 佳能株式会社 | Image processing apparatus and image processing method |
JP2009118798A (en) * | 2007-11-16 | 2009-06-04 | Tokyo Medical & Dental Univ | Apparatus and method for amplifying nucleic acid, and method of culturing cell and amplifying nucleic acid |
US20140045712A1 (en) * | 2010-02-12 | 2014-02-13 | Darren Roy Link | Digital analyte analysis |
CN103501907A (en) * | 2011-01-10 | 2014-01-08 | 伊鲁米那股份有限公司 | Systems, methods, and apparatuses to image a sample for biological or chemical analysis |
CN104081207A (en) * | 2011-12-23 | 2014-10-01 | 雅培医护站股份有限公司 | Integrated test device for optical and electrochemical assays |
US20150017648A1 (en) * | 2013-02-22 | 2015-01-15 | Bio-Rad Laboratories, Inc. | Devices, systems and methods for thermal control of droplet detection |
CN104198392A (en) * | 2014-08-13 | 2014-12-10 | 中国科学技术大学 | LED-based Multi-window and multi-path detection method of digital polymerase chain reaction PCR |
CN105969655A (en) * | 2015-03-10 | 2016-09-28 | 松下知识产权经营株式会社 | Method for analyzing multiple nucleic acid targets |
CN105543073A (en) * | 2016-01-08 | 2016-05-04 | 西安交通大学 | Integrated digital nucleic acid amplification detecting system |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111182972A (en) * | 2017-08-15 | 2020-05-19 | 欧姆尼奥姆股份有限公司 | Scanning device and method for detecting chemical and biological analytes |
CN111182972B (en) * | 2017-08-15 | 2022-03-08 | 欧姆尼奥姆股份有限公司 | Scanning device and method for detecting chemical and biological analytes |
CN108456622A (en) * | 2018-01-26 | 2018-08-28 | 深圳市博瑞生物科技有限公司 | A kind of date storage method and device |
CN108456622B (en) * | 2018-01-26 | 2022-03-11 | 深圳市博瑞生物科技有限公司 | Data storage method and device |
CN109920474A (en) * | 2019-03-14 | 2019-06-21 | 深圳市检验检疫科学研究院 | Absolute quantification method, device, computer equipment and storage medium |
CN109920474B (en) * | 2019-03-14 | 2021-03-02 | 深圳市检验检疫科学研究院 | Absolute quantitative method, device, computer equipment and storage medium |
CN111270017A (en) * | 2020-04-03 | 2020-06-12 | 深圳华因康基因科技有限公司 | Primer probe combination for detecting novel coronavirus based on digital PCR and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107287106A (en) | The novel method and system of detection of nucleic acids are carried out using quantitative PCR and digital pcr | |
CN106811521A (en) | For the method and system of nucleic acid amplification | |
CN107287337A (en) | Novel formulation, the method and system of detection of nucleic acids are carried out using quantitative PCR and digital pcr | |
US11142790B2 (en) | Microfluidic device | |
CN103998394B (en) | Cell capture system and using method | |
CN104722342B (en) | Slip chip device and method | |
CA2858608C (en) | Sample analysis system | |
CN103620373B (en) | Using the method for analyte of interest in filter and microstructured surface detection sample | |
CN107429426A (en) | Multiple emulsion nucleic acid amplification | |
US11904310B2 (en) | High-throughput dynamic reagent delivery system | |
JP6096769B2 (en) | Filter support with phase change medium | |
Demaree et al. | An ultrahigh-throughput microfluidic platform for single-cell genome sequencing | |
CN103269787A (en) | Device and method for processing target component in tube | |
Li et al. | Integrated microfluidic reverse transcription-polymerase chain reaction for rapid detection of food-or waterborne pathogenic rotavirus | |
CN102859367A (en) | Device and method for manipulating droplets using gel-state medium | |
ES2809566T3 (en) | Methods and systems for nucleic acid amplification | |
Saleh et al. | Rapid detection of Cyprinid herpesvirus-3 (CyHV-3) using a gold nanoparticle-based hybridization assay | |
Kim et al. | On-site extraction and purification of bacterial nucleic acids from blood samples using an unpowered microfluidic device | |
WO2019143812A1 (en) | Methods of assaying for the presence of microorganisms | |
CN108801746A (en) | A kind of device of separation and enrichment body fluid components | |
JP2008289473A (en) | Nucleic acid amplification method and vessel used therefor | |
CN107109334A (en) | Apparatus and method for carrying out chemical reactions | |
US20190184402A1 (en) | Methods and systems for analyzing nucleic acids | |
Biller et al. | Isolation and characterization of cyanobacterial extracellular vesicles | |
Zimny et al. | Hydrogel droplet single-cell processing: DNA purification, handling, release, and on-chip linearization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171205 Address after: 100085 Zhongguancun development building, Zhongguancun, Haidian District, Haidian District, Beijing, two layer A211 Applicant after: COYOTE BIOSCIENCE CO., LTD. Address before: 214203 floor 4 of Building No. 4, building No. 4, Optoelectronic Industrial Park, Yixing economic and Technological Development Zone, Yixing City, Jiangsu Applicant before: Cajudi biotechnology Yixing Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171024 |
|
WD01 | Invention patent application deemed withdrawn after publication |